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INVOLVEMENT OF THE RNA POLYMERASE II-ASSOCIATED PAF1 COMPLEX 
IN TRANSCRIPTIONAL REGULATION AND 3'-END FORMATION OF snoRNAS 
 
Kathryn Elizabeth Sheldon, PhD 
University of Pittsburgh, 2005
 
Transcription elongation is an important regulatory step in the RNA polymerase II 
transcription cycle. Previous work from our laboratory and others strongly suggests that the Paf1 
complex interacts with and regulates the activity of RNA polymerase II during transcription 
elongation. Affinity purification of Paf1 revealed that it exists in a complex in vivo with Ctr9, 
Rtf1, Cdc73 and Leo1 called the Paf1 complex. To further investigate the function of the Paf1 
complex in vivo, we used a genetic approach to study the component Rtf1 and microarray 
analyses to identify Ctr9-regulated genes. Null mutations in RTF1 confer two phenotypes 
associated with defective transcription elongation, sensitivity to base analogs and the Spt- 
phenotype. To identify novel mutations in RTF1, we performed a genetic screen for rtf1 
mutations that confer conditional mutant phenotypes. We identified three new rtf1 missense 
mutations. To identify proteins that functionally interact with the Paf1 complex, we performed a 
screen for multicopy suppressors of the rtf1 mutations. This screen identified NAB3 as a 
suppressor of rtf1. Nab3 interacts with the RNA polymerase II-associated hnRNP Nrd1. 
Together, Nrd1 and Nab3 are required for efficient 3'-end formation of certain 
nonpolyadenylated RNA polymerase II transcripts, including snoRNAs. Using assays to detect 
transcriptional readthrough of snoRNA genes, we have shown that deletion of certain Paf1 
complex members causes strong defects in snoRNA 3'-end formation. By chromatin 
immunoprecipitation (ChIP) analysis, we have found that the Paf1 complex and Nab3 associate 
with snoRNA genes in vivo. In the second approach, expression analyses revealed a role for the 
Paf1 complex in directly regulating the expression of certain genes that are not transcribed 
during growth in rich media. ChIP experiments indicated that the Paf1 complex associates along 
the length of ARG1 and with the promoter region of SER3. Together, our results reinforce the 
idea that the Paf1 complex is involved in the production of mRNAs and provide evidence that 
  iv
the Paf1 complex also participates in snoRNA transcription and 3'-end formation during RNA 
polymerase II transcription. 
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 1.0  Chapter 1: Introduction 
1.1 The chromatin nature of the DNA template in Eukaryotes 
1.1.1 Organization of DNA within the nucleus 
There are several impediments to transcription in cells but none as prevalent as the 
chromatin character of the eukaryotic DNA template. Genomic DNA does not exist in isolation 
within the nucleus, rather the heritable matter exists in complex with proteins to form chromatin. 
The basic unit of chromatin structure is the nucleosome where 146 bp of DNA is wound roughly 
two times around an octamer of four conserved histone proteins (Luger and Hansen, 2005). 
Histone octamers consist of two histone H3, histone H4, histone H2A and histone H2B proteins 
(Luger and Hansen, 2005). A fifth histone protein, histone H1, is known as the linker histone and 
associates with DNA in between nucleosomes (Luger and Hansen, 2005). Several studies suggest 
a twofold symmetry for the histone octamer where two histone H2A-H2B dimers associate and 
flank a histone H3-H4 tetramer (Luger and Hansen, 2005).  
Unlike many non-histone chromosomal proteins, the histone octamer does not bind with 
sequence specificity to DNA. The nonspecific nature of the association between the components 
of the nucleosome allows for higher-order organization within the eukaryotic genome. The 
hierarchy of chromatin structural levels ranges from "beads on a string" or the 10nm fiber to 
higher levels of condensation that allows for compaction of large eukaryotic genomes (Loden 
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 and van Steensel, 2005). A model for the compaction and condensation of genomic DNA is 
through the packing, stacking and/or looping of the chromatin fiber (Luger and Hansen, 2005). 
Histone H1 plays an important role in the higher order compaction of chromatin (Bustin et al., 
2005). Importantly, regions of eukaryotic genomes can be differentially compacted; 
heterochromatin is densely compacted and contains transcriptionally silent genes and 
euchromatin is characterized by a more loosely compacted structure that is transcriptionally 
active (Fahrner and Baylin, 2003).  
Histones are small, positively charged proteins that are lysine and arginine rich. The basic 
histone octamer associates with the negatively charged phosphate backbone of the DNA 
molecule through ionic interactions as indicated by crystallographic studies (Luger and 
Richmond, 1998; Luger and Richmond, 1998). Due to the proximity of the histone proteins to 
the template, it is not surprising that they are important for the proper regulation of transcription. 
The ordered chromatin structure surrounding the promoter region 5' of genes is a potent obstacle 
to initiation of transcription as well as transcription elongation (Boeger et al., 2005; Hartzog et 
al., 2002). Micrococcal nuclease and DNase I treated nuclei have provided information regarding 
the positions of nucleosomes within the promoters of genes (Yaniv and Cereghini, 1986). In one 
example, cells grown under non-inducing conditions for PHO gene regulation demonstrate 
ordered nucleosomes over the PHO5 promoter region including the TATA box (Haswell and 
O'Shea, 1999; Steger et al., 2003). Upon induction of PHO5, a dramatic change in nucleosome 
organization occurs such that the UAS and TATA elements are exposed to transcription factors 
for initiation (Korber et al., 2004; Steger et al., 2003).   
Eukaryotic histones contain a protein motif and important functional domains that are 
conserved in eukaryotes. The so-called histone fold was identified using X-ray crystallography 
 2
 first in histones and later in the structures of other transcription factors. For example, several 
TATA binding protein (TBP)-associated factors or TAFs contain the histone fold motif (Luger 
and Richmond, 1998; Luger and Richmond, 1998). Certain TAFs heterodimerize through this 
interaction domain and these interactions are required for constituting the general transcription 
factor IID (Davidson et al., 2005). The basic structure of the histone fold motif is composed of 
three alpha helices where alpha helix 1 is linked to alpha helix 2 through loop 1 and helix 2 is 
connected to alpha helix 3 by loop 2 (Luger and Richmond, 1998; Luger and Richmond, 1998). 
Other important regions within the histone proteins are their amino terminal and carboxyl 
terminal domains. These regions of the histones are important sites for post-translational 
modifications that potentially affect histone-histone interactions within the nucleosome or 
histone-DNA associations (Peterson and Laniel, 2004). Interestingly, proteins in the prokaryotic 
domain archaea were discovered with a structure similar to the histone fold domain of eukaryotic 
histones (Sandman and Reeve, 2000). Unlike eukaryotic histones however, archaeal histone 
proteins do not possess amino terminal or carboxyl terminal extensions (Sandman and Reeve, 
2000). Comparison of the primary amino acid sequences of archaeal histones and the sequences 
of the four core histone proteins in eukaryotes strongly suggests that archaeal histones are less 
diverged from the common archaeal-eukaryotic ancestral histone protein (Sandman and Reeve, 
2000). Evidence suggests that archaeal histones form a tetrameric complex wrapped by 
approximately 80 bp of DNA rather than the octameric complex that is observed in eukaryotes 
(Sandman and Reeve, 2000). Together, analyses to date are consistent with the idea that histone 
proteins of eukaryotes and archaea bacteria shared a common precursor and one of the functions 
of this protein may have included DNA organization. 
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 The packaging of DNA has vital roles in transcription, DNA repair, DNA replication and 
cell division for organisms in all domains of life. Machinery in the cell has evolved to allow 
access to the genetic material for transcription, DNA repair and replication. The three 
predominant mechanisms used by eukaryotes to achieve access to the template are histone 
modification, incorporation of histone variants within nucleosomes, and ATP-dependent 
chromatin remodeling. In the following sections, these mechanisms will be addressed.  
1.1.2 Histone tail modifications  
Upon closer inspection of the nucleosome structure, it was evident that the amino-terminal 
tails of the octamer subunits were solvent-exposed and disordered (Luger and Richmond, 1998; 
Luger and Richmond, 1998). A number of studies had revealed that the amino terminal tails of 
the individual histones could be post-translationally modified with a number of moieties 
including, acetyl, methyl, phosphate and ubiquitin (Wu and Grunstein, 2000). More recent 
evidence clearly demonstrated that these modifications do occur in vivo and that they are 
physiologically relevant for a number of DNA related processes, including transcription (Wu and 
Grunstein, 2000). The addition of a phosphate group to histones has implications for 
transcription and cell division (Nowak and Corces, 2000; Nowak and Corces, 2004). 
Specifically, histone H3 phosphorylation at serine 10 may be involved in transcriptional 
activation (Nowak and Corces, 2000). In addition, histone H3 serine 10 phosphorylation 
correlates with chromatin condensation that is required for proper segregation of chromosomes 
in mitosis and meiosis in metazoans (Nowak and Corces, 2000; Nowak and Corces, 2004). 
Acetylation of histones at promoters by histone acetyltransferases (HATs) often correlates with 
transcriptional activity (Kingston and Narlikar, 1999). In contrast, removal of the acetyl group 
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 from histones by histone deacetylases (HDACs) at the promoter correlates with reduced levels of 
transcription (Kingston and Narlikar, 1999). HDACs are also involved in the formation of 
heterochromatin. For example, the Saccharomyces cerevisiae (S. cerevisiae) HDAC Hda1 is 
required for silencing chromatin near telomeres (Rundlett et al., 1996). The acetylation state of 
histones and therefore the transcriptional activity of genes, can be regulated by the activity of 
HATs and HDACs (Kingston and Narlikar, 1999). In addition, the post-translational addition of 
methyl groups to histone H3 at lysine 4 (K4) is associated with active or recently transcribed 
genes in S. cerevisiae (Briggs et al., 2001; Zheng et al., 2004). Histone H3 K4 is also methylated 
in human cells by the human counterpart of the Set1 histone methyltransferase in yeast (Tenney 
and Shilatifard, 2005). Interestingly, methylation of histone H3 in human cells is incompatible 
with histone H3 K9 methylation (Nishioka et al., 2002). In metazoans hypermethylated histone 
H3 K9 is associated with heterochromatin (Stewart et al., 2005). The methylation of histones, 
unlike the acetyl or phosphate modifications, was generally thought to be a stable modification 
since no histone demethylases had been identified and analyses suggested that once transcription 
ceased it took many generations to dilute away the epigenetically marked histones (Ng et al., 
2003). However, a protein named LSD1 exhibited the long sought after histone demethylase 
activity and was found associated within transcriptional repressor complexes that also contained 
HDACs (Lee et al., 2005; Shi et al., 2005). Interestingly, LSD1 is conserved from 
Schizosaccharomyces pombe to humans but is not present in S. cerevisiae (Shi et al., 2004). 
Histone monoubiquitylation has also emerged as a histone modification associated with 
transcription, specifically the monoubiquitylation of histone H2B on K123 (Ng et al., 2003; Ng 
et al., 2002; Wood et al., 2003). Notably, ubiquitylation of histone H2B K123 is required for 
subsequent histone H3 K4 and H3 K79 methylation (Ng et al., 2002). Nakayama and colleagues 
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 have proposed a histone code that is conserved in eukaryotes and establishes epigenetic 
inheritance through the sequential modification of histones (Nakayama et al., 2001). The histone 
code is constantly evolving as novel sites of histone modification are being identified and their 
functions in DNA metabolism investigated.  
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Figure 1: Post-translational histone modifications  
Known or suspected histone modifications are mapped to the amino terminal domains of the four 
histones. This diagram was organized based on a similar figure from Jaskelioff and Peterson 
(2003). Histones H2A, H2B, H3, and H4 and their amino terminal (NH3) histone tails are 
indicated. Acetylated, methylated, ubiquitylated and phosphorylated amino acid residues are 
indicated by yellow lollipops, green rectangles, black diamonds, and gray triangles, respectively. 
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1.1.3 Histone variants  
The many post-translational modifications on histones and their roles in the histone code 
are further complicated by the discovery of variant histone proteins that can replace the canonical 
histones within nucleosomes in certain regions of the genome (Palmer et al., 1987). Histone H3 
variants include H3.3 and CENPA (Fretzin et al., 1991; Palmer et al., 1987). Histone H3 is 
replaced by H3.3 in Drosophila in a replication-independent manner at transcriptionally active 
genes (Ahmad and Henikoff, 2002). CENPA replaces histone H3 within the nucleosomes of the 
centromere (Palmer et al., 1987). There are several variants of histone H2A, which include 
H2AX, H2A.Z, macroH2A, and H2ABBD as reviewed in (Redon et al., 2002; Sarma and 
Reinberg, 2005). Yeast contains the H2AX and H2A.Z versions of H2A with H2AX as the major 
constituent of nucleosomes (Downs et al., 2000). The histone H2A variant H2A.Z or Htz1 in S. 
cerevisiae replaces H2A at transcriptionally active genes that border heterochromatin-like areas 
in the genome (Meneghini et al., 2003; Zhang et al., 2004). Recently, a genome-wide study 
determined Htz1-containing nucleosomes localize within the promoters of genes transcribed by 
RNA polymerase II (Zhang et al., 2005). In contrast to earlier analyses, which indicated Htz1 is 
required to establish heterochromatin-like border near the telomeres (Zhang et al., 2004), Htz1-
containing nucleosomes are located throughout the entire genome (Zhang et al., 2005). Zhang 
and colleagues have demonstrated that Htz1-containing nucleosomes are less stably associated 
with chromatin than canonical nucleosomes and this property allows for Htz1-containing 
nucleosomes to be subject to transcription-induced removal or loss, which correlates with 
increased capacity for transcriptional activity (Zhang et al., 2005). Taken together, chromatin 
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 modification and histone variant substitution contribute to chromatin structure and participate in 
regulating transcription. 
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Figure 2: Histone H3 and Histone H2A variants 
Histone H3 and Histone H2A and their variants adapted from Sarma and Reinberg (2005). The 
conserved histone fold domain (HFD) and the amino and terminal tails are diagrammed in this 
cartoon. Top panel features histone H3 and its variants. The histone H3.3 variant has proposed 
roles in transcriptional activity while histone variant CENPA functions in kinetochore assembly 
(Ahmad and Henikoff, 2002; Van Hooser et al., 2001). H3.3 differs from the canonical H3 with 
the yellow highlighted residues, one in the amino terminal tail and three in the HFD. The amino 
terminal region of CENPA differs from the amino terminal tail of H3 and other core histone 
proteins and is diagrammed by a lighter color of orange. The light blue rectangle in the CENPA 
HFD directs CENPA to centromeric DNA. Bottom panel exhibits the histone H2A variants that 
differ greatly from H2A within their carboxyl terminal domains. H2AX participates in DNA 
repair and recombination, H2A.Z plays a role in gene expression and chromosome segregation, 
macroH2A takes part in X chromosome inactivation, and H2ABBD may be involved in 
transcriptional activation as reviewed in (Redon et al., 2002; Sarma and Reinberg, 2005). The 
H2AX variant of H2A is the predominant form of H2A in S. cerevisiae while the minor form is 
H2A.Z (Downs et al., 2000). MacroH2A contains a carboxyl terminal extension as compared to 
canonical H2A. H2ABBD contains an amino terminal tail that is distinctly different from H2A 
and lacks residues that are known sites of modification in H2A (Figure 1).  
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1.1.4 Chromatin remodeling factors 
An evolutionarily conserved method to reveal transcriptional regulatory sequences within 
the chromatinized template is the utilization of ATP-dependent chromatin remodeling factors. As 
the name of this category implies, these factors use the energy of ATP hydrolysis to physically 
move or reposition nucleosomes to expose the promoter region to the general transcription 
machinery (Kingston and Narlikar, 1999; Lusser and Kadonaga, 2003; Studitsky et al., 2004). 
Nucleosome positioning has been well studied for the PHO5 gene of S. cerevisiae (Haswell and 
O'Shea, 1999) and genome-wide approaches are being used to characterize the positions of 
nucleosomes in yeast (Yuan et al., 2005). These studies could provide insight into which 
chromatin remodeling complexes are important for the regulation of certain genes under different 
conditions. What will make these analyses difficult is the observed redundancy across these 
different remodeling complexes since not all chromatin remodeling complexes are essential for 
viability (Tsukiyama et al., 1999). Chromatin remodeling complexes relavent to transcription in 
yeast will be discussed in subsequent sections. 
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1.2 Initiation of transcription by RNA polymerase II  
1.2.1 Elements of the RNA polymerase II promoter 
DNA sequence elements within promoters instruct the general transcription factors and 
RNA polymerase II where to initiate transcription. The transcript is initiated just 20 to 30 bp 
downstream of the TATA box in higher eukaryotes and viral protein coding genes while the 
TATA box lies 40 to 120 bp upstream of the initiation site in S. cerevisiae as reviewed in (Smale 
and Kadonaga, 2003; Struhl, 1989). This TATA box was named after its consensus sequence, 
which in yeast is TATA(A/T)A(A/T)N, where N is any nucleotide (Bucher, 1990). The TATA 
element is important since it is responsible for directing the polarity of transcription (Kim et al., 
1993; Kim et al., 1993; O'Shea-Greenfield and Smale, 1992; Xu et al., 1991). The initiator (Inr) 
element of metazoans is another conserved sequence involved in transcription start site selection 
(Corden et al., 1980; Javahery et al., 1994; Smale and Baltimore, 1989). In fact, transcription 
initiates within the Inr element (Smale et al., 1990). Together, these core promoter elements 
direct the polarity of transcription (Emami et al., 1997; Smale et al., 1990). Another promoter 
element involved in basal transcription is the transcription factor IIB recognition element (BRE) 
(Lagrange et al., 1998). The BRE lies upstream of the TATA box at some eukaryotic promoters 
as reviewed in (Smale and Kadonaga, 2003). A core promoter element identified downstream of 
the transcription start site is the downstream promoter element (DPE) of higher eukaryotes 
(Kutach and Kadonaga, 2000). This element usually exists within TATA-less promoters and 
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 functions together with the Inr to recruit transcription factors (Kutach and Kadonaga, 2000). 
Notably, not all RNA polymerase II transcribed genes will contain all four components of the 
core promoter mentioned here, rather these genes will contain different combinations of these 
elements as reviewed in (Smale and Kadonaga, 2003). 
In addition to the core promoter other specific DNA sequences are required for regulating 
transcription as reviewed in (Smale and Kadonaga, 2003). Upstream activating sequences (UAS) 
and upstream repressor sequences (URS) often reside upstream of the core promoter elements. 
These proximal regulatory sequences are recognized by specific factors that activate or repress 
transcription of the adjacent gene. Furthermore, there are transcription enhancer elements that 
can be located kilobases upstream or downstream of the relevant gene. Interaction between either 
the UAS/URS and/or enhancer elements with core promoter elements is essential for the control 
of transcription. This interaction is mediated by the RNA polymerase II general transcription 
machinery, gene-specific regulatory proteins and accessory factors. 
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Figure 3: Idealized eukaryotic RNA polymerase II promoter 
An idealized version of an RNA polymerase II promoter adapted from Smale and Kadonaga 
(2003). The elements required for transcription are depicted relative to the transcription start site 
(arrow) and are not drawn to scale. The core promoter elements, BRE, TATA box, Inr, and DPE 
sequence are indicated by rectangles. Surrounding the core promoter elements are sequences 
required for transcriptional regulation including the UAS/URS upstream of the core promoter 
and an enhancer element depicted downstream of the core promoter. 
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1.2.2 The RNA polymerase II machine 
RNA polymerase II is intricately assembled and is subject to many levels of regulation 
important for proper transcription of protein-coding genes and to small nuclear and small 
nucleolar transcripts. The twelve subunits of RNA polymerase II comprise an enzyme complex 
of about 0.5MDa in yeast as reviewed in (Cramer, 2004). All subunits are absolutely essential for 
the transcription of almost all genes as reviewed in (Cramer, 2004). Together they form a large, 
multifunctional enzyme responsible for reading the DNA template and incorporating the 
appropriate incoming nucleotide into the growing RNA chain, backtracking along the template 
where necessary to allow for transcript cleavage using the intrinsic nuclease activity of the 
enzyme, to create proper RNA molecules (Zhang et al., 2003). Interestingly, RNA polymerase II 
shares three subunits, Rpb5, Rpb6 and Rpb8, with RNA polymerases I and III (Woychik et al., 
1990). X-ray crystallographic studies indicate that Rpb5, Rpb6 and Rpb8 associate with the 
largest subunit of RNA polymerase II as shown in Figure 4. Together, Rbp1 and Rbp2 form the 
bulk of the enzyme. A carboxyl terminal extension on Rpb1, the largest subunit of RNA 
polymerase II, consists of heptapeptide repeats that are subject to differential phosphorylation by 
specific protein kinases during initiation and elongation phases of transcription (Komarnitsky et 
al., 2000). The post-translational phosphorylation modification and its significance will be 
discussed in further detail in subsequent sections. The second largest subunit of RNA polymerase 
II has been implicated in transcriptional efficiency and processivity during transcriptional 
elongation (Mason and Struhl, 2005; Shaw and Reines, 2000). In addition, in yeast the Rpb4-
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 Rpb7 submodule dissociates from the RNA polymerase II assembly (Tan et al., 2003). Rpb7 has 
been proposed to participate in transcript termination due to association with a transcription 
termination factor (Mitsuzawa et al., 2003). Interaction and communication within the 
constituents of RNA polymerase II is important for the function of the machine in transcription. 
Furthermore, the surfaces, pores and crevices of RNA polymerase II allow for interaction of 
RNA polymerase II with incoming nucleotides, the DNA template that exists in close association 
with nucleosomes, and transcription regulatory factors (Kettenberger et al., 2004). 
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Figure 4: Two-dimensional representation of RNA polymerase II 
Cartoon of RNA polymerase II adapted from Cramer (2004). This diagram represents a view 
from the top of the enzyme and serves to provide a map for the physical associations among and 
between the twelve subunits of RNA polymerase II. The individual subunits are designated 
Rpb1-12. The arrow indicates upstream DNA entering the RNA polymerase II active site. The 
Rpb4-Rbp7 submodule that dissociates from RNA polymerase II under certain conditions is 
shaded gray. 
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1.2.3 Regulation of transcription by phosphorylation of the carboxyl terminal domain 
(CTD) of the largest subunit of RNA polymerase II 
RNA polymerase II is unique among RNA polymerases involved in eukaryotic 
transcription. Specifically, the largest subunit of RNA polymerase II contains a consensus 
heptapeptide repeat sequence of YSPTSPS at the C-terminal domain (CTD) that becomes 
differentially phosphorylated during the transcription cycle (Cho et al., 2001; Komarnitsky et al., 
2000). The number of repeats varies from organism to organism with 26 repeats in 
Saccharomyces cerevisiae and 52 repeats in humans (Palancade and Bensaude, 2003). Moreover, 
the nature of the CTD repeat sequence is degenerate with respect to the number of consensus 
versus nonconsensus repeats in the CTD across eukaryotes (Palancade and Bensaude, 2003). 
Studies on CTD phosphorylation appear to agree that Ser-5 of the heptad repeat is 
phosphorylated by a cyclin-dependent kinase associated with the general transcription machinery 
at the 5' region of the gene during initiation (Cho et al., 2001; Komarnitsky et al., 2000). Further, 
as RNA polymerase II travels toward the 3' end of the gene Ser-2 becomes preferentially 
phosphorylated (Cho et al., 2001; Komarnitsky et al., 2000). The correlation between CTD 
phosphorylation state and the phase of the transcription cycle suggests these modifications may 
regulate different stages of transcription (Palancade and Bensaude, 2003). 
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Figure 5: Phosphorylation of the CTD of RNA polymerase II correlates with stages in the transcription cycle 
The phosphorylation state of RNA polymerase II changes depending on the phase of the 
transcription cycle. The bent arrow indicates the site of transcription initiation. RNA polymerase 
II is depicted by a yellow rectangle with a yellow CTD. The RNA transcript is shown in navy. 
The heptad repeat is indicated with the amino acid residues in gray. Serine -2 or -5 are 
predominantly phosphorylated when depicted in black with a phosphate group, depicted by an 
orange circle, attached. Initiation of transcription begins when hypophosphorylated RNA 
polymerase II is recruited to the promoter. The transition between initiation and elongation is 
coincident with phosphorylation of Ser-5 within the CTD.  As elongation proceeds 
phosphorylation of Ser-5 becomes less prevalent while phosphorylation of Ser-2 becomes 
increasingly predominant.  
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1.2.4 Basal transcription: Assembling the preinitiation complex 
The basal components of RNA polymerase II transcription include several factors 
conserved in eukaryotes. Prior to entering the transcription cycle, RNA polymerase II must be 
recruited to the promoter of the gene. RNA polymerase II molecules that are hypophosphorylated 
on their CTD are recruited to the transcription preinitiation complex (PIC) that is assembled at 
gene promoters (Bensaude et al., 1999; Lin et al., 2002; Lin et al., 2003). Components of the 
transcription machinery associate with the template in order to establish a "launch pad" for the 
RNA polymerase II holoenzyme as reviewed in (Hampsey, 1998). The founding member of the 
PIC, is TBP (Buratowski et al., 1989). TBP is a small protein that binds within the minor groove 
of DNA with high sequence specificity for the TATA element causing an 80° bend within the 
minimal promoter element just upstream of the gene to be transcribed (Lee et al., 1991; Wu et 
al., 2001). A unique feature of TBP is that it is essential for transcription by RNA polymerases I 
and III in addition to its role in RNA polymerase II transcription (Kim and Roeder, 1994). A 
protein with homology to TBP referred to as TBP-related factor (TRF) identified in metazoans is 
expressed in certain cells or tissue types and may be important for maintaining cell identity by 
controlling gene expression (Hansen et al., 1997). Moreover, TRF can replace TBP in basal 
transcription assays in vitro and TRF can replace TBP for activated transcription in vivo (Hansen 
et al., 1997). Archaeal systems also contain a TBP homolog that together with archaeal 
homologs of RNA polymerase II and transcription factor IIB (TFIIB) are required for 
transcription (Bell and Jackson, 2001; Bell et al., 2001). As observed for the conservation of 
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 histone proteins in archaea and eukaryotes, the sequence similarity of TBP homologs and their 
conserved roles in transcription emphasize their importance in the cell. 
The general transcription factors assemble around TBP at the promoter to form the PIC to 
recruit RNA polymerase (Qiu et al., 2004). Conserved TBP-associated factors (TAFs) in 
complex with TBP form the general transcription factor TFIID (Chen and Hampsey, 2002). 
TAFs are also associated with the coactivator complex SAGA (Spt-Ada-Gcn5 acetyltransferase) 
and participate in regulating transcription initiation (Lee et al., 2000). The transcription factor 
TFIIA associates with TBP bound at the TATA box (Biswas et al., 2004). TFIIA was originally 
identified as a general transcription factor (Matsui et al., 1980; Reinberg et al., 1987). However, 
more recent studies suggest the activity of TFIIA is more accurately described as a 
transcriptional coactivator that interacts with TFIID (Biswas et al., 2004). TFIIB binds DNA in 
association with TBP at the core promoter to form the TFIIB-TBP-DNA ternary complex 
(Nikolov et al., 1995). Order of addition experiments in in vitro reconstitution assays suggested 
that once TFIIA and TFIIB have associated with TFIID, TFIIB makes contact with RNA 
polymerase II and TFIIF (Buratowski et al., 1989; Fang and Burton, 1996; Ha et al., 1993; Lei et 
al., 1998) and reviewed in (Hampsey, 1998).  RNA polymerase II enters the assembling PIC 
associated with TFIIF (Lei et al., 1998). The roles of TFIIF include suppressing nonspecific 
DNA binding and stabilization of the PIC (Flores et al., 1989; Killeen and Greenblatt, 1992). 
Another role for TFIIF includes participation in DNA melting at the PIC in association with 
TFIIE and TFIIH (Robert et al., 1998). TFIIE enters the PIC after RNA polymerase II and TFIIF 
(Buratowski et al., 1989). One possible role for TFIIE may be to recruit TFIIH (Flores et al., 
1992). In addition, TFIIE is important for DNA melting (Holstege et al., 1995; Robert et al., 
1996). Association of TFIIH with the PIC leads to an opening of the DNA at the promoter likely 
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 through the DNA helicase activity of TFIIH (Kim et al., 2000). The Kin28 subunit of TFIIH also 
possesses ATPase and cyclin-dependent kinase activity that is regulated by the associated cyclin 
Ccl1 (Valay et al., 1993). Importantly, the target of the kinase activity is the Ser-5 residue within 
the heptad repeat of the CTD (Liu et al., 2004). Compared to other components of the PIC, 
TFIIH is unique since it is also involved in nucleotide excision repair as reviewed in (Lee and 
Young, 2000). The basal transcription machinery is a complex array of proteins that assemble 
into a protein scaffold to recruit RNA polymerase II and function in transcription initiation. 
Following PIC assembly, DNA melting and promoter clearance are essential for productive 
transcription. DNA within the promoter must be opened in order for transcription initiation to 
occur since opening leads to the formation of a transcription bubble. TFIIF may play an 
important role in DNA melting since it is required to wrap DNA around the PIC potentially 
increasing torsional stress in the template (Robert et al., 1998). The zinc ribbon motif of TFIIE is 
implicated in contacting promoter DNA and may be required in the formation of or maintenance 
of the DNA complex (Qian et al., 1993). This TFIIE activity may be stimulated by TFIIH since 
TFIIH has helicase activity. Once DNA is open, transcription initiation may begin by 
incorporating nucleotides according to the DNA template. The growing RNA chain forms an 
RNA-DNA hybrid within the active site of RNA polymerase II (Kettenberger et al., 2004). In 
vitro, many transcripts initiated by RNA polymerase II are released before reaching full length. 
This process is referred to as abortive initiation. To overcome abortive initiation and arrest, 
initiating RNA polymerase II must become competent for promoter clearance. Competency for 
promoter clearance depends on associations between the template and RNA polymerase II, the 
length of the nascent transcript, and availability of necessary cofactors such as ATP, as reviewed 
in (Dvir, 2002). The more stable associations between RNA polymerase II and the template the 
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 more likely RNA polymerase II is to proceed into productive transcription. The stability of RNA 
polymerase II with the template increases with increasing length of the transcript since the 
growing chain of nucleotides can make increasing contacts within RNA polymerase II as 
reviewed in (Dvir, 2002). Once promoter clearance occurs, initiating RNA polymerase II is 
competent to transition into the elongation phase of transcription.  
1.2.5 Gene-specific transcriptional activators 
Activated RNA polymerase II transcription requires association of RNA polymerase II with 
the mediator complex. Together, RNA polymerase II and the mediator complex form the RNA 
polymerase II holoenzyme (Li et al., 1995). Mediator is an evolutionarily conserved complex 
that aids in recruitment of RNA polymerase II through transcriptional activators (Wang et al., 
2005). The role of mediator and other transcriptional coactivators will be described in section 1. 
2. 5. 2. in the context of transcriptional activators. 
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Table 1: Proteins and protein complexes important for transcriptional regulation  
 
 
Yeast Complex/Protein Proposed Function(s) 
SBF cell cycle specific transcriptional activator 
MBF cell cycle specific transcriptional activator 
SAGA coactivator; histone acetyltransferase activity 
SLIK coactivator; histone acetyltransferase activity 
Ctk1 Ser-2 specific CTD kinase 
Fcp1 Ser-2 specific CTD phosphatase 
TREX recombination; transcription elongation; couples elongation to mRNA export 
FACT transcription elongation; histone chaperone activity 
Spt6 transcription elongation; chromatin assembly 
Spt4-Spt5 transcription elongation 
Elongator transcription elongation; histone acetyltransferase activity 
The Paf1 complex transcription elongation; recruits histone modifiers; 3'-end formation 
Dst1/Ppr2 (TFIIS) transcription elongation; stimulates transcript cleavage 
SWI/SNF nucleosome remodeling activity; nucleosome sliding; octamer transfer 
RSC nucleosome remodeling activity; ATP-dependent DNA translocation  
ISW1 nucleosome remodeling activity; nucleosome sliding 
Chd1 nucleosome remodeling activity; chromatin assembly 
INO80 nucleosome remodeling activity; nucleosome displacement; nucleosome 
sliding  
SWR1 nucleosome remodeling activity; exhanges nucleosomal H2A with H2A.Z  
SET1/COMPASS methyltransferase; methylates histone H3 on K4 
Set2 methyltransferase; methylates histone H3 on K36 
Rad6-Bre1 ubiquitin conjugase and ubiquitin ligase; monoubiquitylates histone H2B on 
K123 
See accompanying text for additional details. 
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 1.2.5.1 Transcriptional activators  
An important class of transcription factors is comprised of gene-specific transcriptional 
activators. Examples of these transcription factors exist across the three domains of life. These 
transcriptional activators are themselves activated under diverse physiological stimuli in order to 
execute a transcriptional plan required to meet the needs of the cell. The stimuli could be cell 
autonomous such as cell cycle regulation or cell non-autonomous for instance as a response to 
nutrient availability. Transcriptional activation occurs through a general mechanism where the 
following steps occur. For example, the transcriptional activator binds a specific DNA sequence 
within the promoter of the activator-dependent gene. Upon activator binding, components of the 
general transcription machinery are recruited to the promoter for high levels of activated 
transcription. TFIID and RNA polymerase II holoenzyme are recruited to promoters subsequent 
to activator binding at the UAS. 
Regulation of the cell cycle is important for asexual reproduction in prokaryotic and 
eukaryotic organisms as well as for the proper growth and development of multicellular 
organisms. In S. cerevisiae, the transcriptional activator SBF is integrally involved in regulating 
the transcription of genes during the G1 to S phase transition of the cell cycle as reviewed in 
(Wittenberg and Reed, 2005). SBF is a heterodimeric activator comprised of the DNA binding 
protein Swi4 and Swi6, which is believed to regulate the activity of Swi4 (Table 1) (Koch et al., 
1993; Moll et al., 1993). A subset of the genes that contain consensus recognition sites, 
CACGAAA, in their promoter are involved in cell cycle progression and these include the G1 
cyclins CLN1 and CLN2 (Bean et al., 2005; Iyer et al., 2001). Importantly, Swi6 forms a 
complex with another DNA-binding protein Mbp1 to form MBF, a transcriptional activator 
complex that is distinct from SBF and also important for progression through the cell cycle 
 30
 (Table 1) (Iyer et al., 2001; Koch et al., 1993; Moll et al., 1993). MBF recognizes and binds to 
the consensus site ACGCGT within the promoters of genes that must be transcribed for the S 
phase of the cell cycle including genes involved in DNA synthesis (Bean et al., 2005; Iyer et al., 
2001). ChIP with antibodies specific towards SBF or MBF followed by microarray analysis 
revealed that some cell cycle regulated genes are regulated by SBF, MBF, or both transcriptional 
activators (Iyer et al., 2001). Therefore Swi4, Mbp1 and Swi6 comprise two transcriptional 
activator complexes with distinct and partially overlapping transcriptional targets important for 
progression through the cell cycle (Bean et al., 2005).  
A transcriptional activator complex analogous to SBF exists in mammalian cells (Costanzo 
et al., 2004; de Bruin et al., 2004; Wittenberg and Reed, 2005). This family of transcription 
factors are known as E2Fs and were originally identified as proteins required for the 
transcriptional activation of early region 2 (E2) of the adenovirus genome (Cam and Dynlacht, 
2003). The similarities between SBF and E2F family members are quite striking. Not only are 
the E2F family members involved in the transcriptional activation of DNA tumor viruses but 
they are also required for regulated progression through the cell cycle in mammalian cells 
through binding specific DNA sequences within the promoters of the genes they regulate (Cam 
and Dynlacht, 2003). The retinoblastoma protein (Rb) is responsible for regulating the 
transcriptional activity of E2F family members whereas Whi5 has been identified in the 
regulation of SBF function (Costanzo et al., 2004; de Bruin et al., 2004). Similar to Whi5 and 
SBF, impaired Rb function causes cells to enter S phase of the cell cycle in an E2F-dependent 
manner as reviewed in (Wittenberg and Reed, 2005). The study of DNA dependent 
transcriptional activation in yeast and mammalian systems provide a reference for learning more 
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 about the regulation of these transcription factors and their involvement in properly regulating 
the cell cycle. 
Another role for transcriptional activators is to activate the transcription of genes important 
for metabolism. There are several genes in S. cerevisiae that are repressed in rich medium and 
induced only when certain nutrients are limiting. One example is the induction of the GAL genes 
that are repressed when glucose is in the growth medium and induced when galactose is the sole 
carbon source available (Bhat and Murthy, 2001). The transcriptional activator responsible for 
GAL gene activation is Gal4 (Bhat and Murthy, 2001). Gal4 is a modular protein that is 
composed of a separable DNA binding domain containing a zinc cluster motif at the amino 
terminus that binds and recognizes a specific DNA sequence within GAL gene promoters 
(UASGAL) (Bhat and Murthy, 2001). Under noninducing conditions, Gal4 is bound to the 
UASGAL in association with Gal80, which blocks Gal4-mediated transcriptional (Bhat and 
Murthy, 2001). During inducing conditions Gal3 enters the nucleus and disrupts interactions 
between Gal4 and Gal80 (Bhat and Murthy, 2001). Gal3-Gal80 interaction at the UASGAL 
elements results in the activation of the GAL genes allowing recruitment of the general 
transcription machinery via the separable carboxyl terminal activation domain of Gal4 (Bhat and 
Murthy, 2001).  
1.2.5.2 Transcriptional coactivators 
A class of proteins called transcriptional coactivators is required to establish contacts 
between components of the general transcription machinery and activators. This class of 
transcription factors includes SAGA, the Srb/Mediator complex, TFIIA, and TAFs. As 
mentioned previously, TFIIA was initially identified as a general transcription factor. The TAFs 
associate closely with TBP and influence TBP-TATA box associations through interactions with 
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 transcriptional activators (Dynlacht et al., 1991; Wu and Chiang, 2001). But the two most 
relevant coactivators for this discussion are the Srb/Mediator complex, now commonly referred 
to as Mediator, and SAGA/SLIK (Table 1). 
The Mediator is functionally linked to activated transcription initiation by RNA polymerase 
II. A genetic screen using truncation mutations within the CTD of RNA polymerase II identified 
extragenic suppressors that reversed the phenotypes of the truncation mutants, which included 
cold and temperature sensitivity, and these genes were designated as SRB (suppressor of RNA 
polymerase B) genes (Nonet and Young, 1989). Complete deletion of the CTD from RNA 
polymerase II is lethal in yeast cells even though the CTD is not required for transcription in 
some in vitro systems (McCracken et al., 1997; Meininghaus et al., 2000). Shortly after the 
identification of SRB genes, a mediator complex was proposed as an activity within a partially 
purified yeast extract that reduced activator induced interference (squelching) in RNA 
polymerase II transcription assays (Kelleher et al., 1990). Purification of this mediator complex 
revealed the presence of the SRB gene products (Myers et al., 1998). Convergence of genetic and 
biochemical studies on Mediator resulted in the observations that Mediator is a multisubunit 
complex important for facilitating transcriptional activation by relaying information from 
transcriptional activators to RNA polymerase II and that Mediator is conserved in eukaryotes 
(Gustafsson and Samuelsson, 2001; Kim et al., 2002; Li et al., 1995; Spahr et al., 2001) 
SAGA (Spt-Ada-Gcn5 acetyltransferase) is a multifunctional coactivator complex that is 
conserved in eukaryotes. Components of SAGA were isolated as suppressors of Ty insertions in 
the promoters of yeast genes as reviewed in (Winston, 1992). Mutations within SPT genes 
coding for subunits of SAGA exhibited Spt- phenotypes similar to mutations in SPT15, which 
codes for TBP (Winston, 1992). Genome wide high density oligonucleotide array analyses 
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 indicated that SAGA and the TAFs might function redundantly as coactivators at certain genes 
since a subset of the yeast genome was regulated by both coactivators (Lee et al., 2000). SAGA 
is recruited to the promoters of genes by transcriptional activators and this association facilitates 
the association of TBP at the promoter, which is a rate limiting step in the formation of the PIC 
(Dudley et al., 1999). A SAGA-like complex (SLIK or SALSA) was recognized as an alternative 
SAGA complex with roles in transcriptional activation. SLIK/SALSA contains a truncated 
version of the SAGA integral component Spt7 and lacks Spt8 (Sterner et al., 2002; Wu and 
Winston, 2002). Specific subunits of SAGA may be important for determining if SAGA will act 
either as an activator or repressor since certain components of SAGA are required for the 
repression of a subset of yeast genes (Belotserkovskaya et al., 2000). Two histone modifying 
enzymes are components of SAGA: the Gcn5 HAT which acetylates histone H3 K14 and the 
ubiquitin specific protease Ubp8, which deubiquitylates histone H2B K123 (Henry et al., 2003; 
Pray-Grant et al., 2005; Tse et al., 1998).  
1.2.5.3 General repressors of transcription  
General transcriptional repressors like Mot1 and the components of negative cofactor 2 
(NC2) regulate transcription by binding to TBP and preventing TBP association with the 
promoter or dissociating TBP already bound to the promoter. Also of interest, transcriptional 
repressors like Mot1 of yeast have been implicated not only in transcriptional repression but in 
transcriptional activation (Andrau et al., 2002; Dasgupta et al., 2005; Dasgupta et al., 2004). 
Mot1 is a member of the SWI/SNF family and contains a DNA-dependent ATPase domain as 
reviewed in (Pugh, 2000). The proposed mechanism of Mot1 function uses the hydrolysis of 
ATP to drive the dissociation of TBP from the promoter (Pugh, 2000). Expression profiles of 
temperature sensitive mot1 cells identified transcripts that were either up-regulated or down-
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 regulated in cells with impaired Mot1 function (Andrau et al., 2002). The potential Mot1 target 
genes were analyzed further by ChIP and indicated direct involvement of Mot1 in the activation 
of a subset of genes (Andrau et al., 2002). Another conserved transcriptional corepressor is 
negative cofactor 2 (NC2), which is composed of Bur6 and Ncb2. BUR6 (bypass upstream 
activating sequence requirements) was isolated in a screen for  mutations that bypass the 
requirement for upstream activating sequences in SUC2 transcription, indicating a role for Bur6 
in repressing transcription of SUC2 (Prelich and Winston, 1993). Interestingly, another mutation 
that also caused a bur phenotype was uncovered in MOT1 (allelic with BUR3) (Prelich, 1997). 
Subsequent characterization of Bur6 revealed amino acid sequence similarity with the 
mammalian transcriptional repressor DRAP1 or NCα (Prelich, 1997). NC2 binds to TBP at the 
promoter and prevents the assembly of the PIC (Pugh, 2000). However, like Mot1, a subset of 
genes require the activity of NC2 for their expression (Cang and Prelich, 2002). Taken together, 
this evidence indicates that the line between transcriptional activators and repressors is quite 
blurred. A rationalization for the observed positive effect of these transcriptional repressors on 
transcription may derive from their dependence on regulatory sequences within the promoters of 
these genes or on different complements of regulatory factor-associated proteins. 
1.2.5.4 Gene specific transcriptional repressors 
In contrast to transcriptional activators, the role of many transcriptional repressors is to 
antagonize the formation of the PIC. Similar to gene-specific transcriptional activators, 
transcriptional repressor proteins limit the transcription of certain genes based on current 
physiological requirements. The regulation of genes involved in various biosynthetic pathways is 
under tight transcriptional control and these genes are only expressed in response to depletion of 
certain nutrients in the growth medium. For example, the Mig1 transcriptional repressor binds 
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 within the promoters of glucose-repressed genes when cells are grown in medium containing 
glucose (Lundin et al., 1994). The ArgR/Mcm1 repressor complex is involved in the repression 
of genes in the arginine biosynthesis pathway (Turner et al., 2002; Yoon et al., 2004). 
Transcriptional repressors act to block assembly of the PIC.  Transcriptional repressor proteins, 
their roles in repression, and possible roles in activation will be discussed below.  
The Mig1 transcriptional repressor exerts its influence through binding to specific DNA 
sequences within the promoters of genes that are glucose repressed. The function of Mig1 is 
regulated in response to limiting glucose. In the presence of glucose, Mig1 is bound to regulatory 
elements within genes and is responsible for recruiting the Ssn6-Tup1 corepressor complex 
(Schuller, 2003). Ssn6-Tup1 association may work through chromatin remodeling or histone 
deacetylation to interfere with the formation of the PIC (Edmondson et al., 1996; Watson et al., 
2000; Zhang et al., 2004). Repression by Mig1 is relieved in response to glucose by a mechanism 
involving phosphorylation by the Snf1 protein kinase (Ostling and Ronne, 1998). 
Phosphorylation of Mig1 causes it to dissociate from its DNA regulatory sequence and 
translocate out of the nucleus as reviewed in(Schuller, 2003). 
Expression of genes in the arginine biosynthetic pathway in S. cerevisiae requires 
transcriptional repressors to ensure that ARG1 and other genes are properly regulated in response 
to arginine availability. The transcriptional repressor responsible for regulating ARG1 expression 
is ArgR/Mcm1, which is composed Arg80, Arg81, Arg82 and Mcm1. ArgR/Mcm1 binds to two 
arginine control elements (ARC) in the promoter of ARG1 (Ricci et al., 2002; Yoon et al., 2004). 
Genes in the arginine biosynthetic pathway are positively regulated by the transcriptional 
activator Gcn4 (Hinnebusch, 1985). Surprisingly, the Gcn4 activator participates in recruiting the 
ArgR/Mcm1 repressor to ARCs within ARG1 for repressor activity (Yoon et al., 2004). ARG1 
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 transcription requires other transcription factors for proper regulation. For example, components 
of the SAGA coactivator complex are important for the repression of ARG1 (Ricci et al., 2002). 
ChIP analysis using antibodies against acetylated histone H3 revealed that histone H3 acetylation 
at ARG1 was dependent on the HAT Gcn5 of SAGA (Ricci et al., 2002). These results are in 
agreement with Northern analyses that demonstrated ARG1 transcripts were derepressed in the 
absence of SAGA components when cells were grown in rich medium (Ricci et al., 2002). These 
observations are consistent with the result that the Rad6 ubiquitin conjugase is also involved in 
repressing ARG1 when cells are growing in rich medium (Turner et al., 2002). Rad6 and SAGA 
are required to prevent TBP binding at the TATA box of ARG1 (Ricci et al., 2002; Turner et al., 
2002). This is noteworthy for SAGA since it has been classified as a transcriptional coactivator 
and in this case it is acting more like a corepressor. Moreover, substitution of the Rad6 target 
histone H2B with a form that cannot be modified by Rad6, also results in derepression of ARG1 
(Turner et al., 2002). This is consistent with the result that the absence of Ubp8, the ubiquitin 
specific ligase component of SAGA, does not result in derepression of ARG1 under normal 
growth conditions (Lee et al., 2005). 
1.2.5.5 Transcriptional corepressors 
Proteins that interfere with PIC formation by interaction with gene-specific repressors 
belong to a group of factors termed transcriptional corepressors. This group of transcriptional 
regulators includes the Sin3-Rpd3 histone deacetylase and Ssn6-Tup1. Sin3-Rpd3 is recruited to 
promoters by transcriptional repressor proteins bound to the upstream regulatory sequences, 
where the complex deacetylates histone H4 on lysine residues 5 and 12 (Kadosh and Struhl, 
1997; Rundlett et al., 1996; Rundlett et al., 1998). The transcriptional repressor Ume6 is bound 
to promoter elements of  genes to recruit Sin3-Rpd3 to maintain the repression of genes involved 
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 in meiosis (Kadosh and Struhl, 1997; Kadosh and Struhl, 1998; Kadosh and Struhl, 1998). Ssn6-
Tup1 represses transcription by positioning nucleosomes over promoters by recruiting the Isw1 
chromatin remodeling factor (Zhang et al., 2004). The association of Tup1 with chromatin is 
enhanced when the histone amino tails are hypoacetylated, this is consistent with the observation 
that Ssn6-Tup1 associates with histone deacetylases in vivo including Rpd3 (Edmondson et al., 
1996; Watson et al., 2000).  
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1.3 Modulation of RNA polymerase II transcript elongation 
1.3.1 Phosphorylation of RNA polymerase II during elongation 
As mentioned previously, the phosphorylation state of the RNA polymerase II CTD 
correlates with different stages in transcription, and the phosphorylation state that corresponds to 
transcript elongation is phosphorylation of Ser-2. The kinase responsible for this co-
transcriptional modification of the CTD in yeast is the CTD kinase 1 (CTDK-1) composed of the 
three subunits Ctk1, Ctk2, and Ctk3 (Table 1) (Sterner et al., 1995).  Based on sequence 
homology searches Ctk1 exhibits similarity to cyclin dependent kinases and Ctk2 exhibits 
limited sequence similarity with cyclin C, while Ctk3 did not exhibit sequence similarity with 
other known proteins at the time of this study (Sterner et al., 1995). The positive transcription 
elongation factor b (P-TEFb) complex exhibited RNA polymerase II kinase activity in human 
cells (Marshall and Price, 1992; Marshall and Price, 1995). Sequence analysis of the components 
of P-TEFb revealed that certain components showed sequence similarity to cyclin-dependent 
kinases and cyclin activating kinases (Grana et al., 1994). These subunits are reminiscent of 
members of CTDK-1 of yeast (Sterner et al., 1995). While it is not clear whether CTKD-1 is the 
bona-fide homolog of P-TEFb, it is clear that these factors share functional similarities (Murray 
et al., 2001). Both P-TEFb and Ctk1 have been implicated in positively regulating transcript 
elongation. P-TEFb has important implications for human diseases such as AIDS, since 
transcription of the HIV-1 genome is an important step in production of viral particles and P-
TEFb is required for positive stimulation of HIV-1 transcript elongation in conjunction with viral 
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 and host factors (Ping and Rana, 2001). DSIF, the human counterpart of the yeast Spt4-Spt5 
complex, was identified based on a requirement for it in inhibiting transcription elongation upon 
exposure to the nucleoside analog 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) (Wada 
et al., 1998). Interestingly, mutations in SPT4 and SPT5 exhibit genetic interactions with ctk1Δ 
cells (Lindstrom and Hartzog, 2001). Like DSIF, the Spt4-Spt5 complex has been implicated in 
regulating RNA polymerase II elongation both positively and negatively (Hartzog et al., 1998; 
Wada et al., 1998). 
CTD dephosphorylation is an important regulatory mechanism that is performed by two 
essential CTD phosphatases in S. cerevisiae. Ssu72 is required for catalyzing the removal of 
phosphate groups on Ser-5, while Fcp1 is essential for removing phosphates from Ser-2 of the 
CTD (Table 1) (Archambault et al., 1997; Archambault et al., 1998; Cho et al., 2001; Friedl et 
al., 2003; Kong et al., 2005; Mandal et al., 2002). Fcp1 associates with a subunit of TFIIF and 
the RNA polymerase II holoenzyme (Archambault et al., 1997; Archambault et al., 1998). As 
shown by ChIP, Fcp1 localizes to the open reading of genes (Cho et al., 1999). TFIIF stimulates 
the phosphatase activity of Fcp1 and dephosphorylation of the CTD is required for re-entry into 
the PIC at the promoter (Archambault et al., 1997; Cho et al., 1999). Additional support for a 
role of Fcp1 in transcription elongation came from the observation that mutations in FCP1 
genetically interact with mutations in genes encoding elongator, an RNA polymerase II-
associated complex implicated in transcript elongation (Kong et al., 2005). The activity of Fcp1 
is modulated by casein kinase II (protein kinase CK2 or CK2) and phosphorylation of Fcp1 by 
CK2 stimulates the association between TFIIF and Fcp1 (Abbott et al., 2005). Fcp1 is conserved 
in eukaryotes and interactions between human Fcp1 and the HIV-1 encoded Tat protein have 
been reported (Abbott et al., 2005; Marshall et al., 1998). In particular, Tat competes with TFIIF 
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 for association with Fcp1 at the HIV-1 promoter. Tat interaction with Fcp1 may prevent 
dephosphorylation of the CTD to allow HIV-1 transcription (Abbott et al., 2005). While 
phosphorylation states of the CTD correlate with various phases of transcription, Fcp1 is also 
important for stimulating RNA polymerase II elongation by a mechanism distinct from its role as 
a CTD phosphatase (Cho et al., 1999). Investigation by the Buratowski group suggested another 
protein is responsible for the dephosphorylation of Ser-5 residues within the CTD (Cho et al., 
1999).  The Ser-5 phosphatase was recently identified as Ssu72, a protein that has been 
implicated in transcription initiation and 3'-end formation of mRNA and snoRNA (He et al., 
2003; Krishnamurthy et al., 2004; Steinmetz and Brow, 2003). Whether Ssu72 is important for 
transcription elongation is not clear. 
1.3.2 RNA polymerase II-associated factors 
A recent study suggests that many proteins associated with RNA polymerase II are not 
involved in improving transcriptional efficiency or processivity (Mason and Struhl, 2005). 
However, genetic and biochemical analyses indicate that many proteins do functionally interact 
with RNA polymerase II (Krogan et al., 2002; Lindstrom et al., 2003; Mason and Struhl, 2005; 
Mueller and Jaehning, 2002; Squazzo et al., 2002). Since RNA polymerase II is a central player 
in the biogenesis of snRNA, snoRNA, and mRNA, it is not surprising that other factors 
important for RNA modification, formation of heterogeneous ribonucleoprotein (hnRNP) 
particles, and export of hnRNPs associate with RNA polymerase II. Other factors expected to 
associate with RNA polymerase II include proteins involved in nucleosome dynamics and 
chromatin structure since evidence suggests that nucleosomes are evicted from the template 
during transcription elongation. Interestingly, several observations indicate that the 19S and 26S 
proteasome associate with elongating RNA polymerase II (Ferdous et al., 2001; Ferdous et al., 
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 2002). The function of the proteasome in regulating transcription has been reviewed in (Kinyamu 
et al., 2005). 
1.3.2.1 The co-transcriptional nature of RNA maturation  
Several proteins involved in RNA processing associate with RNA polymerase II. These 
include the enzymes required for adding the 7-methyl guanosine cap to the 5'-end of the newly 
transcribed mRNA. In S. cerevisiae, the capping reaction is performed by a methyltransferase 
and a heterodimeric complex composed of a guanylyltransferase and an RNA 5'-triphosphatase, 
which are encoded by the ABD1, CEG1, and CET1 genes respectively (Kim et al., 2004; 
McCracken et al., 1997; Rodriguez et al., 2000; Schroeder et al., 2000; Schroeder et al., 2004). 
The addition of a functional 7-methyl guanosine cap is required for translation of the mRNA (Gu 
and Lima, 2005). Together, Abd1 and Ceg1-Cet1 associate with the RNA polymerase II CTD in 
a manner dependent on Ser-5 phosphorylation (Komarnitsky et al., 2000; McCracken et al., 
1997). Unlike Ceg1-Cet1, Abd1 associates along the entire open reading frame with RNA 
polymerase II indicating Abd1 may function in RNA polymerase II transcript elongation 
(Komarnitsky et al., 2000; Schroeder et al., 2000; Schroeder et al., 2004).  
Splicing of the nascent transcript also occurs co-transcriptionally. Observations indicate 
that splicing factors associate with elongating RNA polymerase II in a CTD-dependent manner 
to facilitate splicing (Bird et al., 2004; McCracken et al., 1997). In particular, the phosphorylated 
form of RNA polymerase II stimulates splicing in in vitro splicing assays (Hirose et al., 1999). 
The CTD may mediate interactions between factors involved in transcription and splicing such 
as S. cerevisiae Spt5 and human TAT-SF1 (Kornblihtt et al., 2004). Both Spt5 and TAT-SF1 are 
involved in regulating elongation and are also linked to splicing. TAT-SF1 associates with 
spliceosomal U small nuclear ribonucleoproteins (snRNP) (Fong and Zhou, 2001). In a study of 
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 TAT-SF1, the Zhou group revealed that the TAT-SF1 elongation factor and spliceosomal 
snRNPS exhibited reciprocal stimulation of transcriptional elongation and splicing (Fong and 
Zhou, 2001). Affinity purification of the transcription elongation factor Spt5 revealed that the 
protein associated with subunits of RNA polymerase II, RNA polymerase II elongation factors, 
RNA processing factors, 3'-end formation factors, and proteins involved in RNA export 
(Lindstrom et al., 2003). Moreover, mutations in SPT5 confer defects in splicing such that 
detectable levels of unspliced yeast transcripts were observed by RT-PCR analysis (Lindstrom et 
al., 2003). These observations illustrate the mutual relationship between transcript elongation and 
co-transcriptional splicing. 
Proteins important for proper shuttling of RNA from the nucleus to the cytoplasm are also 
associated with RNA polymerase II. A founding member of the THO/TREX nuclear RNA export 
complex called HPR1 was originally identified in a screen for mutations associated with hyper-
recombination (Table 1) (Aguilera and Klein, 1988). Several observations suggested that Hpr1 
participated in transcription. Deletion of HPR1 resulted in the derepression of SUC2 a glucose-
repressed gene and hpr1Δ cells exhibited reduced GAL1 transcription upon galactose induction 
(Zhu et al., 1995). Additionally, Hpr1 was identified as an RNA polymerase II-associated protein 
in association with Paf1, Cdc73 and Ccr4 (Chang et al., 1999). A role for Hpr1 in transcription 
elongation was inferred by the observation that hpr1Δ cells exhibit kinetic defects in the 
induction of a galactose-inducible lacZ gene in yeast and hpr1Δ cells exhibit defects in 
transcribing long genes or genes with high G+C content (Chavez and Aguilera, 1997; Chavez et 
al., 2001). In the latter case, long genes and genes with high G+C content are assumed to require 
elongation factors to improve elongation efficiency or processivity of transcription over the 
length of the open reading frame or to aid in overcoming defects in elongation due to DNA 
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 sequences that may impair elongation. THO2 was discovered in a screen to identify multicopy 
suppressors of the hyperrecombination phenotype of a deletion of HPR1 (Piruat and Aguilera, 
1998). Further biochemical characterization of Tho2 revealed it was a member of a tetrameric 
complex associated with Hpr1, Mft2, and Thp2 (Chavez et al., 2000). Individual components of 
the THO complex reside in the nucleus based on visualization of functional GFP fusion 
constructs and microscopy (Chavez et al., 2000). Furthermore, deletion of individual THO 
complex members exhibited similar phenotypes and defects in transcription elongation (Chavez 
et al., 2000). Additional insight into the role of the THO complex came from the affinity 
purification of the RNA export protein Sub2, which indicated that the THO complex associated 
stoichiometrically with Sub2 (Strasser et al., 2002). Other proteins that associated with Sub2 in 
addition to the members of the THO complex include Tex1 and Yra1, proteins involved in 
mRNA export (Strasser et al., 2002). The Sub2 containing complex is referred to as TREX for 
transcription/export (Strasser et al., 2002). TREX is recruited to actively transcribed genes and 
mutation of TREX components causes defects in export of poly(A)+ RNA from the nucleus, 
indicating that members of the TREX complex are functionally linked with transcription 
elongation and mRNA export (Strasser et al., 2002). The members of the TREX complex are 
conserved between yeast and humans (Masuda et al., 2005; Strasser et al., 2002). Therefore, it is 
likely that members of the THO complex are important for association of mRNA export proteins 
like Yra1 and Sub2 with transcribing RNA polymerase II.  
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1.3.3 RNA polymerase II-associated factors involved in chromatin structure and function 
Several analyses have investigated the mechanism whereby RNA polymerase II transcribes 
nucleosome-containing templates since nucleosomes are a potent barrier to elongating RNA 
polymerase II (Bednar et al., 1999; Bednar and Woodcock, 1999). A possible mechanism for 
transcription of RNA polymerase II through the chromatin template is that the histones dissociate 
from DNA.  Alternatively the histones remain associated with the template during RNA 
polymerase II transcription as postulated by the spooling or step-around model (Studitsky et al., 
1994; Studitsky et al., 1995). Briefly, these models suggest that as RNA polymerase II 
approaches a nucleosome, histone-DNA contacts are partially disrupted and the exposed surface 
of the histone octamer is available to make contacts with DNA that has been newly transcribed 
(Bednar et al., 1999) (Studitsky et al., 1994; Studitsky et al., 1995). Transcriptional intermediates 
have also been analyzed using electron cryomicroscopy. Observations from this study provided 
support for the model of transcription through nucleosomes where histones remain intact (Bednar 
et al., 1999; Bednar and Woodcock, 1999). Importantly, the electron cryomicroscopy studies also 
provided support for the formation of nucleosomal DNA-RNA polymerase II intermediates that 
cause RNA polymerase II pausing (Bednar et al., 1999; Bednar and Woodcock, 1999; Studitsky 
et al., 1995). These biochemical studies demonstrate the need for proteins in vivo that are 
important for aiding RNA polymerase II in traversing the nucleosome-assembled template. 
Many RNA polymerase II-associated factors have been implicated in assisting RNA 
polymerase II in overcoming nucleosome-induced pausing during elongation. One group of RNA 
polymerase II-associated factors was identified in a screen for genes that suppress the insertion 
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 of δ elements, or long terminal repeats of yeast retrotransposons, between the core promoter and 
UAS sequences (SPT genes) (Clark-Adams et al., 1988; Fassler and Winston, 1988; Winston et 
al., 1984). The δ insertions alter the utilization of transcription start sites. This Spt- screen 
uncovered several factors that restored transcription initiation to the normal transcriptional start 
site. Moreover, two different categories of SPT genes were revealed based in part on individual 
mutant phenotypes. The first category of SPT genes exhibited similar mutant phenotypes with 
mutations in SPT15, which codes for TBP. Mutations in genes within the second group of SPT 
genes conferred phenotypes similar to those of histone mutants. Further genetic characterization 
of the latter class of Spt factors, including Spt4, Spt5, Spt6, and Spt16, suggests that they may be 
important for chromatin structure (Compagnone-Post and Osley, 1996; Malone et al., 1991; 
Swanson et al., 1990; Swanson et al., 1991; Swanson and Winston, 1992).  
1.3.3.1 Yeast FACT 
The yeast protein Spt16 associates with Pob3 in a complex that is referred to as FACT 
(facilitates chromatin transcription) (Table 1) (Orphanides et al., 1998). The human homolog of 
FACT is comprised of the human Spt16 protein and SSRP1, a protein with sequence similarity to 
Pob3 (Brewster et al., 2001). What is unusual about the similarity between SSRP1 and Pob3 is 
that SSRP1 contains an extended carboxyl terminal domain (Brewster et al., 2001). The extended 
carboxyl terminal end of SSRP1 exhibits similarity to Nhp6, which may recruit FACT to 
histones (Formosa et al., 2001). As mentioned above, mutations in the essential gene SPT16 
confer Spt- phenotypes similar to mutations in histone genes, indicating a role for Spt16 in 
chromatin structure (Malone et al., 1991). Affinity purification of FACT revealed that it 
associates with RNA polymerase II, and proteins that associate with elongating RNA polymerase 
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 II such as the Paf1 complex, Spt4-Spt5, and Chd1 (Krogan et al., 2002). Interestingly, the 
association between FACT and Chd1 appears to be conserved since a human homolog of Chd1 
associates with SSRP1 through two-hybrid interactions (Kelley et al., 1999). Yeast and 
Drosophila FACT have been shown to associate with actively transcribed regions of the genome 
by ChIP and immunofluoresence assays (Kim et al., 2004; Mason and Struhl, 2003; Saunders et 
al., 2003). Mutations in SPT16 result in aberrant transcription initiation within the open reading 
frames of certain yeast genes, presumably due to defects in chromatin structure (Kaplan et al., 
2003). In fact, recent analyses from the Reinberg lab indicate that FACT possesses histone 
chaperone activity where the acidic carboxyl terminal region of Spt16 is required for the 
disruption of a histone H2A-H2B dimer (Belotserkovskaya et al., 2003).  In support of a role for 
FACT in histone chaperone activity, mutations in SPT16 are synthetically lethal with defects in 
the HIR/HPC (histone regulatory/histone promoter control) (Formosa et al., 2002). The 
HIR/HPC proteins are involved in replication-independent nucleosome deposition (Formosa et 
al., 2002). The possibility that Spt16 may regulate RNA polymerase II transcription through 
chromatin structure is in agreement with the observation that FACT associates with a subunit of 
DNA polymerase α, such that FACT may also be important for stabilizing chromatin structure 
during DNA replication (Schlesinger and Formosa, 2000; Wittmeyer and Formosa, 1997; 
Wittmeyer et al., 1999). 
1.3.3.2   Spt6 
Another RNA polymerase II-associated factor that is important for regulation of 
transcription through maintaining chromatin structure is Spt6 (Table 1). Micrococcal nuclease 
experiments with spt6 strains demonstrated defects in the chromatin structure of the SUC2 gene 
similar to those caused by mutations in histone genes (Bortvin and Winston, 1996). In addition, 
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 mutations in SPT6 and genes encoding histones suppress the SUC2 transcriptional phenotype of 
snf2 and snf5 strains (Bortvin and Winston, 1996). This study also provided the first evidence 
that Spt6 associated with tetramers of histone H3 and H4 and can assemble nucleosomes on 
plasmid DNA in vitro (Bortvin and Winston, 1996). Interestingly, spt6 cells exhibit transcription 
initiation from cryptic TATA boxes within the open reading frames of genes, causing the 
production of both full length mRNAs and short mRNAs that result from transcription initiation 
within the gene (Kaplan et al., 2003). This observation suggests that Spt6 is critical for 
maintaining proper chromatin structure during transcription elongation. Affinity purification of 
Spt6 revealed that it associates with RNA polymerase II, the RNA polymerase II-associated 
elongation factor Spt5, and a novel RNA polymerase II-associated protein called Iws1 (interacts 
with Spt6) (Krogan et al., 2002). Association of Spt6 with RNA polymerase II appears to be a 
conserved function since Drosophila Spt6 co-localizes to open reading frames and polytene 
chromosomes with RNA polymerase II (Saunders et al., 2003). Spt6 physically associates with 
components of the nuclear exosome, a complex of 3' to 5' exonucleases important for mRNA 
surveillance and maturation of snRNA and snoRNA, and could act to couple the exosome with 
elongating RNA polymerase II (Andrulis et al., 2002). These observations point to conserved 
functions of Spt6 in regulating chromatin structure during transcription elongation and linking 
transcription with the nuclear exosome complex. In vitro transcription studies indicated that 
human Spt6 was also important for transcription of a naked DNA template (Endoh et al., 2004). 
1.3.3.3 Spt4-Spt5 
The conserved transcription elongation factors Spt4-Spt5 coordinate several events during 
transcript elongation by RNA polymerase II (Table 1). DSIF, the human counterpart of Spt4-
Spt5, was identified based on a requirement for it in inhibiting transcription elongation upon 
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 exposure to the nucleoside analog 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) (Wada 
et al., 1998). In vitro transcription analyses using partially purified components suggested that 
DSIF affects elongation both positively and negatively (Wada et al., 1998; Wada et al., 1998). 
Like DSIF, the Spt4-Spt5 complex has been implicated in regulating RNA polymerase II 
elongation both positively and negatively (Hartzog et al., 1998; Wada et al., 1998). Interestingly, 
Spt5 exhibits homology with an essential bacterial transcription elongation and termination 
factor called NusG (Wada et al., 1998). Biochemical analysis of Spt4, Spt5, and Spt6 indicated 
that Spt4 and Spt5 form a complex in vivo and that a less abundant complex of Spt5-Spt6 also 
exists in vivo (Krogan et al., 2002; Swanson and Winston, 1992). Affinity purification of an 
epitope-tagged version of Spt5 revealed associations between Spt5 and RNA polymerase II, 
transcription initiation factors, RNA capping factors, RNA processing factors, and proteins 
involved in RNA polymerase II elongation (Lindstrom et al., 2003). Also, mutations in SPT5 
caused defects in the splicing of certain transcripts and deletion of SPT4 caused defects in proper 
3'-end formation at the GAL10 locus (Kaplan et al., 2005; Lindstrom et al., 2003). Mutations in 
SPT5, DST1 and RPB2 cause defects in poly(A) site utilization such that poly(A) sites within the 
coding regions of genes are preferred to the canonical poly(A) sites of certain yeast genes (Cui 
and Denis, 2003). These observations suggest that the Spt4-Spt5 complex regulates different 
events during elongation by RNA polymerase II. 
1.3.3.4 Elongator 
An RNA polymerase II-associated protein complex that is important for transcription 
elongation is elongator (Table 1). This protein complex was isolated based on its interaction with 
hyperphosphorylated RNA polymerase II purified from a non-soluble chromatin preparation 
(Otero et al., 1999). Elongator interacted genetically with TFIIS, where deletion of an elongator 
 49
 component in combination with deletion of the gene encoding TFIIS resulted in enhanced 
sensitivity to the base analog 6-azauracil (6AU) (Otero et al., 1999). Characterization of Elp3, a 
member of the elongator complex, demonstrated amino acid sequence similarity with histone 
acetyltransferases, and "in gel" HAT assays revealed that Elp3 was capable of acetylating the 
amino terminal tails of the histones H3, H4, H2A, and H2B (Wittschieben et al., 1999). Further 
characterization of the intact, six subunit elongator complex revealed specific acetylation of 
histone H3 K14 and histone H4 K8 (Winkler et al., 2002). Interestingly, the HAT component of 
SAGA also acetylates histone H3 K14 (Grant et al., 1997). Not only are acetylated histone levels 
reduced in elp3Δ lysates but genetic interactions among genes encoding certain components of 
the SAGA coactivator complex and genes encoding elongator indicate these HAT-containing 
complexes possess similar or overlapping functions (Winkler et al., 2002; Wittschieben et al., 
2000). Together, the evidence indicates a role for elongator during transcription elongation and 
that the HAT activity of Elp3 is required for this function. However, ChIP assays using epitope-
tagged forms of elongator provided contradictory evidence in that elongator did not associate 
with the open reading frames of transcribed genes and was localized to the cytoplasm (Pokholok 
et al., 2002). If elongator is not associated with DNA, then how could elongator have been 
identified as an RNA polymerase II-associated factor? This question is being addressed and 
recent analysis using RNA immunoprecipitation (RIP) indicates that elongator associates with 
the nascent, unspliced RNA of RNA polymerase II transcribed genes (Gilbert et al., 2004). This 
study raises questions about interpreting negative results of ChIP experiments. However, other 
questions regarding the function of elongator remain such as whether the true targets of Elp3 
HAT activity are histone tails or proteins associated with RNA during elongation. 
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 1.3.3.5 The Paf1 Complex 
Another RNA polymerase II-associated complex is the Paf1 complex and it consists of five 
proteins including Paf1, Ctr9, Rtf1, Cdc73, and Leo1 (Table 1) (Mueller and Jaehning, 2002; 
Squazzo et al., 2002). Paf1 (RNA polymerase II-associated factor 1) and Cdc73 were originally 
identified by immunopurification of RNA polymerase II using antibodies directed toward the 
CTD (Shi et al., 1997; Wade et al., 1996). TFIIB, TFIIF, and TFIIS were also identified in the 
fraction that associated with RNA polymerase II as described in other biochemical analyses of 
RNA polymerase II (Kim et al., 1994; Shi et al., 1997; Wade et al., 1996). Compared to other 
schemes, the Jaehning lab method for purification of RNA polymerase II revealed a new 
complement of proteins; for example, the Srb/Mediator complex was not identified in the 
fraction of proteins that associate with RNA polymerase II unlike the preparation from the 
Kornberg lab (Kim et al., 1994; Shi et al., 1997; Wade et al., 1996). Association of the Paf1 
complex with RNA polymerase II was supported by further biochemical studies, where 
individual members of the Paf1 complex were affinity purified and RNA polymerase II was 
present in the eluted fractions (Krogan et al., 2002; Mueller and Jaehning, 2002; Squazzo et al., 
2002). Further analysis of affinity purification of members of the Paf1 complex revealed 
association of the Paf1 complex with other RNA polymerase II-associated factors including 
Spt4-Spt5, Spt16-Pob3, and Chd1 (Krogan et al., 2002). The potential functional link indicated 
by biochemical analyses with the Paf1 complex, Spt4-Spt5 and Spt16-Pob3 was supported by 
genetic analyses (Krogan et al., 2002; Mueller and Jaehning, 2002; Simic et al., 2003; Squazzo et 
al., 2002). RTF1 was identified as a mutational suppressor of a TBP mutant with altered DNA 
binding specificity, suggesting a role for Rtf1 in transcription initiation (Stolinski et al., 1997). 
Deletion of individual Paf1 complex members confers similar phenotypes like sensitivity to the 
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 6AU and the Spt- phenotype (Krogan et al., 2002; Squazzo et al., 2002). But paf1Δ and ctr9Δ 
mutants exhibit the most severe phenotypes including temperature sensitivity (in some strain 
backgrounds), sensitivity to caffeine, sensitivity to hydroxyurea and slow growth (Betz et al., 
2002; Mueller and Jaehning, 2002). Interestingly, deletion of leo1Δ suppressed the hydroxyurea 
sensitivity of ctr9Δ strains and rtf1Δ suppressed the temperature sensitivity of paf1Δ cells 
(Mueller and Jaehning, 2002), indicating that Rtf1 and Leo1 may antagonize the function of Paf1 
and Ctr9. Taken together, these observations suggest a role for the Paf1 complex in transcription 
elongation despite early indications that it may be involved in initiation. 
Members of the Paf1 complex are required for histone modifications associated with 
actively transcribed genes. Absence of Rtf1, Paf1, and Ctr9 results in the reduction of methylated 
histone H3 K4 and histone H2B K123 ubiquitylation (Ng et al., 2003; Ng et al., 2003). Set1 is 
recruited to the 5' end actively transcribed genes and methylates histone H3 K4 (Ng et al., 2003). 
Set1 recruitment to the 5' region of genes is dependent on prior histone H2B K123 ubiquitylation 
by Rad6-Bre1 (Ng et al., 2003; Wood et al., 2003). Interestingly, Rad6 and Bre1 are required for 
subsequent trimethylation but not monomethylation of histone H3 K4 (Dehe et al., 2005). 
Association and activation of Rad6-Bre1 is dependent on the Paf1 complex (Laribee et al., 2005; 
Wood et al., 2003; Xiao et al., 2005). In particular, Rad6-Bre1 is targeted to promoters 
independently of the Paf1 complex but requires the Paf1 complex for association with elongating 
RNA polymerase II (Xiao et al., 2005). These observations reveal a requirement for the Paf1 in 
proper histone modifications that occur concurrently with transcript elongation by RNA 
polymerase II. 
The Paf1 complex is conserved from yeast to humans and homologs have also been 
identified in plants (He et al., 2004; Oh et al., 2004; Rozenblatt-Rosen et al., 2005; Woodard et 
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 al., 2005; Yart et al., 2005). Studies of the Paf1 complex in yeast have provided information 
regarding the functional interaction of the Paf1 complex with RNA polymerase II, transcription 
elongation factors, and proteins involved in 3'-end formation (Mueller and Jaehning, 2002; 
Rozenblatt-Rosen et al., 2005; Sheldon et al., 2005; Simic et al., 2003; Squazzo et al., 2002; 
Woodard et al., 2005; Yart et al., 2005). Functional analyses of the human Paf1 complex have 
drawn on and extended these analyses. The product of the hyperparathyroidism-jaw tumor gene 
(HRPT2), parafibromin, exhibits sequence similarity with Cdc73 (Rozenblatt-Rosen et al., 2005). 
The most compelling evidence that parafibromin was a component of the human Paf1 complex 
was the observation that affinity purified parafibromin eluted with the human homologs of Paf1, 
Ctr9, and Cdc73 (Rozenblatt-Rosen et al., 2005; Yart et al., 2005). Moreover, the human Paf1 
complex associates with RNA polymerase II that is phosphorylated on Ser-2 and Ser-5 (Yart et 
al., 2005). Localization studies of parafibromin and hLeo1 indicated that they reside in the 
nucleus (Rozenblatt-Rosen et al., 2005; Woodard et al., 2005). Like the yeast Paf1 complex, the 
human Paf1 complex associates with the histone H3 K4 lysine methyltransferase and this 
association is diminished in cells expressing mutant forms of parafibromin (Rozenblatt-Rosen et 
al., 2005). The human Paf1 complex may be involved in tumor suppressor function since cell 
proliferation and increased cyclin D1 expression were observed in cells transfected with a 
construct expressing a mutation in parafibromin that is associated with parathyroid cancer 
(Woodard et al., 2005). These results are consistent with observations that the yeast Paf1 
complex is required for regulating the transcription of cell-cycle regulated genes (Betz et al., 
2002; Koch et al., 1999; Mueller and Jaehning, 2002; Porter et al., 2002). Interestingly, hRtf1 
was not identified in association with the human Paf1 complex. This is in contrast to studies in 
yeast where Rtf1 is a component of the Paf1 complex (Krogan et al., 2002; Mueller and 
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 Jaehning, 2002; Rozenblatt-Rosen et al., 2005; Squazzo et al., 2002; Yart et al., 2005).  These 
results indicate that hRtf1 may not associate with the human Paf1 complex in vivo (Rozenblatt-
Rosen et al., 2005; Yart et al., 2005). One possible explanation for these observations is that the 
function of Rtf1 has diverged from yeast to human. Alternatively, human Rtf1 may carry out a 
conserved function that does not require its association with the Paf1 complex. 
1.3.4 Chromatin remodeling factors involved in transcription 
1.3.4.1 The SWI/SNF chromatin remodeling complex 
The prototypical chromatin remodeling complex is SWI/SNF, first identified in S. 
cerevisiae (Table 1) (Smith and Peterson, 2005). The catalytic component of SWI/SNF is Snf2 
and contains the Swi2/Snf2 ATPase/helicase motif that is important for the catalytic activity of 
the remodeling complex (Martens and Winston, 2003; Smith and Peterson, 2005). The catalytic 
region is comprised of several domains including the DEAD-like helicase domain, helicase 
superfamily C-terminal domain, and a bromodomain. Importantly, the catalytic subunits of many 
chromatin remodeling complexes share amino acid sequence similarity with the Swi2/Snf2 
ATPase/helicase motif of Snf2 (Smith and Peterson, 2005). Proteins containing DEAD-like 
helicase domains are involved in different aspects of RNA metabolism and function by 
unwinding dsRNA (Fuller-Pace, 1994). Factors possessing the helicase superfamily C-terminal 
domain or DEAD/H domain reportedly have helicase activity, ATP binding, and nucleic acid 
binding associated with them (Caruthers and McKay, 2002). The bromodomain of a Swi2 
paralog has been shown to anchor RSC at acetylated histone H3 K14 in S. cerevisiae (Kasten et 
al., 2004; Smith and Peterson, 2005). 
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 Several S. cerevisiae SWI/SNF complex components were originally identified in two 
different genetic screens to uncover transcriptional regulators of HO and SUC2 (Haber, 1977; 
Neigeborn and Carlson, 1984; Stern et al., 1984), as reviewed in (Carlson and Laurent, 1994). 
Based on the genetic screen and the mutations isolated, components of SWI/SNF were 
categorized as transcriptional activators (Cote et al., 1994). Additional analyses provided 
compelling evidence for the role of SWI/SNF members as transcriptional activators from yeast to 
humans (Cote et al., 1994). Transcriptional defects caused by mutations in SWI/SNF were 
suppressed by deletion of one copy of the genes coding for H2A and H2B and the observed 
repression was corrected at the level of chromatin structure in the case of SUC2 (Hirschhorn et 
al., 1992). Elimination of either Snf2 or Swi1 of SWI/SNF reduced Gal4 binding as observed in 
β-galactosidase assays (Cote et al., 1994). Genome-wide expression analyses in SNF2 and snf2Δ 
cells provided additional support for a role of SWI/SNF in transcriptional regulation of 
individual genes (Sudarsanam et al., 2000). Observations from this analysis also revealed that 
SWI/SNF is required for the repression of certain genes (Sudarsanam et al., 2000). Therefore, 
SWI/SNF provides an example of the potential for ATP-dependent chromatin remodeling factors 
to participate in both activation and repression. 
SWI/SNF-like complexes have been identified in higher eukaryotes, where Brahma (Brm) 
is the SWI/SNF homolog in Drosophila and BRG1 and BRM1 have been identified as the 
SWI/SNF homologs in humans (Elfring et al., 1994; Wang et al., 1996). In an experiment where 
the Swi2/Snf2 ATPase/helicase motif of BRG1 is replaced with that of Snf2 in S. cerevisiae, the 
heterologous protein rescued transcriptional activation in snf2 cells, suggesting functional 
conservation between yeast SWI/SNF and human SWI/SNF (Khavari et al., 1993).  
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 1.3.4.2 The RSC chromatin remodeling complex 
Individual components of the RSC chromatin remodeling complex were identified in part 
by sequence homology with components of SWI/SNF (Table 1) (Du et al., 1998). Sth1, the 
catalytic component of RSC shares extensive sequence similarity with Snf2 yet, Sth1 is essential 
(Du et al., 1998). Other essential components of the RSC complex, Rsc6, Rsc8, and Sfh1, were 
identified by the Kornberg lab based on their sequence similarity to Snf12, Swi3, and Snf5 
respectively  (Angus-Hill et al., 2001; Cairns et al., 1996; Cao et al., 1997; Du et al., 1998). 
Importantly, RSC complex purified from yeast extract exhibits DNA-dependent ATPase activity, 
the ability to remodel nucleosomes in vitro, and the ability to transfer a histone octamer to naked 
DNA in vitro (Kornberg and Lorch, 1999; Saha et al., 2002). Mutation of SFH1 resulted in cell 
cycle arrest and yeast extracts from synchronized cells revealed that Sfh1 is controlled by 
phosphorylation in the S phase of mitosis (Cao et al., 1997). These observations suggested that 
the chromatin remodeling activity of RSC is regulated by the cell cycle in yeast (Cao et al., 1997; 
Du et al., 1998).  
Evidence in support of a role for RSC at the level of chromatin remodeling came from both 
genetic and biochemical studies. For example, temperature sensitive mutations in STH1 
combined with deletion of histone genes cause enhanced lethality at increased temperatures (Du 
et al., 1998). Not only do members of RSC genetically interact with genes encoding the histone 
proteins but RSC physically associates with core histone particles (Saha et al., 2002; Saha et al., 
2005). Further, using reconstituted nucleosomal arrays and in vitro assays the Peterson lab 
demonstrated that RSC and SWI/SNF both remodel nucleosomal arrays and the histone tails are 
required for this activity (Logie et al., 1999).  
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 Due to the high abundance of RSC complex as compared to SWI/SNF in S. cerevisiae, it is 
possible that RSC provides essential chromatin remodeling activities while other chromatin 
remodeling complexes like SWI/SNF share some overlapping function with RSC. Interestingly, 
genetic and biochemical studies have provided evidence for two distinct RSC complexes that 
may have partially overlapping roles (Cairns et al., 1999; Ng et al., 2002). The two RSC 
complexes differ in that one RSC complex contains Rsc1 and the other contains Rsc2 (Cairns et 
al., 1999; Ng et al., 2002). Rsc1 and Rsc2 contain similar domains including two bromodomains, 
a bromo-associated homology domain, and an AT hook domain (Cairns et al., 1999). 
Identification of RSC component homologs in metazoans is complicated by the high sequence 
similarities shared across the subunits of RSC and SWI/SNF complexes (Muchardt and Yaniv, 
2001). Mammalian cells contain the two proteins Brg and Brm that exhibit similarity with 
Snf2/Swi2 (Mohrmann et al., 2004; Wang et al., 1996). Brg and Brm containing complexes 
purify with proteins similar to the yeast SWI/SNF complex (SWI/SNF-A or BAF) (Mohrmann et 
al., 2004; Wang et al., 1996). While Brg copurifies with another set of proteins to form 
SWI/SNF-B or PBAF, this complex is distinct from Brg or Brm containing SWI/SNF-A 
complexes since it contains Polybromo, a component that contains six bromodomains and shares 
sequence similarity within and outside the bromodomains of Rsc1, Rsc2 and Rsc4 (Mohrmann et 
al., 2004). Further investigation must be performed if the mammalian RSC homolog is to be 
identified. 
1.3.4.3 The conserved "imitation switch" chromatin remodeling factors 
Imitation switch or ISWI was isolated in a screen to identify novel members of the 
SWI/SNF family in Drosophila (Table 1) (Elfring et al., 1994). Similar to SWI/SNF, ISWI 
proteins contain a domain with similarity to the DNA-dependent ATPase domain of SWI/SNF 
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 (Elfring et al., 1994). ISWI is distinguished further from SWI/SNF in that ISWI contains a 
SANT domain. SANT domains are associated with chromatin remodeling and have been 
identified in Swi3, Ada2, N-COR, TFIIIB B" (Tsukiyama et al., 1999). Not only is ISWI 
speculated to function as a chromatin remodeling protein based on its primary amino acid 
sequence, but another group identified Drosophila ISWI as a component necessary to remodel 
chromatin in vitro (Tsukiyama et al., 1999). Recombinant ISWI and ISWI associated with NuRF 
or CHRAC can mobilize nucleosomes by sliding by a mechanism in which nucleosomes remain 
intact (Hamiche et al., 1999; Langst et al., 1999). Two ISWI homologs were identified in S. 
cerevisiae using the primary amino acid sequence of Drosophila ISWI (Tsukiyama et al., 1999). 
Both Isw1 and Isw2 associate within distinct protein complexes in vivo and each complex is 
associated with ATP dependent nucleosome remodeling activity like their Drosophila homologs 
(Tsukiyama et al., 1995; Tsukiyama et al., 1999).  
The nucleosome sliding ability of ISWI is important for transcriptional elongation and 
termination in S. cerevisiae (Morillon et al., 2003). In fact, microarray analysis identified genes 
that are both positively and negatively regulated by Isw1 and Isw2 (Fazzio et al., 2001; Vary et 
al., 2003). Isw1 localizes to the open reading frames of transcriptionally active genes (Morillon 
et al., 2003). Defects associated with proper Isw1 function include loss of signal for CTD Ser-2 
and Ser-5 phosphorylation and histone H3 methylation along actively transcribed genes 
(Morillon et al., 2003). Interestingly, Isw1 associates with trimethylated histone H3 K4 (Santos-
Rosa et al., 2003). Association of Isw1 with transcribed genes may therefore depend on 
interactions between methylated histone H3 and Isw1. Transcription run-on assays indicate that 
catalytic Isw1 mutants are defective for proper transcription termination (Morillon et al., 2003). 
Together, these observations indicate that interaction between Isw1 and trimethylated histone H3 
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 K4 may be important to target Isw1 to actively transcribed genes and that the conserved ATPase 
domain of Isw1 is important for transcription termination.  
1.3.4.4 The Chd1 chromatin remodeling factor regulates transcription 
The conserved chromatin remodeling factor Chd1 is involved in remodeling chromatin and 
associates with the open reading frames of actively transcribed genes (Table 1) (Kelley et al., 
1999; Simic et al., 2003; Stokes and Perry, 1995; Stokes et al., 1996; Tran et al., 2000). Chd1 
possesses two chromodomains, a DNA binding domain and the SNF2/SWI2 ATPase/helicase 
domain (Delmas et al., 1993). Chromodomain-containing factors have been implicated in 
chromatin related processes including remodeling of chromatin (Brehm et al., 2004; Jones et al., 
2000). Recent evidence indicates that a chromodomain of Chd1 in yeast is important for 
interaction between Chd1 and methylated histone H3 K4 (Pray-Grant et al., 2005). Chd1 
biochemically associates with the yeast coactivator complexes SAGA and SLIK, which share 
similar protein components (Pray-Grant et al., 2005).  
In addition to a role for Chd1 in coactivator function, Chd1 is also required for the 
transcription of a subset of genes. Microarray analyses indicated that Chd1 positively and 
negatively regulates the expression of certain genes (Tran et al., 2000). The requirement for 
Chd1 was shown to be direct for a sample of Chd1 regulated genes (Tran et al., 2000). The 
ATPase/helicase activity of Chd1 may be important for its role in transcriptional regulation. 
Evidence for this possibility came from a synthetic lethality screen performed with a chd1Δ 
strain, which indicated that SNF2 became essential in the absence of CHD1 (Tran et al., 2000). 
This genetic interaction suggests that Chd1 and Swi2 possess similar or overlapping functions in 
the cell. In support of this idea, purified yeast Chd1 was shown to alter interactions between 
DNA and nucleosomes in an ATP-dependent fashion (Tran et al., 2000). Importantly, the 
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 nucleosome remodeling activity differed from SWI/SNF in in vitro assays, supporting the notion 
that these proteins are required for different aspects of nucleosome organization. The chromatin 
remodeling activity of Chd1 may be important for transcription elongation. This hypothesis was 
tested by performing ChIP (ChIP) with an epitope-tagged version of Chd1 and measuring the 
relative occupancy of Chd1 along actively transcribed genes (Simic et al., 2003). Importantly, 
Chd1 associated with transcribed open reading frames (Simic et al., 2003). The occupancy of 
Chd1 over the genes analyzed in this study indicated that Chd1 association was dependent in part 
on an RNA polymerase II-associated protein Rtf1 and that Rtf1 and Chd1 associated in vivo 
through Co-IP and two-hybrid analysis (Simic et al., 2003). 
1.3.4.5 The INO80 chromatin remodeling complex 
INO80 was identified in a genetic screen to identify mutants that exhibit inositol 
auxotrophy (Table 1) (Ebbert et al., 1999). The primary amino acid sequence of Ino80 revealed 
significant sequence similarity to the SWI/SNF catalytic subunit (Ebbert et al., 1999). 
Biochemical analysis of Ino80 indicated that it was a component of a high molecular weight 
complex (Ebbert et al., 1999; Shen et al., 2000). Mutations in the INO80 complex caused defects 
in the induction of the phosphate inducible gene PHO5 that correlated with impaired nucleosome 
positioning over the PHO5 promoter (Steger et al., 2003). Identification of INO80 subunits 
indicated that actin-related proteins are members of the INO80 complex (Shen et al., 2003). 
Interestingly, actin-related protein 8 (Arp8) associates with histones and exhibits a preference for 
histone H3 and H4 (Shen et al., 2003). These observations indicate that the Arp8 component of 
the INO80 complex may be important for INO80 to establish association with nucleosomes prior 
to nucleosome mobilization. Additional characterization of Ino80 revealed that Ino80 possessed 
ATPase activity as predicted based on sequence similarity to Snf2. Unlike Snf2, Ino80 associates 
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 with Rvb1 and Rvb2 and ino80Δ mutations confer sensitivity to hydroxyurea, methyl 
methanesulphonate, as well as ionizing and ultraviolet radiation. Rvb1/Rvb2 are similar to the 
RuvB protein in bacteria that is involved in double strand break repair and recombination (Shen 
et al., 2000). Together, these observations indicate that INO80 is important for DNA repair as 
well as transcription. 
1.3.4.6 Swr1 is a Snf2 paralog that catalyzes the replacement of histone H2A with H2A.Z 
An attempt to identify the mechanism of histone variant substitution uncovered another 
Snf2-related protein, Swr1 (Table 1). Affinity purification of Swr1 followed by mass 
spectrometry identified Htz1, the histone H2A.Z variant, and several components of the Swr1 
complex (Kobor et al., 2004; Mizuguchi et al., 2004). Members of the Swr1 complex included 
several proteins that possess domains associated with chromatin remodeling (Kobor et al., 2004). 
One interesting observation was that certain components of the Swr1 complex have been 
identified as members of the INO80 chromatin remodeling complex and the NuA4 HAT 
complex (Kobor et al., 2004; Mizuguchi et al., 2004). Unlike mutations in INO80, swr1Δ 
mutants do not exhibit sensitivity to hydroxyurea, ultraviolet radiation, or methanesulphonate 
(Mizuguchi et al., 2004). Microarray analyses provided evidence that Swr1 and Htz1 are required 
for the repression of an overlapping set of genes (Kobor et al., 2004; Krogan et al., 2003; 
Meneghini et al., 2003; Mizuguchi et al., 2004). The subset of genes co-regulated by Swr1 and 
Htz1 reside close to telomeres (Kobor et al., 2004; Krogan et al., 2003; Mizuguchi et al., 2004). 
ChIP localized Htz1 to the promoter or 5' region of Htz1-target genes. Htz1 association at these 
regions was reduced in the absence of Swr1 (Krogan et al., 2003; Mizuguchi et al., 2004; Raisner 
et al., 2005). Recent observations also point to the incorporation of H2A.Z within nucleosomes 
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 positioned over the promoter region of both active and inactive genes (Raisner et al., 2005). 
However, Htz1 density mapping indicated that Htz1 is also incorporated within TATA-less 
promoters of repressed genes. These results in conjunction with localization analyses performed 
by the Greenblatt lab support the idea that incorporation of the H2A.Z variant may function like 
a boundary element to prevent the spreading of heterochromatin from the telomere (Krogan et 
al., 2003; Meneghini et al., 2003). Remarkably, the Wu lab demonstrated that the Swr1 complex 
catalyzes the ATP-dependent exchange of nucleosomal H2A with Htz1 in vitro (Mizuguchi et 
al., 2004). This group postulated that the exchange of other histone variants may also be 
catalyzed by other chromatin remodeling complexes that contain a Snf2-related protein 
(Mizuguchi et al., 2004). 
1.3.5 Chromatin modifying proteins 
Chromatin modifying proteins are an emerging class of post-translational modification 
enzymes that target specific residues within histone proteins. These modifications have been 
associated with long term epigenetic effects on transcriptional activity and transcriptional 
repression. Unlike chromatin remodeling factors, these enzymes do not require ATP hydrolysis 
for chromatin modification, but they do require certain co-factors; for example S-
adenosylmethionine is a cofactor involved in methylation of certain histone residues by SET 
domain containing methyltransferases (Trievel et al., 2002; Trievel et al., 2003). As mentioned 
previously, a wide range of histone modifications occur including phosphorylation, methylation, 
acetylation, and ubiquitylation, which have important implications for transcription in yeast and 
metazoans.  
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 1.3.5.1 Set1 and Set2 methylate histone H3 K4 and K36 respectively 
The lysine and arginine residues within histone proteins are targets for methylation and this 
reaction is catalyzed by a class of protein that contains SET (Su(var)39, Enhancer of zeste, 
Trithorax) domains (Briggs et al., 2001). In particular, Set1 and Set2 are two SET domain 
containing proteins that are responsible for the methylation of histone H3 K4 and histone H3 
K36, respectively (Table 1) (Hampsey and Reinberg, 2003; Strahl et al., 2002). Methylation of 
histone H3 K4 and K36 is not essential for viability, nor are the proteins that catalyze the 
methylation (Briggs et al., 2001). Set1 catalyzes the methylation of mono-, di-, or trimethylation 
on histone H3 K4 (Briggs et al., 2001). The Set1 protein contains motifs in addition to the SET 
domain, including an RNA recognition motif (RRM) and a central region that do not have 
functions ascribed to them. However, the RRM domain can exert positive effects on methylation 
by Set1 and the central domain can inhibit methylation by Set1 (Schlichter and Cairns, 2005). 
Importantly, histone H3 K4 trimethylation is enriched at the 5' region of actively transcribed 
genes as analyzed by ChIP experiments and recruitment of Set1 relies on the phosphorylation of 
the CTD by TFIIH (Ng et al., 2003). Not surprisingly, Set1 and members of the Set1-
methyltransferase complex (COMPASS) also associate with this region of actively transcribed 
genes (Ng et al., 2003). Trimethylation of histone H3 is a stable epigenetic mark for recently 
transcribed genes (Ng et al., 2003). The histone methyltransferase activity of Set1 is implicated 
in the regulation of certain genes, including PHO5 and the GAL genes, which are typically 
repressed during growth in rich medium (Carvin and Kladde, 2004). Together, Set1 recruitment 
and histone H3 K4 methylation are functionally linked to the regulation of transcription 
elongation. 
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 Recruitment of Set2 to actively transcribed genes is also dependent upon the 
phosphorylation state of RNA polymerase II. However, unlike Set1, Set2 does not require prior 
histone H2B K123 ubiquitylation for  methylating histone H3 K36 (Briggs et al., 2002; Strahl et 
al., 2002). Also unlike Set1, Set2 is required for histone H3 K36 methylation at the promoter and 
the open reading frames of actively transcribed genes (Krogan et al., 2003; Xiao et al., 2003). 
Affinity purification of Set2 and RNA polymerase II revealed reciprocal interactions between 
RNA polymerase II and Set2 (Li et al., 2002; Xiao et al., 2003). Several observations indicated 
that Set2 interacted with the phosphorylated form of RNA polymerase II. First, association of 
affinity purified Set2 with GST-CTD was enhanced when the GST-CTD had been incubated 
with HeLa nuclear extract and ATP (Li et al., 2002). Second, RNA polymerase II phosphorylated 
on Ser-2 and Ser-5 was identified in epitope-tagged Set2 immunoprecipitates by immunoblotting 
(Krogan et al., 2003; Xiao et al., 2003). Third, histone H3 K36 methylation was reduced in 
strains that contained truncation mutations within the CTD or cells that did not contain the Ser-2 
specific CTD kinase (Xiao et al., 2003). Lastly, the domain required for the Set2 and Rpb1 
interaction (SRI) was mapped to the carboxyl terminal region of Set2 (Kizer et al., 2005). Using 
unmodified, Ser-2 phosphorylated, Ser-5 phosphorylated, or Ser-2 and Ser-5 doubly 
phosphorylated synthetic CTD peptides, the Strahl lab demonstrated that the SRI bound with the 
greatest affinity to the doubly modified CTD peptides (Kizer et al., 2005). Interestingly, 
mutations in SET2 confer sensitivity to the base analog 6AU similar to mutations in genes that 
code for elongation factors (Krogan et al., 2003; Li et al., 2002). Furthermore, using set2Δ cells 
in synthetic genetic analysis by crossing the strain to cells with deletions within genes involved 
in elongation uncovered genetic interactions with SET2 and the genes coding for subunits of 
COMPASS, the Paf1 complex and the proteins required for histone H2B K123 ubiquitylation 
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 (Krogan et al., 2003). These results provide strong support for the role of Set2 and histone H3 
K36 methylation in participating in RNA polymerase II transcript elongation. 
1.3.5.2 Rad6-Bre1 ubiquitylate histone H2B on lysine 123 (K123) 
The activities of Rad6 and Bre1 are required for the ubiquitylation of histone H2B K123 
and this histone modification is conserved in higher eukaryotes. Rad6 and Bre1 possess ubiquitin 
conjugating and ubiquitin ligase activity, respectively (Table 1). Histone H2B K123 
monoubiquitylation does not target histone H2B for degradation via the proteasome degradation 
pathway, rather this modification is associated with actively transcribed genes. It is noteworthy 
that Rad6 is involved in other cellular processes that require its ubiquitin conjugating activity 
(Ulrich, 2002). Components of the Paf1 complex are required for normal levels of histone H2B 
K123 ubiquitylation (Ng et al., 2003; Wood et al., 2003; Xiao et al., 2005). Moreover, Rad6-
Bre1 associate with actively transcribed genes and hyperphosphorylated RNA polymerase II 
(Xiao et al., 2005). Rad6 is recruited to the promoters of genes in a Paf1 complex-independent 
manner but occupancy of Rad6 and histone H2B K123 ubiquitylation over the coding regions of 
genes is dependent upon the Paf1 complex (Wood et al., 2003; Xiao et al., 2005). Interestingly, 
Rad6 activity at the promoter and within the coding regions of genes is dependent upon Bre1 and 
the Paf1 complex (Xiao et al., 2005). The activity of Rad6 is also dependent on the CTD and the 
Ser-2 and Ser-5 kinases, which is consistent with a role for Rad6 in the transition between 
transcription initiation and elongation (Xiao et al., 2005). The 6AU sensitivity of rad6Δ strains 
and strains where the only form of histone H2B is replaced with histone H2B K123R is also in 
agreement with a role for Rad6 and ubiquitylation of H2B K123 in elongation (Xiao et al., 
2005). Histone H2B K123 ubiquitylation occurs transiently at the promoters of actively 
transcribed genes where ubiquitylation and deubiquitylation, by the ubiquitin specific protease 
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 Ubp8 component of the SAGA/SLIK coactivator, is required for activation of transcription 
(Henry et al., 2003). Together, these observations indicate that Rad6 and Bre1 are required for 
transcription elongation. 
1.3.6 Factors required for RNA polymerase II elongation processivity 
The general term transcription elongation factor implies that the function of this class of 
proteins is important for the processivity and elongation rate of RNA polymerase II.  Reference 
to processivity in this context describes the ability of RNA polymerase II to traverse the length of 
the coding region of a gene while elongation rate conveys information regarding the time it takes 
to transcribe the length of a given gene (Mason and Struhl, 2005). Recent analysis of a collection 
of RNA polymerase II-associated factors revealed that only members of the THO complex and 
Spt4 were required for processive elongation (Mason and Struhl, 2005).  Treatment of cells with 
6AU, a drug that lowers intracellular pool of UTP and GTP, revealed a decrease in processivity 
in wild-type cells as determined by the post-transcriptional density of RNA polymerase II on a 
model gene (Mason and Struhl, 2005). This processivity defect was aggravated in cells lacking 
transcription elongation factor IIS (TFIIS) or the Ser-2 CTD kinase (Table 1) (Mason and Struhl, 
2005). Collectively, the observations from this study argue against a role for RNA polymerase II-
associated factors in contributing to the elongation rate of transcribing polymerase (Mason and 
Struhl, 2005). Rather, protein complexes associated with RNA polymerase II are important for 
the processivity of the enzyme since the ability of RNA polymerase II to transcribe to the end of 
the gene was compromised when cells lacked Spt4 or members of the THO complex (Mason and 
Struhl, 2005). This study also reinforced the idea that RNA polymerase II-associated factors may 
be redundant with respect to their role in RNA polymerase II processivity because a need for 
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 processivity factors was not required unless the cell was insulted with drugs that presumably 
reduce cellular levels of nucleotides (Mason and Struhl, 2005). 
Components of RNA polymerase II and the transcription elongation factor TFIIS contribute 
to processivity of RNA polymerase II. The analysis by Mason and Struhl stressed the connection 
between elongation rate and processivity such that elongation rate of RNA polymerase II was 
dependent upon the enzyme's processivity (Mason and Struhl, 2005). They also suggested that 
elongation rate of RNA polymerase II is determined by the empirical enzymatic properties of 
RNA polymerase II (Mason and Struhl, 2005). Interestingly, RNA polymerase II and TFIIS are 
physically and functionally linked, where TFIIS stimulates the intrinsic nuclease activity of RNA 
polymerase II as reviewed in (Wind and Reines, 2000). The RNA cleavage activity is provoked 
in response to RNA polymerase II pausing or arrest that is induced by certain DNA templates 
(reviewed in (Wind and Reines, 2000)).  
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1.4 Regulation of 3'-end processing and transcription termination 
1.4.1 Transcript cleavage factors form the 3'-ends of polyadenylated and 
nonpolyadenylated transcripts 
RNA polymerase II generated transcripts must be cleaved at their 3'-ends prior to 
maturation. Factors important for transcript maturation were originally identified biochemically, 
based on their ability to either endonucleolytically cleave pre-mRNA or catalyze the cleavage 
and polyadenylation of pre-mRNA (Edmonds, 2002). Genetic studies in yeast have also 
contributed to the identification of additional components of the cleavage and polyadenylation 
machinery required for 3'-end formation (Ahn et al., 2004; Barilla et al., 2001; Cheng et al., 
2004; Cui and Denis, 2003; Dichtl et al., 2004; Hirose and Manley, 1998; Kaplan et al., 2005; 
Kim et al., 2004; Komarnitsky et al., 2000; Krishnamurthy et al., 2004; Licatalosi et al., 2002; 
Meinhart and Cramer, 2004; Nedea et al., 2003). Recent studies have demonstrated that the 
cleavage and polyadenylation machinery associate with actively transcribing RNA polymerase II 
and their recruitment is dependent upon phosphorylation of Ser-2 of the CTD.  
Two general modes of 3'-end formation take place in eukaryotes: poly(A)-dependent and 
poly(A)-independent. Both varieties utilize RNA elements, whether the elements recognized are 
poly(A) sites as in the polyadenylation pathway or the specific four nucleotide RNA motifs 
identified by either Nab3 or Nrd1 in the poly(A)-independent pathway (Carroll et al., 2004; 
Steinmetz and Brow, 1996). RNA sequence recognition is followed by endonucleolytic cleavage 
to produce 3'-ends that are subsequently processed. The pathways diverge such that 
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 polyadenylated transcripts acquire poly(A) tails and nonpolyadenylated transcripts are processed 
by the exosome, a complex containing 3’-5’exonucleases important for producing mature 3’ ends 
of sn/snoRNAs (Allmang et al., 1999; Allmang et al., 1999).  
Some proteins have been demonstrated to participate in both types of 3'-end formation 
while others do not appear to have overlapping roles in 3'-end formation (Dheur et al., 2003; 
Morlando et al., 2002; Nedea et al., 2003; Steinmetz and Brow, 2003). A complex important for 
proper 3'-end formation of both types of transcripts is termed the holo-CPF in yeast (Nedea et al., 
2003). The APT (Associated with the Pta1 subunit of CPF) subcomplex of CPF bridges CPF 
with CFIA (He et al., 2003; Nedea et al., 2003). Importantly, mutations within the components of 
CFIA and APT cause transcriptional read through of certain snoRNAs. The role of the holo-CPF 
is most likely direct because ChIP results indicate the presence of CPF components at these loci 
(Nedea et al., 2003). The Pti1 and Ref2 subunits of the APT complex are proposed to uncouple 
cleavage from polyadenylation during 3’-end formation of snoRNA messages (Dheur et al., 
2003; Nedea et al., 2003).  
The phosphorylation state of the CTD and its implications in RNA processing is more 
established than that of elongation factors in 3'-end formation. While the Paf1 complex 
associates with RNA polymerase II over protein coding genes, work from the Buratowski 
laboratory has shown that the Paf1 complex dissociates from RNA polymerase II near the 
poly(A) site (Kim et al., 2004). In addition, deletion of Paf1 complex members causes bulk 
poly(A) tail length of mRNAs to be shorter than poly(A) tails in wild-type cells (Mueller et al., 
2004). Therefore, it is possible that the Paf1 complex collaborates in pathways to correctly 
couple cleavage and polyadenylation for mRNAs and to uncouple cleavage and polyadenylation 
for SNR transcripts with the APT module of holo-CPF. Recent observations from the Jaehning 
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 lab support this idea because absence of Paf1 results in 3'-extended mRNAs (Penheiter et al., 
2005). 
1.4.2 Transcript termination of RNA polymerase II  
RNA polymerase II must complete the transcription cycle by dissociating from the DNA 
template thus allowing RNA polymerase II re-entry within the transcription cycle at the stage of 
initiation. The CTD itself is important for mediating transcription termination (Kim et al., 2004). 
Interactions between the CTD and poly(A) sites within the mRNA transcript allow for 
termination through a mechanism that is initiated by cleavage at the poly(A) site and subsequent 
degradation of the 5'-cleaved transcript (Dye and Proudfoot, 2001; Kaneko and Manley, 2005; 
Kim et al., 2004; West et al., 2004). The yeast RNA polymerase II-associated transcription 
termination factor Rat1 is a 5'-3' exonuclease that recognizes the 5'-cleaved ends of mRNAs and 
degrades them (Kim et al., 2004). Once Rat1 reaches the RNA polymerase II it is possible that 
Rat1 destabilizes RNA polymerase II-DNA associations causing dissociation of the enzyme in a 
manner reminiscent to rho-dependent transcription termination in bacteria. There rho hydrolyzes 
ATP to destabilize interactions between RNA polymerase and the template (Richardson, 2002).   
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1.5 Rationale to Investigate the role of Rtf1 and members of the Paf1 complex in 
transcription and identification of novel function(s) of the Paf1 complex 
Evidence from our lab implicated a functional role for Rtf1 in transcription elongation by 
RNA polymerase II. Mutations in genes whose protein products are important for the transition 
from transcription initiation to elongation exhibited severe synthetic defects when combined with 
a deletion of RTF1 (Costa and Arndt, 2000). Subsequent biochemical experiments performed in 
our lab and others placed Rtf1 in the context of a multiprotein complex that also contains Paf1, 
Ctr9, Cdc73, and Leo1, known as the Paf1 complex (Chang et al., 1999; Krogan et al., 2002; 
Mueller et al., 2004; Squazzo et al., 2002). Significantly, the Paf1 complex associates with RNA 
polymerase II along the open reading frames of actively transcribed genes. This evidence 
strongly indicated the Paf1 complex may regulate events that occur during elongation. However, 
we could not completely eliminate the possibility that the Paf1 complex functioned in 
transcription initiation since the Paf1 complex was identified based on its association with RNA 
polymerase II and general transcription factors and because mutations within RTF1 suppressed 
the altered DNA binding specificity of a TBP mutant (Chang et al., 1999; Shi et al., 1997; 
Stolinski et al., 1997; Wade et al., 1996). 
The role of the Paf1 complex in transcription was somewhat controversial when I began my 
thesis research. We developed a research plan that would center our efforts on identifying 
missense mutations within RTF1 that could be used in downstream genetic and expression 
analyses. Ideally, the point mutants we recovered could be used to identify genes that in high 
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 dosage could suppress their mutant phenotypes. Through the identification and characterization 
of multicopy suppressors of rtf1, we speculated that the function ascribed to these suppressors 
would clarify the function of the Paf1 complex in transcription or uncover new roles for the Paf1 
in transcription or other processes. During the isolation of rtf1 mutants and characterization of 
multicopy suppressors, a complementary study was ongoing. We sought Paf1-dependent target 
genes using microarrays. Identification of genes that require the Paf1 complex for their 
transcriptional regulation could be valuable tools for further evaluating the role of the Paf1 
complex in transcription initiation and elongation. These two approaches were successful in that 
they led to the discovery that the Paf1 complex is involved in forming 3'-ends of certain RNA 
polymerase II transcripts and the Paf1 complex physically associates with RNA polymerase II 
transcribed genes for their repression.  
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 2.0  Chapter 2: Identification of multicopy suppressors of a conditional rtf1 mutation 
2.1 Introduction 
The affinity purification of Rtf1 revealed that Rtf1 is a component of the Paf1 complex. 
This observation offers a framework for the function of Rtf1 as well as other members of the 
Paf1 complex in the cell. While previous studies implicated Rtf1 and the Paf1 complex in RNA 
polymerase II transcription, the roles of the Paf1 complex during transcription are not well 
understood.  
Several attributes have been assigned to the Paf1 complex based on numerous biochemical 
and genetic studies. For example, RNA polymerase II, elongation factors involved in modulating 
histone octamer integrity during transcription, and proteins known to remodel nucleosomes 
during active transcription interact physically with the Paf1 complex (Krogan et al., 2002; 
Lindstrom et al., 2003; Mueller and Jaehning, 2002; Simic et al., 2003; Squazzo et al., 2002). 
Additionally, ChIP experiments indicate that the Paf1 complex, RNA polymerase II and other 
known elongation factors co-localize to transcribed genes. Genetic interactions have been 
reported for deletions of individual members of the Paf1 complex as well as studies that revealed 
deletion of members of the Paf1 complex affect elongation and histone modification (Ng et al., 
2003; Ng et al., 2003; Rondon et al., 2004; Xiao et al., 2005). Together, these observations 
strongly support a role for the Paf1 complex in transcription elongation through an effect on 
chromatin structure. However, recent work from the Struhl lab suggests that the Paf1 complex 
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 and other reported elongation factors may not have a role in RNA polymerase II elongation 
efficiency or processivity in vivo (Mason and Struhl, 2005). Alternatively, in vitro evidence 
indicates that efficient transcription elongation on naked DNA requires certain members of the 
Paf1 complex (Rondon et al., 2004; Rondon et al., 2003). The results from the Struhl lab 
suggests that while the Paf1 complex may be associated with actively transcribing RNA 
polymerase II the precise function of the Paf1 complex remains to be resolved. While it is odd 
that transcription elongation factors may not directly affect RNA polymerase II transcription 
efficiency or processivity, results from the Jaehning lab offered some insight into this conundrum 
by uncovering evidence that an important role of the Paf1 complex may occur off the DNA 
template (Mueller et al., 2004; Penheiter et al., 2005; Yart et al., 2005).  Specifically, deletion of 
paf1Δ resulted in RNA polymerase II transcripts that exhibited shorter than average poly(A) 
tails, altered poly(A) site utilizations and changes in rRNA processing . The intriguing possibility 
is that the function of the Paf1 complex involves the bridging or coordination of events occurring 
on the template with those occurring off the template, however this remains to be elucidated. To 
better define the role of Rtf1 and the Paf1 complex in transcription we sought additional proteins 
that functionally interact with Rtf1.  
To identify proteins that functionally or physically interact with Rtf1 we chose to perform a 
high copy number genetic screen with specific rtf1 missense mutations. First, we generated 
temperature sensitive RTF1 alleles using error-prone PCR. These mutants were screened for 
conditional 6-azauracil (6AU) sensitivity and subsequently for conditional Spt- phenotypes. 
Three novel rtf1 missense mutations were identified and characterized. We chose one rtf1 
mutation for the dosage suppression screen, rtf1-107. This mutation results in the substitution of 
methionine 289 for lysine. The rtf1-107 mutation confers a conditional 6AU phenotype as well 
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 as a weak Spt- phenotype at the permissive temperature. A high copy number library was 
transformed into this strain to identify multicopy suppressors of the rtf1-107 mutant. Many 
suppressor candidates were identified, however, we focused on one candidate, NAB3. Nab3 was 
of particular interest since it is functionally linked to RNA polymerase II transcript termination 
(Steinmetz et al., 2001). 
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2.2 Methods and materials 
2.2.1 Yeast strains and methods 
Rich (YPD), synthetic complete (SC), synthetic dextrose (SD), and 5-fluoroorotic acid 
(5FOA) media were prepared as described previously (Rose  et al., 1990).  Media containing 
50μg/ml of the base analog 6AU were prepared essentially as described (Squazzo et al., 2002). 
Unless otherwise indicated, the yeast strains used in this study are isogenic with FY2 (Winston et 
al., 1995), a GAL2+ derivative of S288C (Table 2). Strains were constructed by tetrad dissection 
or transformation (Rose  et al., 1990). All deletion strains were created using a PCR-based 
method (Ausubel et al., 1988) with the exception of the nrd1∆ strain, KKY100, which was 
constructed by using the disruption plasmid pRS316-nrd1∆::HIS3 (Steinmetz and Brow, 1996) 
to replace the essential NRD1 gene in the diploid strain KKY97. 
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Table 2: Yeast strains used in Chapter 2 
 
 
STRAIN GENOTYPE ORIGIN 
AY5 MATa rtf1Δ102::ARG4 his4-912δ lys2-173R2 leu2Δ1 trp1Δ63 arg4-12 Arndt lab 
AY6 MATα rtf1Δ102::ARG4 his4-912δ lys2-173R2 trp1Δ63 ade8 arg4-12 " 
KY406 MATα his4-912δ lys2-128δ leu2Δ1 ura3-52 trp1Δ63 ade8 " 
KY410 MATα rtf1Δ101::LEU2 his4-912δ lys2-128δ leu2Δ1 ura3-52 trp1Δ63 " 
KY562 MATa rtf1Δ102::ARG4 his3Δ200 lys2-173R2 ura3-52 trp1Δ63 arg4-12 " 
KY656 MATa rtf1Δ100::URA3 his4-912δ lys2-128δ leu2Δ1 ura3-52  " 
KY664 MATα  his3Δ200 his4-912δ  leu2Δ1 ura3-52 trp1Δ63 " 
KY767 MATa his4-912δ leu2Δ1 trp1Δ63 ade8 " 
KKY37 MATα rtf1-105 his4-912δ lys2-128δ leu2Δ1 ura3-52 ade8 " 
KKY40 MATα rtf1-100 his4-912δ lys2-128δ leu2Δ1 ura3-52 ade8 " 
KKY45 MATα rtf1-107 his4-912δ lys2-128δ leu2Δ1 ura3-52 ade8 " 
KKY54 MATa rtf1-100 his4-912δ leu2Δ1 trp1Δ63 " 
KKY56 MATα rtf1-100 his4-912δ leu2Δ1 trp1Δ63 " 
KKY58 MATα rtf1-107 his4-912δ leu2Δ1 trp1Δ63 " 
KKY60 MATα rtf1-107 his4-912δ  leu2Δ1 trp1Δ63 ade8 " 
KKY64 MATα rtf1-105 his4-912δ leu2Δ1 trp1Δ63 " 
KKY97 MATa/MATα rtf1Δ102::ARG4/RTF1 his3Δ200/" HIS4/his4-912δ lys2-
173R2/LYS2 LEU2/ leu2Δ1 ura3-52/" trp1Δ63/" arg4-12/ARG4 
" 
KKY100 MATa/MATα rtf1Δ102::ARG4/RTF1 NRD1/nrd1Δ::HIS3 his3Δ200/" 
HIS4/his4-912δ δ lys2-173R2/LYS2 LEU2/leu2Δ1 ura3-52/" trp1Δ63/" 
arg4-12/ARG4 
" 
KKY128 MATα rtf1Δ102::ARG4 nrd1Δ::HIS3 arg4-12 or ARG4 his3Δ200 his4-
912δ lys2-173R2 leu2Δ1 ura3-52 trp1Δ63 pRS316-NRD1 
" 
KKY129 MATa nrd1Δ::HIS3 arg4-12 or ARG4 his3Δ200 lys2-173R2 ura3-52 
trp1Δ63 pRS316-NRD1 
" 
KKY143 MATa nrd1Δ::HIS3 cdc73Δ::KANMX4 his3Δ200 lys2-173R2 ura3-52 
trp1Δ63 pRS316-NRD1 
" 
nrd1-5 MATα nrd1-5 cup1Δ his3 lys2 leu2 ura3 trp1 ade2 Brow lab 
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2.2.2 Plasmids 
Standard techniques were used for plasmid construction, isolation, and transformation of S. 
cerevisiae and Escherichia coli (E. coli) strains (Ausubel et al., 1988; Rose  et al., 1990). RTF1 
was subcloned into a pRS314 vector backbone and subsequently amino terminally tagged using a 
triple HA1 epitope  (Stolinski et al., 1997).  
Library plasmid 305 contains a genomic fragment that encodes the essential gene NAB3. 
NAB3 was subcloned from 305 into pRS425 by ligating a 3.8 kb SwaI-NcoI end-filled fragment 
into the SmaI digested pRS425 vector resulting in pKK5. This plasmid was transformed into 
KKY58 to confirm that NAB3 suppressed the Spt- phenotype of rtf1-M289K in high copy 
number. 
Library plasmid 309 contains the RTG3 gene within the genomic fragment. This construct 
was digested with NcoI and SwaI releasing a fragment of 2.1 kb in length containing RTG3. The 
NcoI site was treated with Klenow to end-fill the resultant 5' overhang to form a blunt end. This 
fragment was ligated into the SmaI digested pRS425 vector and candidates were identified using 
restriction analysis. 
2.2.3 Isolation and characterization of rtf1 alleles 
2.2.3.1 Error-prone PCR.  
A modified PCR protocol was used to incorporate mutations into and amplify RTF1. The 
final reaction conditions included 1X PCR buffer (Promega), 2.5mM MgCl2 (Promega), 50μM 
each dNTP, 2 fmole pLS21-5 (HA3-RTF1 in the pRS314 vector (Stolinski et al., 1997)), 30 
pmole LQ30, 30 pmole  LQ31, and 1 unit of Taq polymerase (Promega) (Table 3). The PCR 
cycling conditions utilized were: 1 cycle-95°C for 3 minutes; 35 cycles-94°C for 1 minute, 54°C 
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 for 2 minutes, and 72°C for 3 minutes; 1 cycle-72°C for 10 minutes; and 1 cycle-4°C  hold.  The 
3.6 kb PCR fragments were separated by 1.0% TAE-low melt agarose gel electrophoresis and 
were gel purified (Wizard PCR Prep, Promega). 
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Table 3: Oligonucleotide sequences used in Chapter 2 
 
 
Oligonucleotide Name 5'-Sequence Purpose 
LQ30 GGGAGCCCCCGATTTAGAG Error-prone PCR RTF1 
LQ31 CTGTGGATAACCGTATTACC Error-prone PCR RTF1 
KA109 GCTCGCTTCGCTACTTGGAGCC Sequence YEp13 
KA110 GGCGCCAGCAACCGCACCTGTG Sequence YEp13 
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2.2.3.2 In vivo homologous recombination.  
pLS21-5 was digested with EcoRI and SpeI to release a 2.5 kb fragment containing RTF1 
and a 5.0 kb fragment containing vector backbone. The vector backbone was gel purified. 
Together, the PCR fragments and the pLS21-5 backbone were transformed into AY6 an rtf1Δ 
strain, where in vivo homologous recombination and plasmid selection on SC-Trp introduced 
rtf1 fragments into pLS21-5 (Muhlrad et al., 1992).  
2.2.3.3 Screen for conditional rtf1 missense mutations.  
Approximately 1800 transformants were screened for the 6AUS phenotype at both 30°C and 
37°C. Those candidates exhibiting sensitivity to 6AU at the elevated temperature were screened 
for the Spt- phenotype. Plasmids from initial candidates were recovered from yeast and 
transformed into E. coli.  Upon re-transformation of the candidate plasmids into KY618, we 
recovered eight candidates that exhibited conditional 6AUS and or Spt- phenotypes. Sequence 
analysis of the original candidates revealed that all contained multiple mutations (Table 4).  For a 
subset of these candidates, mutations were separated by subcloning or site-directed mutagenesis 
(QuikChange, Stratagene) to obtain single missense mutations. These plasmids were analyzed 
for the ability to complement the 6AUS and Spt- phenotypes of the rtf1Δ strain. Plasmids that 
conferred 6AUS and/or Spt- phenotypes were characterized further (Table 5). 
2.2.3.4 Integration of rtf1 point mutations.  
The N-terminal HA1 epitope tag was removed from Rtf1 prior to integration of the rtf1 
alleles into the yeast genome to eliminate any possible influence of the tag on the Rtf1 mutant 
protein. Digestion of the candidate plasmids was performed with NdeI (New England Biolabs 
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 (NEB)) to release the 99 bp fragment encoding the triple HA1 tag. The cohesive NdeI ends of the 
candidate plasmids were ligated using T4 DNA ligase (Roche) using varying concentrations of 
linearized plasmid to promote intramolecular ligation. Ligation reactions were transformed into 
E. coli, single colonies were purified, and plasmids were isolated from standard overnight 
cultures. Diagnostic restriction enzyme digests using BamHI (NEB) were performed with 
pLS21-5 and plasmids isolated from the intramolecular ligation reactions to identify plasmids 
lacking the 99 bp fragment encoding the HA1 epitopes.  
The rtf1-100 (Q172R), rtf1-105 (V274D), and rtf1-107 (M289K) mutations were integrated 
at the endogenous RTF1 locus by the two-step gene replacement method in KY410 using the 
URA3-marked integrating vector pRS306 (Scherer and Davis, 1979). Plasmids containing the 
three point mutations were digested sequentially with SpeI (NEB) followed by SalI to release a 
2.7 kb product. pRS306 was also sequentially digested with SpeI and SalI to linearize a 4.3 kb 
fragment. The 2.7 kb SpeI-SalI fragments containing the rtf1 missense mutations were ligated 
with the SpeI-SalI linearized pRS306 backbone with T4 DNA ligase. Diagnostic digests were 
performed to identify plasmids containing the rtf1 mutation inserts. Integrating vectors 
containing the proper DNA inserts were digested with EcoRI, which linearized the plasmids 5' to 
the coding region of RTF1. DNA fragments were gel purified and transformed into KY410 log 
phase cultures allowing in vivo recombination to occur between the fragment and the rtf1Δ locus 
using SC-Ura media to maintain the integrating DNA under selection. Single stably, transformed 
candidates were purified. Transformants were grown on YPD in small patches, scraped into 1ml 
H2O with sterile toothpicks, and 100μl of suspension was spread onto solid 5FOA containing 
media to select for cells that have "looped out" the region of DNA containing URA3 and 
rtf1Δ101::LEU2. Individual colonies from the 5FOA plate were patched onto YPD and replica 
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 printed to the following medium: YPG, YPD, SC-Ura, SC-Leu and SC complete. Candidates that 
grew on glycerol containing media and did not grow on medium lacking uracil or leucine were 
analyzed by Southern analysis to confirm integration at the RTF1 locus (data not shown).  
To ensure that the HA1 epitope tag was not influencing the phenotypes of the original 
candidates, the phenotypes conferred by the rtf1 mutations lacking the tag were analyzed using 
dilution analysis. In brief, saturated overnight cultures were pelleted, washed two times with 
H2O, and ten fold serial dilutions were spotted onto media to analyze 6AUS and Spt- phenotypes 
at both the permissive and restrictive temperatures. 
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Table 4: Original RTF1 mutants and plasmids 
 
 
ISOLATE AMINO ACID SUBSTITUTIONS ENCODED BY THE 
RTF1 MUTANT GENE 
AMINO ACID SUBSTITUTIONS  
ANALYZED 
pDM1 E264G, V274D E264G, V274D 
pDM2 E186G, V403I, L409STOP E186G 
pDM3 Q172R, K246E, Y341F Q172R, K246E, Y341F 
pDM4 R223G, T282P, deletion at T282 R223G, T282P 
pDM5 K41R, D243G, Q409L, K473R, Q502L None 
pDM6 M289K, K495STOP M289K 
pDM7 K246STOP, F253L, F312L, Y327C, Y338F, K391R None 
pDM8 D218G, D236G, Y301H, L345S, K390I None 
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Table 5: Isolated RTF1 point mutants 
 
 
AMINO ACID SUBSTITUTION ALLELE DESIGNATION PHENOTYPE 
Q172R rtf1-100 Conditional Spt- 
V274D rtf1-105 Weak Spt-, conditional 6AUS 
M289K rtf1-107 Weak Spt-, conditional 6AUS 
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2.2.4 Immunoblotting analysis 
2.2.4.1 Analysis of Rtf1 protein levels.  
Whole cell lysates were prepared as described in (Squazzo et al., 2002; Stolinski et al., 
1997) and samples were resolved on 7.5% SDS-polyacrylamide gels. Nitrocellulose filters were 
probed with anti-Rtf1 antisera diluted to 1:4000 in Blotto (5% w/v dry nonfat milk in TBST; 
TBST = 50mM Tris-HCl pH 7.4, 150mM NaCl, 0.05% Tween-20) (Squazzo et al., 2002) or anti-
L3 antisera diluted to 1:5000 in Blocko (TBST plus 3% w/v BSA) (Vilardell and Warner, 1997), 
which served as the loading control. Immunoreactive proteins were detected by 
chemiluminescence (Pierce) of HRP-coupled secondary antibodies (Amersham Biosciences) and 
visualized using BioMax film. 
2.2.4.2 Analysis of histone H3 lysine 4 (K4) trimethylation levels.   
Protein extracts were prepared essentially as described in (Ng et al., 2003). The extracts 
were separated on 15% SDS-polyacrylamide gels. Nitrocellulose filters were probed with a 
1:2000 dilution of ab8580 (Abcam) in Blotto overnight at 4°C as described in (Ng et al., 2003). 
This antibody detects the trimethylated  K4 residue of histone H3.  Filters were stripped and re-
probed with anti-L3 antisera and developed as described above. 
2.2.5 High copy number suppressor screen 
The average size of genomic inserts in the LEU2-marked 2-micron library used in this study 
is approximately 10 kb. We determined that the number of colonies to screen with 99% 
probability of covering the complete S. cerevisiae genome for multicopy suppressors of rtf1-107 
would be approximately 6000 (Ausubel et al., 1988). A pilot transformation was performed to 
empirically determine the amount of library DNA to transform, the volume and dilution of 
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 transformation mixes to spread, and the number of selective plates required for use in the screen. 
The actual screen utilized three library pools, where 2μg of each library pool were used in the 
transformation. Three transformation mixes were prepared for each library pool, three plates 
were spread per transformation mix for a total of 27 plates to screen. To estimate the number of 
colonies screened, the colonies from three randomly chosen plates were counted and averaged to 
determine that roughly 13,000 colonies were analyzed in this screen. 
The transformants were screened for their ability to suppress the 6AUS phenotype of rtf1-
107 at 37°C on SC-Leu-Ura medium supplemented with 50μg/ml 6AU as compared to SC-Leu-
Ura medium alone. Transformants were also screened for the ability to restore the phenotype of 
the rtf1 mutants to Spt+ at 30°C by comparing growth on SD-Leu-His and SD-Leu plates. In 
order to identify potential candidates, 388 transformants that conferred suppression of either or 
both phenotypes were patched onto SC-Leu and re-replica printed to media as described above. 
Transformants were purified and 79 remained after replica printing. Library plasmids were 
recovered from yeast and transformed into E. coli. To eliminate the possibility that RTF1 was 
present within the genomic fragments, candidates were placed into groups based on the 
appearance of EcoRV restriction digest patterns when compared to pLS21-5 or YEp13, the 
plasmid library vector backbone. Representative library plasmids were retransformed into rtf1-
107 cells. Library plasmids that conferred suppression upon retransformation were sequenced 
using oligonucleotides KA109 and KA110 that hybridized to YEp13 sequences flanking the 
insert (Table 3). The Saccharomyces Genome Database (SGD) http://www.yeastgenome.org/ 
(Balakrishnan et al.), in combination with sequence data of the candidates provided detailed 
information on each genomic insert.  
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 2.2.6 Analysis of nrd1-5 combined with deletions of Paf1 complex members 
Double deletion strains containing pRS316-NRD1 were transformed with pRS314, pRS314-
NRD1 or pRS314-nrd1-5. Purified rtf1Δ nrd1Δ and cdc73Δ nrd1Δ transformants were passaged 
over 5FOA containing medium to evict the pRS316-NRD1 plasmid. The indicated strains were 
subjected to dilution analysis on the following types of media and incubated at the designated 
temperatures: YPG at 30°C and YPD at 30° or 37°C. paf1Δ nrd1Δ and ctr9Δ nrd1Δ 
transformants were purified on SC-Trp selective media. Dilution analysis was performed with 
these cells as in section 2.2.3.4., using the specified media and plates and incubated at the 
temperatures listed: YPG at 30°C and 5FOA at 30° or 37°C. 
2.2.7 Analysis of strains lacking individual components of the Paf1 complex containing 
2-micron NAB3  
Empty vector and high copy number NAB3 were transformed into wild-type cells and cells 
deleted for members of the Paf1 complex.  Transformants were selected and purified on medium 
lacking leucine. Dilution analysis was performed as described in section 2.2.3.4., with the 
indicated media and the plates were incubated at 30°C. 
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2.3 Results 
2.3.1 Isolation of mutations conferring conditional rtf1 phenotypes  
Mutations in RTF1 and genes encoding other members of the yeast Paf1 complex confer 
sensitivity to 6AU (6AU) and suppression of transposable element insertion mutations within 
promoters (Spt phenotype = suppression of Ty) (Krogan et al., 2002; Riles et al., 2004; Squazzo 
et al., 2002). The Spt- phenotype is associated with defects in both transcription initiation and 
elongation (Hartzog et al., 2002; Winston and Sudarsanam, 1998). To elucidate the functions of 
the Paf1 complex, we performed a genetic screen to identify novel missense mutations in RTF1. 
We specifically screened for RTF1 mutations that confer stronger 6AUS and Spt- phenotypes at 
higher growth temperatures (37°C) than at lower growth temperatures (30°C). By screening for 
conditional mutations we hoped to avoid the isolation of complete loss-of-function alleles. 
Approximately 1800 transformants were screened for conditional sensitivity to the base analog 
6AU; after purification and retransformation eight rtf1 candidate plasmids conferred  
temperature sensitivity to 6AU (D. M. Mauger and K. M. Arndt, unpublished observations). 
Cells containing these rtf1 alleles were replica printed to media lacking histidine to assay for a 
temperature sensitive Spt- phenotype. Each plasmid conferred a weak to severe Spt- phenotype 
comparable to that of an rtf1Δ mutant (D. M. Mauger, K. E. Sheldon and K. M. Arndt, 
unpublished observations). Sequence analysis of the eight rtf1 alleles suggested that the 
phenotypes might be due to multiple mutations (Table 4). Therefore, subcloning and site-directed 
mutagenesis were used to isolate individual missense mutations from candidate plasmids pDM1, 
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 pDM2, pDM3, pDM4 and pDM6 for further characterization. Plasmids containing the missense 
mutations were transformed into rtf1Δ cells for complementation analysis. We sought rtf1 
mutations that could complement the phenotypes of the rtf1 null strain at the permissive 
temperature but not at the restrictive temperature. 
2.3.2 Characterization of missense mutations in RTF1  
Three new missense mutations encoding single amino acid substitutions in Rtf1 were 
identified (Table 5). The rtf1-100 mutation, which encodes a glutamine 172 to arginine (Q172R) 
substitution, confers a conditional Spt- phenotype, as indicated by suppression of the his4-912δ 
insertion mutation and cell growth on medium lacking histidine at 37°C but not at 30°C (Figure 
6). The rtf1-105 (V274D) and rtf1-107 (M289K) alleles cause conditional sensitivity to 6AU; 
however, these mutations also cause weak Spt- phenotypes at 30°C (Figure 6). The amino acids 
altered by the mutations lie within a highly conserved region of Rtf1 but are not themselves 
invariant across species (Figure 7). Interestingly, the region in which the point mutations reside 
has been shown to be essential for Rtf1 function based on the phenotypic analysis of a series of 
internal deletions within RTF1 (K. L. Roinick and K. M. Arndt, unpublished observations). 
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Figure 6: Conditional RTF1 alleles exhibit sensitivity to 6AU and the Spt- phenotype  
Characterization of rtf1 point mutants. Equivalent numbers of cells from RTF1 (KY767), rtf1-
105 (KKY64), rtf1-100 (KKY56), rtf1-107 (KKY58) and rtf1∆ (KY656) strains were spotted in 
ten-fold serial dilutions onto the indicated media. Sensitivity to 6AU was examined on SC-Ura 
medium supplemented with 50µg/ml 6AU (5 days of incubation). The Spt- phenotype was 
analyzed on medium lacking histidine (3 days of incubation). 
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Figure 7: Comparison of Rtf1 sequence to similar proteins in other eukaryotes 
Primary amino acid sequence alignment using Rtf1 proteins from S. cerevisiae, C. elegans, and 
H. sapiens. Rtf1 (accession number P53064) amino acid sequence from Saccharomyces Genome 
Database was used for a BLAST search that identified proteins with similar amino acid 
sequences in C. elegans (accession number CAB03200) and H. sapiens (accession number 
AAH15052). ClustalW was used to align the amino acids sequences. Conserved amino acid 
identity is indicated by red colored letters and amino acid similarity is indicated by blue letters. 
Yellow rectangles indicate the residues altered by the three rtf1 point mutations. 
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The conditional phenotypes of the rtf1 point mutants suggest that Rtf1 retains partial 
function at the permissive temperature. We performed immunoblot analysis to measure 
expression of Rtf1 from the conditional alleles. For each of the mutant strains, similar levels of 
Rtf1 were detected when cells were grown at 30°C or incubated for 2 hr at 37°C (Figure 8A). 
However, the rtf1-105 and -107 mutants express Rtf1 to lower levels than the wild-type control 
strain (Figure 8A). Steady state levels of histone H3 K4 trimethylation in the mutant strains 
correlate with Rtf1 protein levels, indicating that the mutations do not cause a specific defect in 
this modification (Figure 8B). 
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Figure 8: Rtf1 is expressed from the rtf1 alleles at both the permissive and restrictive temperatures and 
histone H3  K4 trimethylation is detected in the rtf1 point mutants          
(A) Immunoblot analysis was performed on wild-type (WT) (KY406), rtf1-105 (V274D; 
KKY37), rtf1-100 (Q172R; KKY40), rtf1-107 (M289K; KKY45) and rtf1∆ (KY410) cells. (B) 
Cultures were grown to early log phase, divided and further incubated at 30° or 37°C for 2 hrs. 
Extract from 1x107 cells per sample was analyzed by immunoblotting with anti-Rtf1 and, as a 
loading control, anti-L3 antisera. Histone H3 K4 trimethylation was analyzed by immunoblotting 
of whole cell extracts prepared from strains grown as in (A). 
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2.3.3 Genes in high copy number that suppress the phenotypes of rtf1-107 
Isolating and determining the identity of the dosage suppressors of rtf1 could uncover new 
as well as confirm established roles for the Paf1 complex. The phenotypes of rtf1-107 strongly 
indicated that defects in Rtf1 function contribute to impaired transcription elongation. To further 
clarify the role of Rtf1 and the Paf1 complex in vivo, we sought to identify multicopy 
suppressors that could reverse the 6AUS and/or Spt- phenotypes of rtf1-107. Since many lines of 
evidence indicate a role for Rtf1 in transcription, the possibility exists that high-copy-number 
suppressors of rtf1-107 could encode factors involved in different aspects of RNA polymerase II 
transcription or factors involved in coupling RNA capping, splicing and processing to 
transcription. Other likely multicopy suppressors include genes encoding mRNA transport 
proteins, such as components of THO/TREX that are intimately linked with elongation and 
hnRNP formation (Fischer et al., 2002; Rondon et al., 2003; Strasser et al., 2002). However, not 
all candidates will be bona-fide suppressors. For example, URA3 or genes encoding drug 
resistant membrane transporters or protein chaperones could confer phenotypic suppression of 
rtf1-107.  
Sequence analysis of the recovered library plasmids revealed inserts with multiple open 
reading frames consistent with the approximate insert size of the library that ranges from 5 Kb to 
10 Kb. Information available from the Saccharomyces Genome Database was used to determine 
the gene most likely responsible for suppression on each library plasmid (Balakrishnan et al.).  
As anticipated, we identified multicopy suppressors that contained RTF1 within the genomic 
insert. For example, plasmid isolate 172 suppressed both the Spt- and 6AUS phenotypes and 
RTF1 was identified within the genomic insert of this plasmid. Additionally, we identified 
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 dosage suppressors likely to suppress the 6AUS phenotype of rtf1-107 nonspecifically. For 
example, candidate 192 was isolated as a multicopy suppressor of 6AUS and its genomic insert 
contained URA3. Overexpression of URA3 could suppress the 6AUS phenotype because Ura3 
catalyzes a reaction important for de novo synthesis of pyrimidines, in turn restoring cellular 
pools of UTP. These candidate plasmids and the genes within their genomic inserts are displayed 
in Table 6 with genes likely to cause suppression in bold type. We discovered that two library 
plasmids, 7 and 176, exhibited different restriction digest patterns and suppressed the 6AUS 
phenotype of rtf1-107 strains (Table 6). Upon sequence analysis these candidates contained 
overlapping genomic inserts. The one gene that they both shared in its entirety was TPO1, 
suggesting that TPO1 was the gene responsible for conferring 6AUR in rtf1-107 cells. Recent 
reports indicate that Tpo1 is a polyamine transporter localized to the vacuolar membrane 
(Uemura et al., 2005).  Interestingly, in response to 6AU and mycophenolic acid (MPA), another 
drug that reduces intracellular pools of GTP, TPO1 is transcriptionally induced similarly to 
IMD2 (IMD2/PUR5) a gene required for pyrimidine biosynthesis (Hedstrom, 1999). The basis 
for the observed 6AUS suppression caused by the overexpression of TPO1 is not clear, but it 
likely does not involve a direct interaction between Tpo1 and the Paf1 complex. 
Library plasmid 91 was also identified on the basis of its ability to confer suppression of the 
6AUS phenotype of the rtf1-107 cells (Table 6). The genomic insert of this candidate contained 
SDT1 among other genes. SDT1 encodes a protein with pyrimidine nuclease activity and is 
known to suppress the 6AUS phenotype of a dst1Δ deletion mutant (Shimoaraiso et al., 2000). 
DST1 encodes the transcription elongation factor TFIIS.  As an elongation factor, TFIIS 
associates with RNA polymerase II and promotes intrinsic transcript cleavage by RNA 
polymerase II to overcome obstacles to elongation (Kettenberger et al., 2003; Kettenberger et al., 
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 2004). Sdt1 involvement in pyrimidine metabolism suggests that suppression of dst1Δ occurs 
indirectly (Nakanishi and Sekimizu, 2002), and therefore, it is likely multicopy SDT1 could 
suppress the 6AUS phenotype of rtf1-107 in a nonspecific fashion.  
Plasmid number 304 was isolated in the dosage suppression screen because it suppressed 
the Spt- phenotype of rtf1-107 (Table 6 and 8). Sequence analysis of the genomic insert revealed 
several likely candidate genes that in multicopy could be responsible for the observed 
suppression. YDJ1 stands out in particular because it encodes a cytosolic HSP40 chaperone 
protein that could indirectly suppress the Spt- phenotype of rtf1-107 (Caplan et al., 1993). 
Overexpression of YDJ1 in rtf1-107 cells could help mutant Rtf1 protein fold properly thereby 
suppressing phenotypes associated with rtf1-107. If this is the case, why does high-copy-number 
YDJ1 not confer resistance to 6AU in rtf1-107 mutants? High-copy-number plasmids containing 
YDJ1 were not identified in this screen as suppressors of the 6AUS phenotype of rtf1-107. One 
explanation for not recovering YDJ1 containing plasmids as multicopy suppressors of the 
conditional 6AUS phenotype of rtf1-107 is that increased dosage of YDJ1 does help mutant Rtf1 
fold properly only at the permissive temperature. Suppressors of the Spt- phenotype of rtf1-107 
cells were screened for at the permissive temperature (30°C) and suppressors of 6AUS were 
screened for at the non-permissive temperature (37°C). An alternative explanation is that 
overexpression of YDJ1 does not cause suppression of the phenotypes of rtf1-107 strains. Rather, 
another candidate on the genomic insert may directly or indirectly suppress the Spt- phenotype of 
rtf1-107. This possibility will be addressed below. 
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Table 6: Multicopy library plasmids that may confer suppression of rtf1-107 through non-specific 
mechanisms  
 
 
Library 
isolate 
Genes within genomic insert Phenotype (s) 
suppressed 
7 TPO1, ISA1, HSP104 6AUR 
91 VRG4, SDT1, COD3, EDC1, NIF3,YGL220W, YGL218W, 
MMM2, KIP3 
6AUR 
176 GPI13, YLL030C, YLL029W, TPO1 6AUR 
192 URA3, TIM9, RPR1, YELCTAU1, MMS21 weak 6AUR 
304 YDJ1, MTQ1, GCD10, NOP2, partial ARP5 Spt+ 
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As expected, library plasmids that suppressed the 6AUS and/or the Spt- phenotypes of rtf1-
107 were identified that contained no obvious candidate genes. Table 7 contains a subset of these 
types of dosage suppressors of rtf1-107. In addition, most of these plasmids do not confer strong 
suppression. The two plasmids in Table 7 that do confer strong suppression contain genes that 
are not directly involved in transcription by RNA polymerase II. The observation that these 
candidates may not confer strong suppression or that genomic inserts conferring strong 
suppression do not have known roles in RNA polymerase II transcription does not mean that 
these candidates should be ignored. Understanding the mechanism of suppression caused by 
these candidates could provide insight into roles that Rtf1 may perform outside of transcription. 
Regardless, while these candidates are considered a low priority, they should be revisited as 
more information about the genes contained within their inserts becomes available. 
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Table 7: Library plasmids capable of rtf1-107 suppression that do not contain "obvious candidate genes" 
within their genomic inserts 
 
 
Library 
isolate 
Genes within genomic insert Phenotype(s) 
suppressed 
47 CCA1, RPH1, ADK2 weak 6AUR,  
weak Spt+ 
169 PHM8, KRE29, HVG1, YER039C-A weak 6AUR,  
weak Spt+ 
197 NOP12, RPS15, RPP2A, PRE6, YOL036W, YOL037C, 
YOL035C, SNR50 
weak 6AUR,  
weak Spt+ 
280 NCE101, RCY1, PRP21, YJL202C, ECM25, YJL200C, 
TT(AUG)J, YJLWDELTA1, YJL199C 
weak Spt+ 
312 KTR4, BEM1, DER1 6AUR 
317 SEC31, SNF3 Spt+ 
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The purpose of identifying dosage suppressors of phenotypes conferred by rtf1-107 was to 
identify genes that functionally interact with RTF1. The function of such genes could provide 
further insight into the function of Rtf1 and the other members of the Paf1 complex in 
transcription as well as extend the type and number of roles for the Paf1 complex in the cell. 
Table 8 contains the most exciting library plasmids isolated from the high-copy-number genetic 
screen performed with rtf1-107. The genomic inserts of the library plasmids in Table 8 contain at 
least one gene with links to RNA polymerase II transcription, RNA metabolism, splicing or 
export, or some other nuclear function. The genes most likely responsible for conferring 
suppression are in bold type. As expected, library plasmids containing RTF1 within the genomic 
insert were capable of suppressing the Spt- phenotype of rtf1-107. Candidate 172 contained 
RTF1 and suppressed both phenotypes caused by the rtf1-107 mutation. 
Six different library plasmids that conferred suppression of the Spt- phenotype of rtf1-107 
were candidates 281, 304, 305, 309, 326, and 352 (Table 8). Candidates 305 and 309 will be 
discussed further in sections 2.3.3.1. and 2.3.3.2., respectively. Suppressor candidate 281 
contained SSD1 within the genomic insert. A reported function for Ssd1 includes RNA binding 
and nuclease activity (Luukkonen and Seraphin, 1999). While Ssd1 is potentially an exciting 
candidate, the fact that SSD1 had been identified in several other high-copy-number suppressor 
screens suggested it may not have a direct role in Paf1 complex function (Kosodo et al., 2001; 
Lorenz and Heitman, 1998; Stettler et al., 1993), and our focus was directed toward other 
candidates. To date, we cannot rule out the possibility of a genetic interaction between RTF1 and 
SSD1. However, it is worth noting here that recent reports on Ssd1 indicate it could be a 
worthwhile candidate for further study. For example Ssd1 has been reported to associate with 
phosphorylated CTD and Set2 (Jones et al., 2004), and be involved in maintaining cell wall 
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 integrity possibly through the target-of-rapamycin (TOR) signaling pathway in yeast (Reinke et 
al., 2004). 
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Table 8: High-copy-number library plasmids that cause suppression of rtf1-107 and contain genes within the 
genomic insert with connections to gene expression  
 
 
Library 
isolate 
Genes within genomic insert Phenotype (s) 
suppressed 
172 PDE1, BRR6, RAI1, YGL244W, RTF1, TAD1, YGL242C 6AUR , Spt+ 
281 SRP101, SSD1, DPL1 Spt+ 
304 YDJ1, MTQ1, GCD10, NOP2, partial ARP5 Spt+ 
305 RSA1, PRM3, YPL191C, NAB3a Spt+ 
309 RTG3 a, SFT2, ECM21 Spt+ 
326 YMR046W-A, YMRCTY1-3, YMRDELTA8, TH(GUG)M, 
NUP116, CSM3 
Spt+ 
352 YNL200C, GCR2, YNL198C, WHI3 Spt+ 
a designates genes tested for their ability to confer suppression in the rtf1-107 strain. 
Bold terms indicate genes that are candidates for suppressing rtf1-107 phenotypes as indicate. 
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Candidate 304 contains a number of genes of interest. The name MTQ1 has been reserved 
on the Saccharomyces Genome Database (Balakrishnan et al.) and is the uncharacterized open 
reading frame, YNL063W. Mtq1 exhibits amino acid sequence similarity with HemK, a protein in 
E. coli, which is a glutamine methyltransferase that modifies peptide release factors involved in 
translation termination (Nakahigashi et al., 2002). Interestingly, the HemK family of 
methyltransferases exhibit amino acid sequence similarity with proteins involved in DNA 
methylation (Nakahigashi et al., 2002). While DNA base methylation is an important 
modification that serves to regulate gene expression in higher eukaryotes, there is no evidence 
that this modification is involved in regulating transcription in S. cerevisiae (Feng et al., 2004). 
Therefore, MTQ1 is likely not the gene responsible for the observed dosage suppression of rtf1-
107.  
Another interesting gene on plasmid 304 is GCD10. Gcd10 forms a heterodimeric complex 
with Gcd14 that is involved in methylating (N)1 the adenine 58 residue within eukaryotic tRNAs 
(Anderson et al., 1998; Anderson et al., 2000; Ozanick et al., 2005). Interestingly, Gcd10 
interacts with TFIIB, a component of the general transcription machinery via two-hybrid analysis 
(Ito et al., 2001). This result was reported in a genome-wide two-hybrid study and has not been 
confirmed independently. In the future, overexpression of GCD10 should assayed in rtf1-107 
cells to determine whether GCD10 and RTF1 do genetically interact. 
The last full length gene of note on candidate 304 is NOP2. The Nop2 protein is important 
for the maturation of the 27S pre-rRNA presumably through the protein's S-adenosylmethionine-
dependent methyltransferase activity that is responsible for the methylation at position 5 of 
cytosine (Hong et al., 1997; King and Redman, 2002). However, the function of NOP2 like the 
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 function of the other genes of interest on plasmid 304, do not directly point to a probable 
mechanism of suppression of the rtf1-107 mutation.  
The partial open reading frame of ARP5 is also worth mentioning. Unfortunately, the 
position of ARP5 on the genomic insert results in the removal of the first 133 nucleotides that 
correspond to the start of the coding region and promoter sequences. With this stated, it is 
possible, although unlikely, that sequences within the vector could contribute to the transcription 
of the remaining coding sequence of ARP5. Further, this candidate would be most likely to 
suppress the Spt- phenotype of rtf1-107 since Arp5 is a component of the INO80 chromatin 
remodeling complex and the Spt- phenotype is associated with defects in chromatin structure 
(Ebbert et al., 1999; Jonsson et al., 2004; Shen et al., 2003). Theoretically, it is possible that 
increased dosage of even a truncated form of Arp5 could reverse the Spt- phenotype in rtf1-107 
cells. Previous evidence from our lab independently verified a functional interaction between 
INO80 and the Paf1 complex. Specifically, genes encoding members of the INO80 complex 
interact genetically with genes encoding the Paf1 complex (M. H. Warywoda and K. M. Arndt, 
unpublished observations). 
NUP116 of library plasmid 326 is the most reasonable candidate to confer suppression of 
the Spt- phenotype in rtf1-107 cells. First, Nup116 is a component of the nuclear pore complex 
(NPC) that interacts with the mRNA export protein Mex67 a protein closely associated with the 
yeast TREX complex (Strasser et al., 2002). Like TREX, the Paf1 complex associates with 
actively transcribing RNA polymerase II and could possibly function in mRNA export (Strasser 
et al., 2002). Second, Nup116 is implicated in snRNA and snRNP particle export (Strawn et al., 
2001). RTF1 functionally interacts with NAB3 and NRD1 as described in section 2.3.3.1., section 
2.3.4.1., and in chapter 3; these genes encode factors that are important for proper transcription 
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 termination of snRNAs and snoRNAs (Steinmetz et al., 2001). Third, a two-hybrid analysis 
conducted in our lab with Rtf1 uncovered an interaction between a component of the nuclear 
pore complex and Rtf1 (K. L. Roinick and K. M. Arndt, unpublished observations). However, 
high-copy-number NUP116 may not directly suppress the Spt- phenotype of rtf1-107 at the level 
of transcription. This mechanism of suppression could occur if extra copies of Nup116 improve 
the kinetics of RNA export out of the nucleus. Since cells containing the mutant form of Rtf1 are 
viable, it is inferred that transcription does proceed albeit with consequences we may not fully 
appreciate. In this manner, RNA polymerase II associated with the mutant form of Rtf1 produces 
transcripts that may be more efficiently exported when NUP116 is overexpressed, perhaps 
compensating for a kinetic defect in RNA synthesis. 
The last library plasmid of interest in Table 7 is 352. This plasmid contains two annotated 
genes that could confer suppression of the Spt- phenotype of rtf1-107 cells. The GCR2 gene 
encodes a transcriptional activator involved in regulating the expression of genes involved in 
glycolysis (Henry et al., 1994; Turkel and Bisson, 1999; Uemura et al., 1997). A second reason 
for our interest in GCR2 is that it was identified in a two-hybrid screen in our lab where the 
sequence encoding the N-terminal region of YMR247C was used as bait (R. Gonda, M. A. Braun, 
and K. M. Arndt, unpublished observation). YMR247C, which is required for viability in cells 
lacking RTF1 (P. J. Costa, M. A. Braun, K. M. Arndt, unpublished observations), has been 
implicated in chromatin dynamics (M. A. Braun and K. M. Arndt, unpublished observations; D. 
Hess and F. Winston, personal communications). Gcr2 could potentially suppress the Spt- 
phenotype of rtf1-107 at the level of transcription since Gcr2 functions in a complex with Gcr1 
to activate transcription of a subset of genes (Henry et al., 1994; Turkel and Bisson, 1999; 
Uemura et al., 1997). Alternatively, multicopy WHI3 could reverse the Spt- phenotype in rtf1-
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 107 strains. The Whi3 protein binds RNA and is implicated in the sequestration of transcripts 
from the G1 cyclin genes CLN2 and CLN3 (Gari et al., 2001; Wang et al., 2004). Overexpression 
of WHI3 leads to a large cell phenotype and ultimately in a lethal arrest in G1 (Gari et al., 2001; 
Nash et al., 2001; Wang et al., 2004). Observations from the Jaehning lab indicate that members 
of the Paf1 complex as well as the G1 specific transcriptional activator SBF are required for the 
transcription of CLN1 and CLN2 and other cell cycle regulated genes (Wittenberg and Reed, 
2005). Further, deletion of either individual subunit of the activator complex SBF, SWI4 or 
SWI6, together with deletion of either RTF1 or PAF1 causes synthetic lethality (Figure 28) (Betz 
et al., 2002; Koch et al., 1999; Porter et al., 2002). Hence, the possibility remains that a 
functional connection between WHI3 and RTF1 results in suppression of the Spt- phenotype of 
rtf1-107  by overexpression of WHI3. 
2.3.3.1 NAB3 is a dosage suppressor of rtf1-107 
Library plasmid 305 was of particular interest since it suppressed the Spt- phenotype of rtf1-
107 strains and contained the NAB3 gene within a large genomic fragment.  Nab3 functions in 
the Nrd1 pathway for 3'-end formation of RNA polymerase II transcripts that are not 
polyadenylated (Conrad et al., 2000; Steinmetz et al., 2001).  Together, the essential Nab3 and 
Nrd1 proteins recognize and bind to specific sequences within snRNA and snoRNA transcripts 
(Carroll et al., 2004) to promote transcript termination and 3'-end formation in a reaction that 
also requires the Sen1 helicase (Steinmetz et al., 2001) and components of the APT and CFI 
cleavage/polyadenylation factor complexes (Cheng et al., 2004; Dheur et al., 2003; Dichtl et al., 
2004; Fatica et al., 2000; Morlando et al., 2002; Nedea et al., 2003; Steinmetz and Brow, 2003).  
Final maturation of snoRNA 3' ends also requires the 3'-to-5' exonuclease activity of the nuclear 
exosome complex (Allmang et al., 1999; Allmang et al., 1999; van Hoof et al., 2000). To 
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 determine whether NAB3 overexpression was responsible for the suppression, the NAB3 gene 
was subcloned into a 2-micron vector and transformed into the rtf1 point mutants, rtf1∆, and 
RTF1+ strains (Figure 9).  While NAB3 overexpression suppressed the Spt- phenotypes caused by 
the three rtf1 point mutations (Figure 9), it did not suppress the phenotypes associated with 
deletion of RTF1 (Figure 9).  Therefore, NAB3 is not a bypass suppressor of rtf1. 
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Figure 9: High-copy-number NAB3 suppresses the Spt- phenotype of conditional mutations in RTF1 
Genetic interaction between RTF1 and NAB3. Vector (pRS425), candidate 305 (library isolate), 
high-copy-number NAB3 (2μ NAB3) were transformed into RTF1 (KY767), rtf1Δ (KY656), rtf1-
107 (M289K; KKY60), rtf1-105 (V274D; KKY64), rtf1-100 (Q172R; KKY54) cells. 
Transformants were used to inoculate saturated overnight cultures. Equivalent numbers of cells 
were spotted in ten-fold serial dilutions onto the indicated media. The Spt- phenotype was 
analyzed on medium lacking histidine and leucine. Plates were incubated at either 30°C or 37°C 
as indicated. 
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2.3.3.2 RTG3 partially suppresses the Spt- phenotype of rtf1-107 
Candidate 309 was also of interest since this plasmid caused the suppression of the Spt- 
phenotype of rtf1-107. The genomic insert contained RTG3, which encodes a basic helix-loop-
helix leucine zipper factor that complexes with Rtg1, another basic helix-loop-helix leucine 
zipper protein (Jia et al., 1997; Rothermel et al., 1997). Together, Rtg1-Rtg3 activate RNA 
polymerase II transcription of genes involved in the retrograde (RTG) and/or TOR signaling 
pathways (Dilova et al., 2004; Dilova et al., 2002). RTG signaling is important for 
communication between the mitochondrion and the nucleus and is induced in the event that the 
activity of the tricarboxylic acid cycle is impaired (Jazwinski, 2005). This results in the 
expression of metabolic and stress-related genes that provide alternate sources of biosynthetic 
precursors (Strawn et al., 2001). Preliminary dilution analyses where RTG3 was subcloned into a 
2-micron plasmid and transformed into RTF1, rtf1Δ and the rtf1 point mutants, indicates 
overexpression of RTG3 is only partially responsible for suppression of the Spt- phenotype of the 
rtf1 missense mutations (Figure 10). The possible relationship between Rtg3 and the Paf1 
complex should remain a research interest since ACO1, a gene regulated by Rtg1-Rtg3 in the 
RTG response, is induced in ctr9Δ cells when analyzed by microarray analysis (Table 16).  
 114
  
Figure 10: Increased dosage of RTG3 partially suppresses the Spt- phenotype of the rtf1 temperature sensitive 
mutants 
Genetic interaction between RTF1 and RTG3. Vector (pRS425), candidate 309 (library isolate), 
high-copy-number RTG3 (2μ RTG3) were transformed into RTF1 (KY406), rtf1Δ (KY410), rtf1-
107 (M289K; KKY60), and rtf1-105 (V274D; KKY64). Transformants were used to inoculate 
saturated overnight cultures. Equivalent numbers of cells were spotted in ten-fold serial dilutions 
onto the indicated media. The Spt- phenotype was analyzed on medium lacking histidine and 
leucine (6 days of incubation at 30°C). 
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2.3.4 Additional genetic analyses support a functional link between RTF1 and NAB3 
2.3.4.1 Multicopy NAB3 causes synthetic growth phenotypes in ctr9Δ and paf1Δ cells 
Since NAB3 is a multicopy suppressor of the rtf1 missense mutants, we were curious to 
determine if NAB3 genetically interacted with the genes encoding other members of the Paf1 
complex. To this end, 2-micron NAB3 was transformed into strains lacking individual members 
of the Paf1 complex. Phenotypic analysis was performed and the data from two separate 
experiments are summarized in Table 9. Interestingly, overexpression of NAB3 in the absence of 
either PAF1 or CTR9 caused synthetic growth defects when compared to empty vector (Table 9). 
The growth defect was so severe in the paf1Δ mutant that liquid cultures did not grow to 
saturation and were not analyzed by dilution analysis (K. E. Sheldon and K. M. Arndt, 
unpublished observations). For ctr9Δ mutants, growth on synthetic dextrose (SD) medium at 
30°C and synthetic complete (SC) medium at 37°C was impaired when transformed with empty 
vector (pRS425) as compared to the growth of wild-type cells on SC media at 30°C. Solid SD 
and SC growth media are prepared essentially the same, however SC medium contains all amino 
acids, uracil and adenine bases but lack the amino acid or base used for selection while SD 
medium contains only the amino acids or bases required to sustain the auxotrophies of the cells, 
lacking the amino acids and bases required for maintaining selection. Healthy cells that are 
supplemented with the appropriate amino acids or bases are capable of growing on either type of 
medium, yet some mutant strains are unable to grow on these synthetic media since they are 
either sick even on rich media or they are defective for inducing biosynthetic pathways. 
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 Importantly, ctr9Δ cells with 2-micron NAB3 are even further impaired for growth on SD plates 
at 30°C or SC plates at 37°C as compared to ctr9Δ cells with vector only. 
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Table 9: Phenotypic analysis of increased NAB3 dosage in cells deleted for individual Paf1 complex members 
 
 
YEAST 
STRAIN 
pRS425  
SD-LEU 
30°C 
pRS425  
SC-LEU 
37°C 
pRS425  
SC-LEU 
30°C 
2μ NAB3  
SD-LEU 
30°C 
2μ NAB3  
SC-LEU 
37°C 
2μ NAB3 
 SC-LEU 
30°C 
wild-type +++a +++++ a +++++ +++ a +++++a +++++ 
rtf1Δ ++ a +++++ a +++++ ++ a +++++a +++++ 
paf1Δ N.D. N.D. N.D. N.D. N.D. N.D. 
ctr9Δ ++a ++a ++++ +a -a ++++ 
cdc73Δ ++++a +++++ a +++++ +++a +++a +++++ 
leo1Δ +++a +++++ a +++++ +++a +++++a +++++ 
a The experiment was performed one time only; unless otherwise indicated all other experiments were 
performed two times. 
N.D. Not Determined. 
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A modest defect in growth was observed for cdc73Δ mutants when transformed with 2-
micron NAB3 (Table 9). cdc73Δ cells containing vector alone did not exhibit severe growth 
defects. However, cdc73Δ strains containing multiple copies of NAB3 grew poorly on SD 
medium at 30°C or SC medium at 37°C as compared to vector-containing cells. Perhaps of some 
significance is the result that the synthetic growth phenotype observed in cdc73Δ cells with 
multiple copies of NAB3 is not as severe as those observed for ctr9Δ mutants with 2-micron 
NAB3.  
Increased dosage of NAB3 displayed no discernable defect in rtf1Δ or leo1Δ mutants as 
compared to empty vector (Table 9). When transformed with either empty vector or 2-micron 
NAB3, these mutants grew similar to wild-type on SC media at either 30°C or 37°C. However, 
rtf1Δ and leo1Δ mutants transformed with either empty vector or high-copy-number NAB3 did 
exhibit poor growth only on SD medium at 30°C as compared to the wild-type control cells. 
These results contrast with those for the ctr9Δ and paf1Δ mutants. While ctr9Δ and paf1Δ 
mutants containing vector or 2-micron NAB3 grew poorly in selective SC media, this could 
simply be due to the poor growth phenotypes of these strains alone. Conversely, the synthetic 
phenotype could be caused by the overexpression of NAB3 in the ctr9Δ cells. This analysis also 
provides additional evidence in support of functional differences between individual members of 
the Paf1 complex. Importantly, this study does strengthen the basis for a functional interaction 
between RTF1 and NAB3.  
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 2.3.4.2 nrd1-5 cells require members of the Paf1 complex for viability at elevated 
temperatures. 
In another approach to test for functional interactions between Nrd1 and the Paf1 complex, 
we generated double mutant strains containing the nrd1-5 mutation and deletions of individual 
components of the Paf1 complex. The nrd1-5 allele alters a single amino acid in the RNA 
recognition motif (RRM) of Nrd1 (Steinmetz and Brow, 1996) and causes a moderate 
temperature sensitive growth phenotype (Figure 11). However, strains that contain nrd1-5 in 
combination with a deletion of RTF1, CDC73, PAF1, or CTR9 exhibit strongly enhanced 
temperature sensitivity (Figure 11). These synthetic interactions between a mutation in nrd1 and 
defects in the Paf1 complex are consistent with our discovery of NAB3 as a dosage suppressor of 
an rtf1 mutation. Taken together, the genetic results demonstrate a functional connection 
between the Paf1 complex and factors involved in poly(A)-independent 3'-end formation. 
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Figure 11: nrd1-5 combined with deletions of individual Paf1 complex members confers synthetic phenotypes 
Paf1 complex members genetically interact with NRD1. A plasmid shuffle experiment was 
performed by transforming pRS314, pRS314-NRD1, or pRS314-nrd1-5 into nrd1Δ RTF1 
(KKY129), nrd1Δ rtf1Δ (KKY128), or nrd1Δ cdc73Δ (KKY143) cells that contained pRS316-
NRD1. Transformants were passaged on 5FOA to select against pRS316-NRD1 plasmid. 
Equivalent numbers of cells were spotted in ten-fold serial dilutions onto YPD (4 days 
incubation). 
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2.4 Conclusions 
2.4.1 Point mutations in rtf1 confer conditional loss-of-function phenotypes 
Mutagenic PCR of RTF1 followed by homologous recombination in vivo was used to 
identify new mutations in RTF1 that confer conditional 6AUS and Spt- phenotypes. From eight 
candidates initially identified, three mutations causing individual amino acid substitutions were 
recovered that conferred conditional mutant phenotypes. The substitutions encoded by the 
mutations were Q172R, V274D, and M289K. These residues reside in the central, conserved 
region of Rtf1 (Figure 7). The rtf1 allele that causes the Q172R substitution is rtf1-100 and 
confers a conditional Spt- phenotype (Figure 6). rtf1-105 that encodes the V274D and rtf1-107 
encoding M289K cause conditional 6AUS and weak Spt- phenotypes (Figure 6). Importantly, the 
phenotypes of the three alleles are not caused by the absence of Rtf1 in the cell as observed by 
immunoblot analysis (Figure 8A). 
2.4.2 NAB3 and RTG3 were identified in a high-copy-number suppressor screen to 
identify genes that suppress the phenotypes of conditional rtf1 alleles 
The rtf1-107 strain was chosen for use in a high-copy-number genetic screen. The goal of 
the screen was to identify library plasmids that suppressed the conditional 6AUS and/or the weak 
Spt- phenotype exhibited by this mutant. Genes responsible for the suppression of the rtf1-107 
phenotypes could be the result of authentic genetic interactions or indirect mechanisms. To 
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 eliminate the latter possibility, the genomic inserts of candidate plasmids were identified. The 
individual genes contained within the inserts were analyzed in detail using the Saccharomyces 
Genome Database (Balakrishnan et al.), literature searches, and web-based protein motif 
searches.  These approaches helped to filter out the genes least likely to confer suppression in 
most cases. However, candidate plasmids also contained genes that have no known roles in 
transcription or RNA metabolism and/or open reading frames without functions ascribed to 
them. Fortunately, a few strong candidate genes likely to be responsible for the observed 
suppression were identified. These candidates included NAB3 and RTG3, as well as a number of 
genes in Table 8. For NAB3 and RTG3, several lines of evidence indicate that they were 
responsible for suppression, including their connection to transcription by RNA polymerase II 
and the observation that library plasmids that contained them suppressed the Spt- phenotype of 
rtf1-107, a phenotype indicative of defects in transcription initiation and elongation. NAB3 and 
RTG3 were subjected to further analysis. 
Both NAB3 and RTG3 were subcloned and tested directly for suppression of rtf1 mutations 
(Figure 9 and Figure 10). Increased dosage of NAB3 suppressed the Spt- phenotype of the rtf1 
point mutants and did not suppress the Spt- phenotype of an rtf1Δ strain. In a preliminary 
experiment, high-copy-number RTG3 partially suppressed the Spt- phenotype of the rtf1 point 
mutants and not the Spt- phenotype of rtf1Δ cells. Additionally, overexpression of NAB3 results 
in synthetic sickness in ctr9Δ and paf1Δ cells (Table 9). The suppression of rtf1-107 caused by 
increased NAB3 is also supported by the observation that nrd1-5 in combination with deletion of 
individual Paf1 complex members resulted in enhanced synthetic phenotypes (Figure 11).  
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 3.0  Chapter 3: A novel role for the Paf1 complex in 3'-end formation of snoRNA 
transcripts 
3.1 Introduction 
 RNA polymerase II is required for the transcription of both polyadenylated and non-
polyadenylated transcripts. The transcripts of protein-coding genes must be polyadenylated 
within the nucleus, otherwise these transcripts will be recognized and degraded via RNA 
surveillance pathways (Penheiter et al., 2005; Vanacova et al., 2005; Wyers et al., 2005; Yart et 
al., 2005). On the other hand, snRNAs and snoRNAs also transcribed by RNA polymerase II are 
not normally polyadenylated and are destabilized by the aberrant addition of poly(A) sequences 
(Vanacova et al., 2005; Wyers et al., 2005). The 3'-ends of polyadenylated and non-
polyadenylated messages are formed similarly and perhaps unexpectedly with a small subset of 
factors that participate in 3'-end formation of both types of transcripts (Dheur et al., 2003; Dichtl 
et al., 2004; Nedea et al., 2003; Steinmetz et al., 2001). Further, RNA polymerase II transcription 
termination of RNA synthesis is tightly coupled with 3'-end formation of the nascent transcript 
(Bentley, 2005; Proudfoot, 2004). Together these processes ensure that mature RNAs are 
properly formed. 
Among factors that associate with RNA polymerase II, Nab3 and Nrd1 are known to 
function in terminating transcription of non-polyadenylated messages. Two-hybrid analysis 
uncovered an interaction between RNA polymerase II and Nrd1 (Conrad et al., 2000). This 
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 interaction may be facilitated through the N-terminal domain of Nrd1, which exhibits sequence 
similarity with proteins known to interact with the C-terminal domain (CTD) of the largest 
subunit of RNA polymerase II through their CTD interaction domain (CID) (Meinhart and 
Cramer, 2004). The CID of the S. cerevisiae Pcf11 protein, a factor involved in terminating the 
transcription of polyadenylated messages, directly contacts the CTD (Hollingworth et al., 2005; 
Meinhart and Cramer, 2004; Noble et al., 2005). Alternatively, the association between Nrd1 and 
RNA polymerase II may be established or maintained through contacts involving the RRM of 
Nrd1 and/or Nab3 and their known binding sequences within the nascent transcript.    
A high-copy-number suppressor screen identified NAB3 as a dosage suppressor of rtf1-107. 
This genetic relationship was further supported upon additional analyses, where overexpression 
of NAB3 in strains lacking individual Paf1 complex members caused synthetic sickness and 
deletion of Paf1 complex members enhanced phenotypes of a mutation in NRD1. These 
observations indicated that Nab3 and Nrd1 do not bypass the function of Rtf1 or the Paf1 
complex. Rather, we propose that a functional link exists between Nab3 and the Paf1 complex. 
The underlying genetic relationships among members of the Paf1 complex and Nrd1 and Nab3 
suggested that Rtf1 and the Paf1 complex could be involved in the 3'-end formation and/or 
transcription termination of snRNAs and snoRNAs. 
To establish a functional relationship between the Paf1 complex and the transcription 
termination factors Nab3 and Nrd1, the processes of 3'-end formation and transcription 
termination needed to be examined in Paf1 complex mutants. Co-IP experiments could be used 
to determine physical interaction among Paf1 complex members and Nrd1 and/or Nab3. Further, 
ChIP could provide detailed information regarding the occupancy and interrelationships of the 
Paf1 complex, Nrd1 and Nab3, and RNA polymerase II on actively transcribed genes. Results 
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 from the above experiments may contribute to ascertain whether the Paf1 complex is 
functionally connected to Nrd1 and Nab3 and provide insight into additional roles performed by 
the Paf1 complex in transcription.  
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3.2 Methods and materials 
3.2.1 Yeast strains 
SC medium was prepared with or without the addition of 100mM CuSO4 as described 
(Steinmetz and Brow, 1996). As described in section 2.2.1, yeast strains used in this study are 
isogenic with FY2 (Table 10). However, two strains outside of the S288c genetic background 
were utilized for an in vivo reporter analysis that required the absence of the CUP1 gene. 
Outside haploid strains 46a and 46α were mated to construct a homozygous cup1Δ strain. In this 
diploid strain, genes encoding the members of the Paf1 complex were singly deleted using a 
PCR-based method (Ausubel et al., 1988) as described in section 2.2.1. and haploid strains were 
recovered using tetrad analysis (Rose  et al., 1990).  These strains were utilized in the ACT1-
CUP1 reporter analysis described in sections 3.2.4.1. and 3.3.1. 
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Table 10: Yeast strains used in Chapter 3 
 
 
STRAIN GENOTYPE ORIGIN 
46α MATα cup1Δ his3 lys2 leu2 ura3 trp1 ade2  Brow lab 
46a MATa cup1Δ his3 lys2 leu2 ura3 trp1 ade2 " 
46α/46a MATα/ MAT a cup1Δ/" his3/" lys2/" leu2/" ura3/" trp1/" ade2/" Arndt lab 
FY118 MATa his4-912δ lys2-128δ leu2Δ1ura3-52 trp1Δ63 Winston lab 
FY348 MATa spt16-197 his4-912δ lys2-128δ leu2Δ1ura3-52 " 
FY1635 MATα spt5-242 his4-912δ lys2-128δ leu2Δ1ura3-52 " 
GHY166 MATa spt4Δ2::HIS3 his3Δ200 lys2-128δ leu2Δ1 ura3-52 trp1Δ63 Hartzog lab 
GHY250 MATα  leo1Δ::URA3 his4-912δ lys2-128δ  leu2Δ1ura3-52  " 
GHY972 MATα HA3::PAF1 his3Δ200 lys2-128δ ura3Δ0 " 
GHY1094 MATα  ctr9Δ::KANMX4 his3Δ200 lys2-128δ leu2Δ1 ura3-52 " 
GHY1177 MATα his4-912δ lys2-128δ  leu2Δ0 ura3Δ0 trp1Δ63 CTR9-6XMYC  
KY508 MATa snf2Δ::HIS3 his3Δ200 lys2-128δ leu2Δ1 ura3-52 Arndt lab 
KY560 MATα rtf1Δ102::ARG4 arg4-12his3Δ200 lys2-173R2 leu2Δ1 ura3-52 " 
KY586 MATα ctk1Δ::HIS3 his3Δ200 lys2-128δ leu2Δ1 ura3-52 " 
KY591 MATa leu2Δ1ura3-52 trp1Δ63  " 
KY632 MATα chd1::URA3 his3Δ200 lys2-128δ leu2Δ1 ura3-52  " 
KY656 MATa rtf1Δ100::URA3 his4-912δ lys2-128δ leu2Δ1 ura3-52  " 
KY661 MATa his3Δ200 his4-912δ lys2-128δ leu2Δ1 ura3-52  " 
KY669 MATa his3Δ200 lys2-128δ leu2Δ1 ura3-52 trp1Δ63 " 
KY693 MATa ctr9Δ::KANMX4 leu2Δ1ura3-52 trp1Δ63 " 
KY671 MATα/ MAT a his3Δ200/" lys2-128δ/" leu2Δ1/" ura3-52/" trp1Δ63/TRP1 
ADE8/ade8 
" 
KY685 MATa paf1Δ::URA3 his4-912δ lys2-128δ leu2Δ(0 or 1) ura3(Δ0 or -52) " 
KY689 MATα cdc73Δ::KANMX4 lys2Δ0 leu2Δ0 " 
KY718 MATa spt5-194 his3Δ200 lys2-128δ ura3-52 " 
KY802 MATa paf1Δ::URA3 his3Δ200 lys2-173R2 ura3(Δ0 or -52) " 
KY817 MATα ctr9Δ::KANMX4 his4-912δ  lys2-128δ  leu2Δ1 ura3-52 " 
KY884 MATa isw2::HIS3 his3Δ200 lys2-173R2 leu2Δ1 ura3-52 trp1Δ63 " 
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 Table 10 (continued) 
KY907 MATa set1::HIS3 his3Δ200 lys2-128δ  leu2Δ1 ura3-52 " 
KY912 MATa set2::HIS3 his3Δ200 lys2-128δ  leu2Δ1 ura3-52 " 
KY927 MATa gcn5Δ::HIS3 his3Δ200 leu2Δ1 " 
KY930 MATα rad6Δ::URA3 his3Δ200 ura3-52 " 
KY935 MATα dot1Δ::HIS3 his3Δ200 ura3-52 " 
KY968 MATa bre1Δ::KANMX4 his3Δ200 ura3-52 " 
KY972 MATa swr1Δ:KANMX4 his3Δ200 lys2-128δ  leu2Δ1ura3-52 " 
MHY57 MATa ino80Δ::HIS3 his3Δ200 his4-912δ lys2-173R2 leu2Δ1ura3-52 " 
MHY63 MATα arg82Δ::URA3 his3Δ200 leu2Δ(0 or 1) ura3(Δ0 or -52) " 
MHY75 MATa isw1::HIS3 his3Δ200 lys2-128δ  leu2Δ1 ura3-52 " 
MHY88 MATa arp8Δ::HIS3 his3Δ200 lys2-128δ  leu2Δ(0 or 1) ura3(0Δ or -52) " 
KKY93 MATα/ MAT a nab3Δ::HIS3/NAB3 his3Δ200/" lys2-128δ/" leu2Δ1/" ura3-
52/" trp1Δ63/TRP1 ADE8/ade8 
"" 
KKY113 MATα cup1Δ  ctr9Δ::KANMX4 his3 lys2 leu2 ura3 trp1 ade2 " 
KKY119 MATα cup1Δ  paf1Δ::KANMX4 his3 lys2 leu2 ura3 trp1 ade2 " 
KKY120 MATa nab3Δ::HIS3 his3Δ200 lys2-128δ  leu2Δ1 ura3-52 trp1Δ63 ade8 
pKK10[HA3NAB3, URA3, CEN/ARS] 
" 
KKY122 MATα  paf1Δ::KANMX4 nab3Δ::HIS3 his3Δ200 lys2-128δ  leu2Δ1 ura3-
52 trp1Δ63 pKK10[HA3NAB3, URA3, CEN/ARS] 
" 
KKY125 MATα  nab3Δ::HIS3 his3Δ200 lys2-128δ  leu2Δ1 ura3-52 trp1Δ63 ade8 
pKK11[NAB3, URA3, CEN/ARS] 
" 
KKY126 MATa paf1Δ::KANMX4 nab3Δ::HIS3 his3Δ200 lys2-128δ  leu2Δ1 ura3-52 
trp1Δ63 ade8 pKK11[NAB3, URA3, CEN/ARS] 
" 
PCY48 MATα  fcp1-110 his3Δ200 lys2-128δ  leu2Δ1 ura3-52 " 
nrd1-5 MATα nrd1-5 cup1Δ his3 lys2 leu2 ura3 trp1 ade2 Brow lab 
YSB1560 MATa ctk1Δ::HIS3 his3Δ200 lys2Δ202  leu2Δ1 ura3-52 trp1Δ63 Buratowski lab 
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3.2.2 RNA isolation and Northern analysis 
3.2.2.1 RNA isolation.  
Cells were grown in YPD and harvested at a density of 1-2x107 cells/ml (Squazzo et al., 
2002). Total RNA was isolated from collected cells using acid-washed glass beads, RNA buffer 
(500mM NaCl; 200mM Tris-HCl, pH 7.6; 10mM EDTA, 1% w/v SDS), and 25:24:1 PCI 
(phenol equilibrated with RNA buffer without SDS; CHCl3; ddH2O equilibrated isoamyl 
alcohol). The aqueous supernatant was precipitated with 100% EtOH, washed with 70% EtOH, 
and resuspended in 100μl ddH2O. Total RNA was subjected to spectrophotometric analysis to 
determine concentration and visualized using TBE-agarose gel electrophoresis. 
3.2.2.2 Northern blotting analysis.  
The indicated RNAs were resuspended in RNA sample buffer (50% deionized formamide; 
1X MOPS; 2.12M formaldehyde; 0.5mg/ml ethidium bromide), electrophoresed through a 1.5% 
denaturing agarose gel, and photographed with the 440CF digital imaging station (Kodak). 
Genescreen filters (PerkinElmer Life Sciences Inc.) were hybridized with random-prime labeled 
probes containing [α-32P]dATP (Dupont NEN) and/or [α-32P]dCTP (Dupont NEN), using PCR-
amplified coding sequences of TRS31, SNR13, YDRO42c, SNR47 and SCR1 (Table 11) (Squazzo 
et al., 2002). The blots were exposed to both phosphorimaging screen and film (Kodak). 
3.2.3 Plasmids 
3.2.3.1 Construction of HA epitope-tagged version of Nab3. 
Nab3 was N-terminally epitope-tagged using PCR primers KKO92 and KK093 that encode 
BglII restriction sites engineered at their 5' ends to amplify the triple HA1 epitope as in (Table 
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 11) (Stolinski et al., 1997).  Site-directed mutagenesis was performed on pKK5 (QuikChange XL 
Site-Directed Mutagenesis Kit, Stratagene) with oligonucleotides KKO90 and KKO91 to 
engineer a single BglII site adjacent to the ATG of NAB3 generating plasmid pKK5 (Table 11). 
pKK6-3 was created by subcloning a sequenced NheI-BsgI fragment that encompassed the 
engineered BglII restriction site of pKK5. A BglII flanked (HA)3 108 bp PCR fragment was  
ligated into the BglII site of pKK6-3 and transformed into E. coli. Candidate plasmids were 
confirmed by sequencing over the 5' end of HA3NAB3 candidates and immunoblotting to identify 
HA3NAB3 gene fusions, resulting in pKK9-3. Plasmids pKK9-3 and pKK6-3 were digested with 
XhoI and SpeI to subclone NAB3 and HA3NAB3 containing inserts directionally into pRS316 
yielding pKK10 and pKK11. Dissection of nab3Δ::HIS3 heterozygote KY93 resulted in haploid 
spores sorting 2:0 for viability and 2:0 for His- phenotypes. The NAB3 and HA3NAB3 containing 
plasmids fully complemented a nab3∆ strain for viability at 30°C and 37°C (K. E. Sheldon and 
K. M. Arndt, unpublished observations). 
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Table 11: Oligonucleotide sequences used for plasmid and probe construction  
 
 
Oligonucleotide  Name 5'-Sequence Purpose 
KKO80 GCGCATCTGACCAACAATTCCC TRS31 Northern probe 
KKO81 GGAATCCTTTGATAATGCCGC TRS31 Northern probe 
KKO82 GATTTTTTAAAGGGTCAGG SNR13 Northern probe 
KKo83 CATTATATATGCAGCGCTACG SNR13 Northern probe 
KKO90 CCATCTGCAAGCCATGAGATCTGATGAAA
ACCATAACAGTG 
Amplify HA1 cassette with BglII site 
KK091 CACTGTTATGGTTTTCATCAGATCTCATG
GCTTGCAGATGG 
Amplify HA1 cassette with BglII site 
KKO92 TGTATAATGAAGATCTTACCCATACGATG
TTCCTGAC 
Engineer BglII site within NAB3 
KKO93 TGTATATAGAAGATCTGCCGCACTGAGCA
GCGTAATC 
Engineer BglII site within NAB3 
KK0142 GGCGGTAACGTAAATCAGAGTAGC YDR042c Northern probe 
KKO143 GCATACCGCTTAATATTGTTATCGC YDR042c Northern probe 
KK0144 GGCTTCAGCTCCATATCTTTTG SNR47 Northern probe 
KKO145 CCACCTATAAAGGATTCGGA SNR47 Northern probe 
KK0171 GTGGGATGGGATACGTTGAG SCR1  Northern probe 
KKO172 TAGCCGGGACACTTCAGAAC SCR1  Northern probe 
KK0182 CCTAGCTAGCCGCGTCATTCTTGCTGATT
TTC 
Clone SNR47(70) into p.G-CYC.ds 
KKO183 CCGGCTCGAGCAGAAATAAAGAAAATGA
AAGCTAC 
Clone SNR47(70) into p.G-CYC.ds 
 
 134
  
3.2.3.2 Subcloning of SNR47 termination sequences into pG-CYC.ds.  
The 70 bp required for normal transcription termination of the SNR47 transcript 
(SNR47(70)) were PCR amplified using the Expand high fidelity PCR system (Roche) and 
oligonucleotides engineered with restriction sites for directional subcloning. KKO182 contains 
an NheI restriction site and amplifies the 5' end of SNR47(70) (Table 11). KKO183 contains a 
XhoI site and amplifies the 3' end of SNR47(70) (Table 11). Restriction digests with NheI and 
XhoI were performed on gel-purified PCR products and pG-CYC.ds (Steinmetz and Brow, 
2003). The products of digestion were subject to ligation, E. coli transformation, and plasmids 
were isolated from individual colonies. Candidate plasmids were subjected to restriction digest 
and sequencing analyses to identify constructs containing the SNR47(70) insert, pGCYC-
SNR47(70).ds. 
3.2.4 In vivo reporter experiments 
3.2.4.1 ACT1-CUP1 reporter assay for 3'-end formation.  
The constructs for the ACT1-CUP1 reporter assay were a generous gift of E. J. Steinmetz 
and D. A. Brow (Steinmetz and Brow, 1996). The ACT1-CUP1 reporter contained a TDH3 
promoter driving the expression of the ACT1 gene. Further, the intron of ACT1 was replaced 
with the transcription termination sequence of SNR13 125-232. The CUP1 gene was subcloned 
downstream of the SNR13 termination sequences. Cup1 confers resistance to Cu2+. The indicated 
cells were transformed with the ACT1-CUP1 constructs and selection was maintained on 
medium lacking leucine. Cultures were subjected to dilution analysis essentially as described in 
section 2.2.3.4., with transformants grown in selective medium overnight and spotted in ten-fold 
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 serial dilutions onto SC-Leu medium or SC-Leu medium supplemented with 100mM CuSO4. 
The plates were incubated at 30°C and the images were recorded.  
3.2.4.2 HIS3 reporter for transcriptional readthrough.  
The reporter assay for transcriptional readthrough developed by Carroll et al. utilizes two 
reporter plasmids (Carroll et al., 2004). The reporter constructs were a generous gift of J. L. 
Corden. Transcription of the control reporter construct is driven by the ADH1 promoter with the 
CYC1 terminator placed downstream of the HIS3 gene to ensure proper transcription of HIS3 and 
histidine prototrophy in his3- cells. The second reporter plasmid contains the same promoter, 
HIS3 reporter gene and terminator, but also contains the SNR47(70) termination sequences 
inserted between the ADH1 promoter and HIS3. The SNR47(70) cassette is recognized by the 3'-
end formation machinery in wild-type cells and the HIS3 reporter gene is not transcribed; mutant 
cells defective for 3'-end formation express HIS3 and exhibit growth in the absence of histidine. 
The two constructs were transformed into RTF1 his3Δ200 (KY669) and rtf1Δ his3Δ200 (KY560) 
strains and maintained under selection on SC-Leu medium. Cultures were grown overnight in 
selective medium. The cells were washed two times with sterile ddH2O and the cell density of 
each culture was determined using a hemacytometer. Serial ten-fold dilutions were prepared and 
spotted onto SC-Leu and SC-His-Leu media. The plates were incubated at 30°C and the images 
were recorded.   
3.2.5 Chromatin immunoprecipitation (ChIP) analysis 
Cells were grown in YPD to 1-2x107 cells/ml.  ChIP assays and immunoprecipitations with 
8WG16 antibody (Covance) or anti-HA antibody conjugated to agarose beads (Santa Cruz 
Biotechnology) were performed as described (Komarnitsky et al., 2000; Simic et al., 2003).  
Nrd1 ChIPs were performed by incubating chromatin extracts overnight at 4°C with a 1:100 final 
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 dilution of Nrd1 antisera (a gift from E. Steinmetz and D. Brow (Steinmetz and Brow, 1998)), 
followed by incubation with protein A-coupled Sepharose beads (Amersham Biosciences).  To 
confirm signal linearity, quantitative PCR was performed on two dilutions of input and 
immunoprecipitated DNA using [α-32P]dATP, and relative ChIP signals were calculated as 
described in the figure legends. Table 12 lists the oligonucleotides used for ChIP at the SNR13 
and SNR47-YDR042c loci. Oligonucleotides KKO146 and KKO147 amplified the 3' end of 
SNR13 from +117 to +333 relative to +1 of the SNR13 gene, which is 124 bp in length (per 
Saccharomyces  Genome Database (Balakrishnan et al.). KKO147 annealed 70 bp upstream of 
the translational start of TRS31. PCR primers amplified the sequences relative to +1 of the 
SNR47 genomic sequence (per Saccharomyces Genome Database (Balakrishnan et al.)). 
Oligonucleotides KKO156 and KKO157 amplified downstream of SNR47 relative to ATG=+1 of 
YDR042c, from -11 to +206  (+531 to +749 relative to SNR47). 
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Table 12: Oligonucleotide sequences used for ChIP in Chapter 3 
 
 
Gene Amplified Relative to +1 
of the Indicated Gene 
5'-Oligonucleotide Sequence Primer Pairs 
SNR13 +117 to +333 KKO146-TCTGACCTTTTAACTTCCCCGTAG 
KKO147- CAATCTTAGCATGAACTTCGTCAC 
NA 
SNR47 -350 to -150 KKO149- AATGGTAACAGCTCATTGAAGAAG 
KKO150- TAGAGTGGATGAAAATTTTGTGAA 
1 
SNR47 -51 to +168 KKO151- GTACTGAGCAAAGTAGGAGAAAGGA 
KKO152-GCAAGAATGACGCGAAAATA 
2 
SNR47 +99 to +303 KKO153- TTATAGGTGGAAACAAACTTTGACA 
KKO154- GCCATTAGTAAGTACGCTTTGTTATC 
3 
SNR47 +298 to +484 KKO155- AATGGCTATTATTTTTGCTAATGACAC 
KKO156- GATTCGCTATTTTCAATAGTAAAGTTTC 
4 
YDR042c -11 to +206 KKO156- CTTTTCACAACATGGAGCAAATA 
KKO157- AAAGTTTCGCTCAGTACTCCAACTA 
5 
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Figure 12: Primer pair hybridization location relative to SNR47 and YDR042c 
The oligonucleotides used to amplify DNA surrounding the SNR47 locus are listed below. The 
primer pairs are labeled 1-5 and hybridize relative to SNR47 and YDR042c as indicated in Table 
12 above. The SNR47 gene is indicated by a gray box and is drawn to scale. 
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3.2.6 Co-IP and immunoblotting analysis 
3.2.6.1 Analysis of Nrd1 protein levels. 
To analyze Nrd1 levels, whole cell extracts (Squazzo et al., 2002) were resolved on 10% 
SDS-polyacrylamide gels and nitrocellulose filters were probed with a 1:3000 dilution of anti-
Nrd1 antisera (Steinmetz and Brow, 1998). L3 levels were determined as described in section 
2.2.4. Immunoreactive proteins were detected by chemiluminescence of HRP-coupled secondary 
antibodies and visualized the 440CF digital imaging station (Kodak). 
3.2.6.2 Co-immunoprecipitation (Co-IP) analysis.  
Cells were grown to a cellular density of 2-5x107 cells/ml in YPD. The cells were harvested 
and protein extract preparation was performed as described in (Squazzo et al., 2002). Co-IPs 
were performed as in (Squazzo et al., 2002) using 2mg of protein extract and the following 
dilutions of primary antibodies to isolate the indicated proteins and associated immune 
complexes: 1) no antibody, 2) 1:150 anti-Myc to precipitate Ctr9-6XMyc, 3) 1:1000 anti-Nrd1, 
and 1:3000 anti-HA to precipitate either 4) HA3-Rtf1 or 5) HA3-Paf1. Extracts and primary 
antibodies were rotated overnight at 4°C. Secondary antibodies conjugated to agarose beads 
(Sigma) were incubated with the primary immune complexes for 1-2 hours at 4°C on a rotator. 
Unbound fractions were collected and bound fractions were washed 5 times with 1X lysis buffer 
(1X lysis buffer=20mM HEPES-KOH, pH7.4; 10% glycerol; 2mM Mg(OAc)2, 10mM EDTA, 
pH7.4; and 0.05% Tween-20) containing 1X protease inhibitors (25ml 100X protease inhibitors 
in ethanol= 0.0039g Pepstatin A, 0.0008g Leupeptin, 0.005g Chymostatin, 0.85g Benzamadine, 
and 0.43g PMSF) without 1mM DTT and either 100 or 150mM NaOAc prior to elution in SDS 
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 sample buffer at 100°C. The bound and unbound fractions were resolved on 10% SDS-
polyacrylamide gels. Nitrocellulose filters were probed with the following dilutions of primary 
antibody 1:1000 anti-Myc in Blotto, 1:3000 anti-HA in Blotto, and 1:1000 anti-Nrd1 in Blocko. 
The filters were probed with the primary antibody used in the immunoprecipitation to 
qualitatively estimate the immunoprecipitation efficiency of the reaction. 
3.2.7 Transcription run on (TRO) assays 
3.2.7.1 Harvesting and permeabilizing cells.  
TRO analysis was performed essentially as described in (Steinmetz and Brow, 2003) and 
constructs were provided generously provided by E. J. Steinmetz and D. A. Brow. Briefly, 
strains transformed with pG-CYC.ds, pG-SNR13-125-232-CYC.ds, or pG-SNR47(70).CYC.ds 
were grown at 30°C, unless otherwise indicated, to an OD600 between 0.12-0.2 in selective 
media. Cells were harvested by centrifugation in the GS-15R centrifuge (Beckman) at 4°C, 
washed in ice-cold ddH2O, and transferred to a pre-chilled eppendorf tube. The cells were 
resuspended in 950μl of ice-cold ddH2O and were permeabilized by adding 50μl of 10% w/v 
sarkosyl and incubating the suspension on ice for 20 minutes. The permeabilized cells were 
microfuged at 4°C for 1 minute at maximum rpm, supernatant was removed with a pipet tip, and 
this procedure was repeated one more time to remove as much Sarkosyl as possible.  
3.2.7.2 Transcript labeling.  
The permeabilized cells were resuspended in 71μl of transcription mix: 60μl 2.5X 
transcription buffer (50mM Tris-HCl, pH7.7; 500mM KCl; 80mM MgCl2), 8μl NTP mix (10mM 
each ATP and CTP), 3μl 100mM DTT. Transcripts were labeled by adding 100μCi of [α-32P]-
UTP (Amersham Pharmacia) and incubating the suspension at 30°C for 5 minutes. The labeling 
 142
 reaction was followed by a 5 minute "chase" at 30°C by adding 10μl 25mM UTP/0.25mM GTP. 
900μl AE buffer (50mM NaOAc, pH 5.2; 10mM EDTA) was added to the suspension to stop the 
labeling reaction.  
3.2.7.3 RNA isolation.  
An equal volume of 40:8:1 aPCI (acid-phenol (Sigma); CHCl3; ddH2O-equilibrated 
isoamyl alcohol) pre-warmed to 65°C was combined with cells resuspended in 400μl TES 
(10mM Tris-HCl, pH 7.5; 10mM EDTA; 0.5% SDS) in 1.5ml screw cap tubes (Sarstedt) and 
incubated for 1 hour, vortexing for 10 seconds every 15 minutes. The lysates were incubated on 
ice for 5 minutes followed by a 5 minute spin at 4°C at 14K rpm in a microfuge. Supernatants 
were extracted again with 40:8:1 aPCI. RNA was EtOH precipitated and resuspended in 40μl 
ddH2O. 
3.2.7.4 RNaseT1 digestion and denaturing gel electrophoresis. 
RNaseT1 digests containing 20μl of total RNA, 5μl RNaseT1 (Ambion, catalog number 
2280) in 100μl TE (10mM Tris-HCl, pH 8.0; 1mM EDTA, pH 8.0) were incubated at 37°C for 2 
hours. The digests were treated with 2.5mg/ml Proteinase K (Roche) and 0.5% SDS, final 
concentration, for 20 minutes at 37°C. Labeled transcripts were EtOH-precipitated and 
resuspended in 15μl formamide loading buffer (80% deionized formamide; 1mM EDTA, pH 8.0; 
0.1% xylene cyanol; 0.1% bromophenol blue). Samples were heated to 95°C for 3 minutes and 
7.5μl of each were subjected to 6%/8.3M urea PAGE analysis. Gels were dried and exposed to 
both phosphorimaging screens and film. 
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 3.2.7.5 5' end labeling of molecular weight standards.  
Approximately 5μg each of BstNI-digested pBR322 (NEB) and 100 bp ladder (Promega) 
were treated with calf intestinal phosphatase (NEB), 25:24:1 PCI extracted, and EtOH 
precipitated. Resuspended DNA markers were 5' end labeled with 20μCi of [γ-32P] ATP 
(Amersham Biosciences) and T4 polynucleotide kinase (NEB) in freshly prepared 1X T4 
polynucleotide kinase buffer (70mM Tris-HCl, pH 7.6; 10mM MgCl2; 5mM DTT). Labeled 
DNA standards were purified over G-50 columns (Roche). Dilutions of labeled markers were 
loaded with RNaseT1 digested RNAs and electrophoresed on denaturing polyacrylamide gels. 
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3.3 Results 
3.3.1 The Paf1 complex is required for 3'-end formation of SNR13 transcripts 
To investigate a possible role for the Paf1 complex in the 3'-end formation of snoRNAs, we 
used Northern analysis to detect transcripts produced from the snoRNA gene SNR13 and the 
downstream protein-coding gene TRS31. For strains defective in 3'-end formation, such as nrd1 
and nab3 mutants, a hybridization probe specific for TRS31 detects an SNR13-TRS31 fusion 
RNA arising from readthrough of the SNR13 termination signals (Figure 13). Northern analysis 
of RNAs expressed from the SNR13-TRS31 locus was performed on strains lacking members of 
the Paf1 complex. While the normal TRS31 transcript was detected in all strains (Figure 13), 
rtf1Δ, paf1Δ, and ctr9Δ mutants express an additional, lower mobility RNA that is also 
recognized by the TRS31 probe and corresponds to the product of transcriptional readthrough. 
The migration of this longer transcript is similar to that seen in strains lacking Ctk1 (Steinmetz et 
al., 2001). When compared to the Paf1 complex mutants, nrd1 and nab3 mutants accumulate 
higher levels of this 3'-extended RNA, as might be expected for central components of the 
termination machinery (Steinmetz et al., 2001). These results indicate that the Paf1 complex 
plays an important role in the 3'-end formation of snoRNA transcripts.  
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Figure 13: Mutation of individual components of the Paf1 complex results in defective 3'-end formation of 
SNR13 messages 
SNR13 readthrough transcripts accumulate in Paf1 complex mutant strains. Top, SNR13-TRS31 
genomic locus and transcription products. The transcriptional readthrough product is indicated as 
SNR13-TRS31. Northern analysis using a TRS31 probe and RNA isolated from the following 
yeast strains: wild-type (KY661), rtf1Δ (KY656), paf1Δ (KY685), ctr9Δ (GHY1094), cdc73Δ 
(KY689), leo1Δ (GHY250), and ctk1Δ (KY586). 
 146
  147
  
Transcriptional readthrough at the SNR13 locus was also analyzed using the ACT1-CUP1 
reporter construct (Steinmetz and Brow, 1996). As described in the Methods and Materials 
section 3.2.4.1. and in Figure 10A, the ACT1-CUP1 reporter construct contains a promoter that 
drives the transcription of the ACT1 gene. The intron in the ACT1 gene is replaced with 
sequences required for proper 3'-end formation of SNR13 transcripts. The CUP1 gene resides 
downstream of the 3'-end formation sequences and confers resistance to Cu2+ only in strains 
where transcription readthrough of the SNR13 termination sequences occurs. ACT1-CUP1 was 
transformed into cup1Δ, paf1Δ cup1Δ, or ctr9Δ cup1Δ strains and dilution analysis was 
performed to determine if these cells were resistant to Cu2+ in the medium. The paf1Δ cup1Δ and 
ctr9Δ cup1Δ cells exhibited resistance to Cu2+ in the growth medium as compared to the wild-
type control cells that lack only the CUP1 gene (Figure 14). This analysis was partially 
complicated by the observation that the paf1Δ cup1Δ and ctr9Δ cup1Δ strains were very slow 
growing or sick when compared to the wild-type cells lacking CUP1. The paf1Δ and ctr9Δ 
deletion strains were constructed in a genetic background with the cup1Δ  allele that is different 
from the S288c background normally used in the lab. This strain background was utilized 
because the single CUP1 gene had been disrupted in it (Steinmetz and Brow, 1996) as compared 
to the S288c genetic background, which contains two copies of the CUP1 gene (Balakrishnan et 
al.). Disrupting both copies of CUP1 in the S288c background would be technically challenging 
due to the homology-based method used for gene disruption in S. cerevisiae. In addition, there 
may be additional CUP1 genes in the S288c genetic background (Balakrishnan et al.). Since, 
PAF1 and CTR9 were disrupted in a genetic background other than S288c, it is possible that 
unknown genetic elements in this background in combination with paf1Δ or ctr9Δ mutations 
 148
 result in severe sickness not observed in the S288c genetic background. In any event, results of 
the ACT1-CUP1 reporter assay in paf1Δ and ctr9Δ mutants indicates that RNA polymerase II 
reads through the sequences required for normal 3'-end formation of the SNR13 message. Taken 
together, results from the ACT1-CUP1 assay and the TRS31 Northern analysis support a role for 
the Paf1 complex in 3'-end formation of SNR13 transcripts. 
 149
  
Figure 14: Deletion of Paf1 complex members causes defects in snR13 3'-end formation in an in vivo reporter 
assay  
Deletion of PAF1 and CTR9 confers resistance to Cu2+ in the ACT1-CUP1 reporter assay. (A) 
Top panel, diagram of the ACT1-CUP1 construct. The TDH3 promoter (indicated by P) drives 
the transcription of ACT1 (gray box). The striped box represents sequences required for 
termination of SNR13 within the ACT1 intron. CUP1 (white box) is fused to the 3'-end of ACT1. 
The asterisk indicates the relative position of the poly(A) site. Bottom panel, product of 
transcription in wild-type (wt) or nrd1-5 strains. Transcription readthrough of SNR13 termination 
sequences results in Cu2+ resistance. (B) Wild-type (wt) (46α), paf1Δ (KKY119), ctr9Δ 
(KKY113), and nrd1-5 (nrd1-5) were transformed with the ACT1-CUP1 reporter construct. 
Transformants were spotted in ten-fold serial dilutions onto SC-Leu media either supplemented 
with or without 100μM Cu2+. α 
 150
  151
  
 
3.3.2 Is there a general requirement for transcription elongation factors in 3'-end 
formation of snR13? 
The Paf1 complex physically and genetically interacts with Spt4-Spt5 and yFACT (Costa 
and Arndt, 2000; Krogan et al., 2002; Lindstrom et al., 2003; Mueller and Jaehning, 2002; 
Squazzo et al., 2002). To determine whether an effect on snR13 3'-end formation is specific to 
the Paf1 complex, we performed Northern analysis on strains containing a null mutation in SPT4 
or specific point mutations in SPT5 and SPT16. While spt4∆ and spt5-194 cells produce only the 
normal TRS31 transcript, spt5-242 cells accumulate the SNR13-TRS31 fusion transcript (Figure 
15A). Interestingly, the spt5-242 mutation but not the spt5-194 mutation can be suppressed by 
defects in the Paf1 complex (Squazzo et al., 2002). The temperature sensitive spt16-197 strain 
did not accumulate the 3'-extended transcript at either the permissive or restrictive growth 
temperatures (Figure 15B). Therefore, an involvement in 3'-end formation is not necessarily a 
property shared by all RNA polymerase II elongation factors. 
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Figure 15: Not all RNA polymerase II-associated elongation factors are important for 3'-end formation of 
SNR13 transcripts 
SNR13 readthrough transcripts accumulate in Paf1 complex mutant strains. (A-B) Northern 
analysis using a TRS31 probe and RNA isolated from the following yeast strains: (A) wild-type 
(wt) (FY118), spt4Δ (GHY166), spt5-194 (KY718), spt5-242 (FY1635), fcp1-110 (PCY448), 
and ctk1Δ (KY586); (B) SPT16 (FY118) and spt16-197 (FY348). 
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We also failed to observe a significant effect of fourteen other RNA polymerase II 
transcription or chromatin factors on snR13 3'-end formation (Figure 16). These factors include 
those involved in histone modification (Set1, Set2, Dot1, Bre1 and Gcn5), chromatin remodeling 
(Isw1, Isw2, Snf2, Chd1, Swr1 and Arg82) or transcriptional activation (Swi4, Swi6, and Mbp1). 
The absence of the SNR13 transcriptional readthrough product in set1Δ, set2Δ and dot1Δ strains 
(Figure 16) suggests that the function of the Paf1 complex in RNA 3'-end formation is 
independent of its role in histone H3 K4, K36 and K79 methylation. Similar conclusions were 
drawn for Swd2, which is a member of both the Set1 histone methyltransferase complex and the 
APT cleavage/polyadenylation factor complex (Cheng et al., 2004; Dichtl et al., 2004). 
Mutations that prevent the methylation of lysine residues in histone H3 do not result in the 
extension of SNR13 transcripts (Figure 16). However, deletion of RAD6, which encodes a factor 
involved in the ubiquitylation of lysine 123 (K123) of histone H2B does result in extended 
SNR13 messages (Figure 16). This observation is of interest since the ubiquitylation of K123 on 
histone H2B, is required prior to lysine methylation of either residues 4 or 79 on histone H3 (Ng 
et al., 2003; Ng et al., 2002; Wood et al., 2003; Wood et al., 2003). SNR13 3'-extended 
transcripts observed in rad6Δ strains could arise indirectly. For example, Rad6 may target 
proteins involved in transcription or 3'-end formation of SNR genes for degradation via the 
ubiquitin-proteasome pathway. 
Interestingly, mutations in ARP8 and INO80 caused defects in 3'-end formation of snR13 
(Figure 16). Arp8 is integral for assembly of the INO80 chromatin remodeling complex while 
Ino80 is the catalytic component of the remodeling complex (Shen et al., 2003). Preliminary 
observations indicate that these factors may not be generally required for 3'-end formation of 
snoRNAs since proper 3'-end formation of snR47 occurred in the absence of Ino80 and Arp8 (K. 
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 E. Sheldon and K. M. Arndt, unpublished observations). The 3'-extended form of snR13 in 
INO80 complex mutants is intriguing since library plasmid 304 from the high-copy-number 
suppressor screen described in section 2.3.3. contained a truncated form of ARP5, another 
member of the INO80 complex. 
 156
  
Figure 16: Several mutations in genes that encode components of chromatin remodeling complexes, histone 
modification proteins, and transcriptional activators do not cause transcriptional readthrough at the SNR13 
locus 
SNR13 readthrough transcripts accumulate in Paf1 complex mutant strains. Northern analysis 
using a TRS31 probe and RNA isolated from the following yeast strains: wild-type (KY669), 
set1Δ (KY907), set2Δ (KY912), dot1Δ (KY935), rad6Δ (KY930), bre1Δ (KY968), gcn5Δ 
(KY927), ino80Δ (MHY57), arp8Δ (MHY88), isw1Δ (MHY75), isw2 (KY884), snf2Δ (KY508), 
chd1Δ (KY632), swr1Δ (KY972), arg82Δ (MHY63) and paf1Δ (KY802). TRS31 or SNR13-
TRS31 transcripts are indicated. 
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Ctk1 and the Ser5-directed CTD phosphatase Ssu72 are required for efficient snoRNA 3'-
end formation (Steinmetz and Brow, 2003; Steinmetz et al., 2001). We asked whether a mutation 
in FCP1, which encodes a Ser2-directed CTD phosphatase, also causes defects in snR13 
synthesis. The fcp1-110 mutation was isolated in a synthetic lethal screen with an rtf1Δ mutation 
and is predicted to truncate the two TFIIF binding domains of Fcp1 (Costa and Arndt, 2000). The 
predicted fcp1-110 protein retains the phosphatase and BRCT domains, and strains expressing 
this protein exhibit nearly wild-type levels of Ser-2 phosphorylation (M. Shirra and K. Arndt, 
unpublished observations). However, like defects in other CTD-modifying enzymes, the fcp1-
110 mutation causes significant accumulation of the SNR13 readthrough product (Figure 15A). 
3.3.3 The Paf1 complex is required for 3'-end formation of SNR47 transcripts 
To ask if there is a general requirement for the Paf1 complex in the proper 3'-end formation 
of snoRNAs, we assayed expression of the SNR47 gene. Northern hybridization probes were 
designed against SNR47 and the uncharacterized ORF YDR042c, which resides downstream of 
SNR47 in the genome (Figure 17). A prominent ~1400 nt transcript was detected by the 
YDR042c probe in rtf1∆, paf1∆, ctr9∆, and nrd1-5 strains (Figure 17). This transcript, which is 
present in greatly reduced levels in wild-type strains, has the approximate size of the predicted 
SNR47-YDR042c chimeric transcript (~1150 nt + poly(A) tail). In addition, a transcript with the 
same mobility was detected by the SNR47 probe (Figure 17). A shorter transcript (marked by 
asterisk in Figure 17), which hybridized to both probes, may represent a degradation product of 
this readthrough transcript. Apparently, wild-type cells do not detectably express YDR042c under 
the growth conditions used in our experiments, in agreement with ChIP results in the absence of 
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 the Paf1 complex correlates with increased RNA polymerase II density over the 5' region of 
YDR042c (Figure 21C). Accumulation of 3'-extended RNAs at both the SNR13 and SNR47 loci 
suggests that the Paf1 complex may be generally required for proper snoRNA synthesis. 
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Figure 17: Transcriptional readthrough from SNR47 into YDR042c occurs in strains lacking components of 
the Paf1 complex 
Top, the SNR47 genomic locus and transcripts detected in wild-type or mutants defective in 
snR47 3'-end formation (SNR47-YDR042c). Transcription of YDR042c is not detected in wild-
type cells. Bottom, Northern analysis on RNA from wild-type (FY118), rtf1Δ (KY656), paf1Δ 
(KY685), ctr9Δ (GHY1094), cdc73Δ (KY689), leo1Δ (GHY250), and nrd1-5 cells. RNA 
samples were loaded in duplicate on the same gel, one-half of which was subjected to Northern 
analysis with a YDR042c probe and the other half with an SNR47 probe. The positions of the 
ethidium bromide stained RNA molecular weight markers are shown. Asterisks denote a 
hybridization signal that is not specific to either the YDR042c or the SNR47 probe. This signal 
may arise from a breakdown product of the chimeric SNR47-YDR042c transcript. Filters were 
reprobed for SCR1 transcript levels as a loading control.  
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To determine whether the Paf1-mediated effect on SNR47 expression maps to the known 
SNR47 3'-end formation element or to some other aspect of the SNR47-YDR042c transcript, we 
used a plasmid-based reporter assay in which the SNR47 3'-end formation element is placed in a 
heterologous context, between a promoter and a reporter gene (Carroll et al., 2004). In the 
control plasmid for this assay, AHC, the ADH1 promoter drives expression of the yeast HIS3 
gene and confers histidine prototrophy to his3∆ strains. The ASHC reporter plasmid contains 70 
bp of SNR47 sequence required for 3'-end formation inserted between the ADH1 promoter and 
HIS3 (Figure 18). RTF1 and rtf1∆ strains containing AHC grow in the absence of histidine, as 
expected (Figure 18). However, while RTF1+ strains containing ASHC grow poorly in the 
absence of histidine, rtf1∆ strains containing this plasmid grow similarly to rtf1∆ strains 
containing the control plasmid that lacks the SNR47 sequence (Figure 18). The results from this 
reporter assay suggest that the Paf1 complex is required for efficient recognition of the SNR47 3'-
end formation signal. 
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Figure 18: Strains deleted for members of the Paf1 complex exhibit transcriptional readthrough in a reporter 
assay 
Top, plasmids used in the reporter assay to monitor snR47 3'-end formation. Bottom, RTF1 
(KY669) and rtf1Δ (KY560) cells transformed with the LEU2-marked plasmids AHC and ASHC 
were plated in ten-fold serial dilutions onto SC-His-Leu and SC-Leu media (2 days incubation at 
30°C). 
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3.3.4 The Paf1 complex co-localizes with RNA polymerase II to SNR47 
To begin to elucidate the mechanism by which the Paf1 complex affects the synthesis of 
snoRNA transcripts, we performed ChIP analysis. Using antibodies toward an epitope-tagged 
form of Paf1 followed by quantitative PCR, we determined the Paf1 complex directly associates 
with the 3'-end of SNR13 (Figure 19). This observation is in agreement with results documented 
in (Nedea et al., 2003), where Nrd1 and Nab3 levels are enriched on DNA downstream of 
SNR13. These studies are complicated by the fact that the distance between SNR13 and TRS31 is 
only 280 bp. Since sonication of chromatin typically results in DNA fragment sizes ranging from 
250 to 500 bp, the separation of these two genes is not within the resolution of sonication. 
Therefore, association of Nrd1, Nab3 or members of the Paf1 complex downstream of SNR13 
could be affected by the recruitment of these factors to the promoter and the 5' region of TRS31 
(Nedea et al., 2003). 
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Figure 19: Epitope-tagged Paf1 is enriched over SNR13 
ChIP analysis of Paf1 occupancy over SNR13. Sonicated chromatin from PAF1 (KY669) and 
HA3-PAF1 (KY783) cells was immunoprecipitated with anti-HA antibody. Two amounts of 
immunoprecipitated (IP) DNA (2μl and 4μl) and input DNA (4μl of 1:125 and 1:250 dilutions) 
were analyzed by PCR. SNR13 ChIP signals were normalized to TELVI signals (Simic et al., 
2003).  
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The Paf1 complex is important for 3'-end formation of snR13 and ChIP revealed that the 
Paf1 complex associates with SNR13. For these reasons, the question of whether the Paf1 
complex associates with SNR47 DNA arose.  Therefore, we designed five sets of primer pairs to 
amplify the region spanning the SNR47 gene and extending downstream into the YDR042c ORF 
(Figure 20A). We chose SNR47 for our ChIP assays because the adjacent YDR042c gene appears 
to be poorly expressed from its own promoter (Figure 17). Therefore, the interpretation of our 
ChIP results should not be complicated by the association of transcription factors with the 
downstream gene. The occupancy of RNA polymerase II was mapped over the SNR47 locus by 
using the CTD-specific antibody 8WG16. As expected, RNA polymerase II associates with the 
SNR47 locus including sequences, amplified by primer pair 3, known to contain Nrd1 and Nab3 
binding motifs (Figure 19B and 19C) (Carroll et al., 2004). In a similar experiment we assayed 
for the presence of the Paf1 complex using strains that express a triple HA-tagged form of Paf1 
(Figure 19D and 19E). The profile of HA3-Paf1 association over SNR47 closely matches that of 
RNA polymerase II. These data are consistent with a direct involvement of the Paf1 complex in 
the synthesis of snR47. 
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Figure 20: RNA polymerase II colocalizes with HA3-Paf1 at the SNR47 locus 
RNA polymerase II and Paf1 co localize to the SNR47 gene. (A) Diagram of the SNR47 locus 
with PCR products amplified in ChIP experiments. (B) Chromatin from wild-type (KY669) cells 
was immunoprecipitated with 8WG16 antibody. Two amounts of immunoprecipitated (IP) DNA 
(2μl and 4μl) and input DNA (4μl of 1:125 and 1:250 dilutions) were analyzed by PCR. The 
reactions included the SNR47 primer pair specified below each panel (arrow denotes PCR 
product) and a primer pair to an intergenic region of chromosome VIII ((Ng et al., 2003); asterisk 
denotes PCR product). (C) SNR47 ChIP signals were normalized to chromosome VIII signals. 
Normalized IP values were divided by normalized input values, and the ratios from three 
independent ChIP experiments were averaged. (D) ChIP was performed on chromatin prepared 
from HA3-PAF1 (GHY972) cells with anti-HA antibody. (E) Quantitation of three HA3-Paf1 
ChIP experiments. 
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3.3.5 Nrd1 association with SNR47 is dependent on the Paf1 complex 
To test whether association of Nrd1 with SNR47 requires a functional Paf1 complex, we 
performed ChIP analysis on Nrd1. These experiments demonstrate that Nrd1 associates with 
SNR47 in a pattern similar to that of RNA polymerase II and the Paf1 complex (Figure 21A and 
21B). Importantly, Nrd1 occupancy over the SNR47 locus is significantly reduced in strains 
lacking Paf1 (Figure 21A and 21B). This reduction in the Nrd1 ChIP signal could be due to 
masked Nrd1 epitopes in chromatin prepared from paf1∆ cells, reduced levels of Nrd1 protein in 
paf1∆ strains, reduced RNA polymerase II occupancy in paf1∆ strains causing a concomitant 
decrease in Nrd1 occupancy, or a requirement for the Paf1 complex in the recruitment or stable 
association of Nrd1 with SNR47. To address the first possibility, we mapped the association of 
Nab3 to SNR47 using antibodies toward an HA3-tagged form of Nab3. Our experiments revealed 
a reduction in HA3-Nab3 occupancy at SNR47 in paf1∆ strains similar to that observed for Nrd1, 
suggesting that a decrease in epitope availability is not responsible for the lower Nrd1 ChIP 
signal at SNR47 (Figure 22A,B). By immunoblotting, we found that Nrd1 levels are increased, 
not reduced, in paf1∆ extracts when compared to PAF1 extracts (Figure 23A). Nab3 levels are 
also similar in PAF1 and paf1Δ cells (Figure 23B). This finding is consistent with a role for the 
Paf1 complex in Nrd1-dependent 3'-end formation, since NRD1 expression is auto-regulated by a 
termination sequence present within its 5' untranslated region (Steinmetz et al., 2001). Finally, 
ChIP analysis using an epitope-tagged form of Rpb3 indicated approximately equivalent 
association of RNA polymerase II with SNR47 in PAF1 and paf1∆ strains, eliminating the 
possibility that reduced Nrd1 occupancy in paf1∆ strains is simply due to reduced levels of RNA 
polymerase II on the gene (Figure 21C). Of interest is the increase in HA-Rpb3 signal detected in 
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 paf1∆ cells downstream of SNR47 over the region spanned by primer pairs 3-5 (Figure 20A and 
21C). While small, this increased signal correlates with the production of the SNR47-YDR042c 
transcriptional readthrough product, which accumulates over time to readily detectable levels. 
These results suggest that the Paf1 complex facilitates 3'-end formation of snR47, at least in part, 
by regulating the recruitment or stable association of Nrd1 and Nab3 with the RNA polymerase 
II elongation apparatus.  
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Figure 21: Association of Nrd1 with SNR47 DNA is dependent on a functional Paf1 complex 
Paf1 is required for normal Nrd1 association with SNR47. (A) ChIP was performed on chromatin 
prepared from PAF1 (KKY120) and paf1Δ (KKY122) cells with anti-Nrd1 antibody (IP) or 
preimmune sera (Pi). Two amounts of immunoprecipitated (IP) DNA (2μl and 4μl) and input 
(In) DNA (4μl of 1:125 and 1:250 dilutions) were analyzed by PCR. The reactions included the 
SNR47 primer pair specified below each panel from figure (arrow denotes PCR product) and a 
primer pair to an intergenic region of chromosome VIII ((Ng et al., 2003); asterisk denotes PCR 
product). (B) Quantitation of three ChIP experiments as in (A). SNR47 ChIP signals were 
normalized to chromosome VIII signals. Normalized IP values were divided by normalized input 
values, and the ratios from three independent ChIP experiments were averaged. Relative ChIP 
signals are shown for Nrd1 in the presence (black bars) or the absence (white bars) of Paf1. (C) 
Quantitation of three ChIP experiments as in (A), expect quantitative PCR was performed using 
DNA immunoprecipitated using anti-HA antibody, which recognizes epitope-tagged versions of 
Rpb3. SNR47 ChIP signals were normalized to chromosome VIII signals. Normalized IP values 
were divided by normalized input values, and the ratios from three independent ChIP 
experiments were averaged. Relative ChIP signals are shown for Nrd1 in the presence (black 
bars) or the absence (white bars) of Paf1. 
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 Figure 22: Association of Nab3 with SNR47 DNA is dependent on a functional Paf1 complex 
Paf1 is required for normal Nab3 association with SNR47. (A) ChIP was performed on chromatin 
prepared from PAF1 (KKY120) and paf1Δ (KKY122) cells with anti-HA antibody (IP) or 
preimmune sera (Pi). Two amounts of immunoprecipitated (IP) DNA (2μl and 4μl) and input 
(In) DNA (4μl of 1:125 and 1:250 dilutions) were analyzed by PCR. The reactions included the 
SNR47 primer pair specified adjacent to the representative experiment and a primer pair to an 
intergenic region of chromosome VIII ((Ng et al., 2003); asterisk denotes PCR product). (B) 
Quantitation of three ChIP experiments as in (A). SNR47 ChIP signals were normalized to 
chromosome VIII signals. Normalized IP values were divided by normalized input values, and 
the ratios from three independent ChIP experiments were averaged. Relative ChIP signals are 
shown for Nrd1 in the presence (black bars) or the absence (gray bars) of Paf1. 
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Figure 23: Nrd1 and Nab3 levels are not reduced in paf1Δ cells 
Nrd1 and Nab3 levels are similar in PAF1 and paf1Δ cells. Protein extracts were resolved by 
SDS-PAGE, transferred to nitrocellulose and immunoblotted with either anti-HA, anti-Nrd1, or 
anti-L3 to serve as a loading control. Protein extracts were prepared from cells grown for ChIP 
as indicated: (A) PAF1 (KKY120) and paf1Δ (KKY122). (B) NAB3 PAF1 (KKY125), NAB3 
paf1Δ (KKY126), HA3-NAB3 PAF1 (KKY120), HA3-NAB3 paf1Δ (KKY22). 
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Since the Paf1 complex may participate in recruiting Nrd1-Nab3 to SNR47, we tested the 
hypothesis that Nrd1-Nab3 physically associates with the Paf1 complex in vivo. We performed 
Co-IP experiments using epitope-tagged versions of Rtf1 (HA3-Rtf1), Paf1 (HA3-Paf1), and Ctr9 
(Ctr9-6XMyc). Protein extracts were precipitated with antibodies against Nrd1, HA, or Myc. In 
addition, we performed a mock immunoprecipitation using no primary antibody for a control. 
We did not detect association between Nrd1 or members of the Paf1 complex using low 
stringency immunoprecipitation washes with either 100 or 150mM of sodium acetate (Figure 
24). Immunoprecipitation efficiencies were tested by immunoblotting with antibodies that were 
used in the corresponding immunoprecipitation reactions. Using HA or Myc to 
immunoprecipitate HA3-Rtf1, HA3-Paf1, or Ctr9-6XMyc and associated proteins, 
immunoblotting with Nrd1 antibodies exhibited near background levels of Nrd1 (Figure 24). The 
most intriguing results were obtained with Ctr9-Myc immunoprecipitation, where the level of 
Nrd1 in the bound fraction was slightly elevated above background (compare to no antibody 
control reaction). These results suggest that members of the Paf1 complex may not be tightly 
associated with Nrd1-Nab3 in vivo and any possible interaction may be transient or mediated 
through another protein. Future co-immunoprecipitation experiments should include antibodies 
specific to RNA polymerase II. This way, probing filters for Nrd1 or members of the Paf1 
complex could serve as a positive control. In fact, a possible candidate for mediating association 
of the Paf1 complex and Nrd1-Nab3 would be RNA polymerase II because Nrd1 associates with 
RNA polymerase II and affinity purification of individual Paf1 complex members revealed the 
presence of RNA polymerase II in eluted fractions (Conrad et al., 2000; Krogan et al., 2002; 
Mueller and Jaehning, 2002; Squazzo et al., 2002).  
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Figure 24: Nrd1 does not co-immunoprecipitate with members of the Paf1 complex 
Co-immunoprecipiation followed by immunoblot analysis indicates Nrd1 does not stably 
associate with members of the Paf1 complex. Protein extracts were prepared from HA3-RTF1 
(KY980), HA3-PAF1(KY783), and CTR9-6XMYC (GHY1177) cells. The protein lysate (L), 
unbound fraction (U) or bound (B) fraction were subjected to SDS-PAGE.  Resolved proteins 
were electotransferred to nitrocellulose and antibodies against Nrd1, HA, or Myc were used to 
detect Nrd1, HA3-Rtf1, HA3-Paf1, or Ctr9-Myc, respectively. (A) Antibodies against Nrd1 or no 
antibody were used in immunoprecipitation experiments. (B) Antibodies toward HA or Myc 
were used in immunoprecipitation experiments. 
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Nrd1 and Nab3 recruitment or association with RNA polymerase II along SNR47 is 
partially dependent on the Paf1 complex (Figure 21A and 21B; Figure 22A and 22B). Since 
Nrd1 and Nab3 association is not completely dependent on the Paf1 complex for recruitment to 
SNR47, the possibility exists that other RNA polymerase II-associated proteins are required for 
stabilizing interactions of Nrd1-Nab3 to elongating RNA polymerase II at SNR47. The amino 
acid sequence of Nrd1 indicates it contains a CID motif similar to Pcf11, a factor involved in 
polyadenylated transcript 3'-end formation. The structure of Pcf11 binding to the CTD has been 
solved and revealed Pcf11 directly interacts with Ser-2 phosphorylated CTD repeats through its 
CID domain (Meinhart and Cramer, 2004). The CTD kinase responsible for phosphorylating Ser-
2 is Ctk1. Thus, we tested chromatin extracts prepared from CTK1 and ctk1Δ cells for Nrd1 
occupancy along SNR47. Preliminary ChIP experiments demonstrated reduced Nrd1 signal over 
SNR47 in a pattern reminiscent of that observed in the absence of Paf1 (Figure 25; Figure 21A 
and 21B). Reduced Nrd1 occupancy over SNR47 in cells that lack the Ser-2 CTD kinase supports 
the idea that Nrd1 may also interact with Ser-2 phosphorylated CTD through the CID motif of 
Nrd1. The observation that Ser-2 phosphorylation and the Paf1 complex are required for 
occupancy of Nrd1 across SNR47 is consistent with the previously reported synthetic genetic 
interactions between ctk1Δ and rtf1Δ (Costa and Arndt, 2000). 
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Figure 25: Nrd1 association with SNR47 requires the function of the CTD kinase Ctk1 
Nrd1 occupancy at SNR47 is dependent on Ctk1. Chromatin from wild-type (FY118) and ctk1Δ 
(YSB1560) cells was immunoprecipitated with anti-Nrd1 antibody. Two amounts of 
immunoprecipitated (IP) DNA (2μl and 4μl) and input DNA (4μl of 1:125 and 1:250 dilutions) 
were analyzed by PCR. SNR47 ChIP signals were normalized to TELVI signals. Normalized IP 
values were divided by normalized input values, and the ratios from two independent ChIP 
experiments were averaged. Relative ChIP signals are shown for Nrd1 in the presence (black 
bars) or the absence (gray bars) of Ctk1. 
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3.3.6 Is the Paf1 complex directly involved in RNA polymerase II transcript 
termination? 
Cumulative evidence strongly indicates the Paf1 complex is required for 3'-end formation 
of snoRNAs. However, since transcript cleavage is intimately linked with transcription 
termination we cannot distinguish between a role for the Paf1 complex in termination and a role 
in post-transcriptional processing. To directly investigate a role for the Paf1 complex in 
termination, we performed transcription run on (TRO) analysis. TRO maps the density of RNA 
polymerase II along the transcription unit. In the assay, one of three G-less cassette constructs 
was transformed into wild-type, paf1Δ and nrd1-5 cells (Figure 26A). In each of these cassettes, 
the 5' G-less cassette is 262 nucleotides in length while the 3' G-less cassette is 132 nt long. The 
construct pG-CYC.ds contains inert spacer DNA sequence that is flanked by the two G-less 
cassettes. pG-SNR13-125-232-CYC.ds contains the sequences required for 3'-end formation of 
SNR13.  The third plasmid is pG-SNR47(70).CYC.ds and contains the region of SNR47 required 
for transcription termination. In these cells, RNA polymerase II molecules are actively 
transcribing the G-less cassettes. However, transcription was halted upon the addition of the 
detergent sarkosyl, an inhibitor of TFIIS (Wind and Reines, 2000). RNA polymerase II 
transcription resumed upon the addition of ATP, CTP, and radiolabeled UTP. This allowed 
labeled UTP to be incorporated within the transcript near the site where RNA polymerase II was 
paused with sarkosyl. Excess GTP and unlabeled UTP were incorporated into the transcript in a 
chase reaction, allowing RNA polymerase II to transcribe through the spacer DNA. Total RNA 
was isolated from these cells for RNaseT1 digestion. Treatment of the RNA with this enzyme 
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 results in endonucleolytic cleavage of RNA adjacent to G residues. The digested RNA was 
resolved on denaturing polyacrylamide gels. 
The hypothesis tested in this experiment is that only cells defective for transcription 
termination containing either pG-SNR13-125-232.CYC.ds or pG-SNR47(70).CYC.ds will result 
in the production of the 132 nt transcript from the downstream G-less cassette (Figure 26A). 
Cells, either wild-type or mutant, containing pG-CYC.ds give rise to two transcripts of 262 nt 
and 132 nt since the spacer DNA contains no termination signals (Figure 26A). However, only 
strains with defects in transcription termination will produce both G-less transcripts when 
containing pG-SNR13-125-232.CYC.ds or pG-SNR47(70).CYC.ds. In the case of nrd1 mutants, 
the cells have lost the ability to recognize the sequences required for termination (Carroll et al., 
2004; Steinmetz et al., 2001).  
Using the G-less cassettes, three experiments were performed in order to determine a role 
for the Paf1 complex in either 3'-end formation or transcription termination. In the first 
experiment pG-CYC.ds or pG-SNR13-125-232.CYC.ds was transformed into the indicated cells 
and TRO analysis was performed. Cells transformed with pG-CYC.ds displayed G-less cassette 
transcripts of 262 nt and 132 nt as predicted (Figure 26B). However, mutant strains defective for 
transcription termination containing the pG-SNR13-125-232.CYC.ds plasmid did not contain the 
132nt transcript (Figure 26B). This result was perplexing since nrd1-5, the positive control for 
transcription termination, did not exhibit a termination defect (Figure 26B).  This observation 
could be explained either due to low sensitivity levels of the experiment or absence of a 
transcription termination defect in nrd1-5 cells. However, evidence from our lab and others 
indicates that the latter explanation may not be correct. First, TRO analyses have previously been 
performed with other nrd1 alleles and defects in transcription termination reported (Steinmetz et 
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 al., 2001). Second, while nrd1-5 is the only nrd1 allele in our lab we have demonstrated that this 
mutation confers strong transcriptional readthrough defects of both snR13 and snR47. Finally, 
the nrd1-5 mutation results in a single amino acid substitution of V368G within the single RRM 
of Nrd1 (Steinmetz and Brow, 1996). Thus, this missense mutation may not confer as strong a 
transcription termination defect as other nrd1 alleles with more severe phenotypes.  
The data obtained from the TRO experiment outlined in Figure 26A-B do not provide 
conclusive evidence to indicate a role for the Paf1 complex in transcription termination of SNR13 
(Figure 26A and 26B). As described above, the positive control for this TRO experiment did not 
exhibit anticipated results according to (Steinmetz et al., 2001). Therefore, we decided to 
challenge cells transformed with the TRO constructs from Figure 26A with a temperature shift, 
which is described below. 
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Figure 26: TRO analysis using SNR13 and SNR47 transcription termination sequences 
Results of the TRO analysis are not definitive. Wild-type (FY118), paf1Δ (KY685), ctr9Δ 
(KY817), and nrd1-5 (nrd1-5) strains were transformed with the indicated plasmids as described 
in the text. Transcription using radiolabeled UTP was reinitiated after Sarkosyl addition to 
induce pausing of elongated RNA polymerase II. Total RNA was isolated, digested with 
RNaseT1 and electrophoresed using denaturing-PAGE.  
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The second TRO experiment was performed similarly to the first experiment except cells 
were shifted from 30°C to 37°C for 90 minutes prior to transcript labeling. We postulated that 
stressing the cells with increased temperature would exacerbate defects in transcription 
termination. As predicted, cells containing pG-CYC.ds displayed G-less cassette transcripts of 
262 nt or 132 nt (Figure 26C). The 132 nt transcript was not present in cells containing the pG-
SNR13-125-232.CYC.ds plasmid (Figure 26C). However, either the duration of the temperature 
shift was not long enough or the level of sensitivity of the TRO analysis with the SNR13 
termination sequences was again too low because we observed no defect in termination for any 
of the strains tested (Figure 26C). Again, this result was reminiscent of the results from Figure 
26B, where nrd1-5 mutants did not exhibit transcription termination defects with SNR13 
termination sequences at the permissive temperature. The results obtained from this TRO 
experiment are not consistent with published observations that suggest Nrd1 and Nab3 are 
involved in transcription termination (Steinmetz et al., 2001). Again, using the TRO assay 
described in Figure 26A and 26C did not provide evidence in support of a role for the Paf1 
complex in transcription termination of SNR13 transcripts (Figure 26A and 26C).  
For experiment three, pG-CYC.ds or pG-SNR47(70).ds was transformed into the indicated 
cells and TRO analysis was performed. Cells transformed with pG-CYC.ds displayed G-less 
cassette transcripts of 262 nt and 132 nt as predicted (Figure 26D). Interestingly, mutant strains 
defective for transcription termination containing the pG-SNR47(70).ds plasmid contained the 
132 nt transcript (Figure 26D). However, wild-type cells also contained a transcript of 132 nt. In 
this preliminary experiment the ratio of 132/262 transcripts from wild-type cells was lower than 
the 132/262 ratio from nrd1-5 cells. paf1Δ cells transformed with the pG-SNR47(70).ds plasmid 
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 did not exhibit the 132 nt transcript (Figure 26D). This observation was unexpected due to ChIP 
experiments performed in PAF1 and paf1Δ cells (Figure 21A-B). These experiments indicated 
that the absence of the Paf1 complex resulted in increased occupancy of RNA polymerase II over 
the 5' region of YDR042c (Figure 21C). A possible explanation for the discrepancy between TRO 
and ChIP experiments is that the TRO experiment is a read out of transcription termination 
defects using a heterologous template. Experiments using transcription termination sequences 
from two genes that require the Paf1 complex for proper 3'-end formation in heterologous 
templates, pG-SNR13-125-232.CYC.ds or pG-SNR47(70).ds, were either inconclusive or not 
supported by ChIP experiments.  
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3.4 Conclusions 
3.4.1 Novel role for the Paf1 complex in the transcription cycle 
Investigation of a possible functional link between Nrd1-Nab3 and the Paf1 complex 
revealed a novel role for the Paf1 complex in 3'-end formation of nonpolyadenylated transcripts. 
High-copy-number suppression of point mutations in rtf1 by NAB3 lead to additional genetic 
analyses. Genetic interactions of deletions within the Paf1 complex with high-copy-number 
NAB3 or mutations in NRD1 hinted toward the possibility that the Paf1 complex may participate 
in forming 3'-ends of RNA polymerase II transcripts. Northern analysis indicated that in the 
absence of certain Paf1 complex members, the 3'-ends of SNR13 and SNR47 transcripts were 
extended (Figure 13 and Figure 17). Observations from in vivo reporter assays also provided 
evidence that the Paf1 complex was required for 3'-end formation of SNR13 and SNR47 
transcripts since paf1Δ and ctr9Δ cells conferred Cu2+ resistance in the ACT1-CUP1 reporter 
assay, and rtf1Δ cells conferred histidine prototrophy when transformed with the ASHC reporter 
construct (Figure 18). Preliminary TRO analyses were difficult to interpret due to sensitivity 
levels of the experiment or results that were contradictory with those from repeated ChIP 
experiments (Figure 26A-26D compare to Figure 21A and 21B). Therefore, we were unable to 
determine whether 3'-extended snR13 or snR47 was a result of defective 3'-end formation or 
transcription termination.  The most compelling evidence in support of a role for the Paf1 
complex in 3'-end formation of nonpolyadenylated transcripts came from the use of ChIP 
experiments. This method demonstrated that the members of the Paf1 complex directly associate 
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 with SNR13 and SNR47 and the pattern of Paf1 complex localization correlated with the density 
of RNA polymerase II (Figure 19 and Figure 20). Moreover, ChIP analysis revealed that Nrd1 
and Nab3 association with SNR47 was dependent upon the Paf1 complex (Figure 21 and Figure 
22). The dependence of Nrd1-Nab3 association with SNR47 on the Paf1 complex may therefore 
manifest in defects in 3'-extended transcripts, because cells lacking Paf1 complex members 
exhibit reduced levels of Nrd1 and Nab3 with SNR47 by ChIP analysis. Two models address the 
possible function of the Paf1 complex in 3'-end formation of nonpolyadenylated transcripts 
(Figure 27A and 27B)  In the first model, the genetic, Northern analysis, and ChIP data described 
support a role for the Paf1 complex in 3'-end formation of SNR transcripts (Figure 27A). The role 
of the Paf1 complex in this model is to recruit Nrd1-Nab3 to RNA polymerase II or stabilize the 
association of Nrd1-Nab3 with elongating RNA polymerase II. The second model (Figure 27B) 
is based on ideas and work from the Buratowski lab (Kim et al., 2004). In their study, they 
analyzed the association and dissociation of elongation factors along the length of genes that 
produce polyadenylated transcripts (Kim et al., 2004). This analysis revealed that the Paf1 
complex dissociates from open reading frames near the poly(A) site, similar to the association 
mapped for Ctk1 (Ahn et al., 2004; Kim et al., 2004). This "exchange" of RNA polymerase II-
associated factors may hold for SNR transcripts where association of Nrd1-Nab3 requires 
dissociation of the Paf1 complex before they can stably associate with RNA polymerase II. 
However, the short length of SNR genes, typically 100 bp, combined with the resolution of ChIP 
experiments make distinguishing between these two models technically difficult.   
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Figure 27: Models for the role of the Paf1 complex in 3'-end formation of SNR transcripts 
Two models that might explain the role of the Paf1 complex in the formation of 3'-ends of SNR 
transcripts. Each diagram depicts RNA polymerase II transcribing downstream of SNR13. Top 
panel, the Paf1 complex may recruit or stabilize associations between Nrd1-Nab3 and RNA 
polymerase II during SNR gene transcription. Bottom panel, dissociation of the Paf1 complex 
may be a prerequisite for the association of Nrd1-Nab3 with transcribing RNA polymerase II. 
This model was originally proposed by the Buratowski lab based on the results of experiments 
with polyadenylated transcripts (Ahn et al., 2004; Kim et al., 2004). 
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3.4.2 The Paf1 complex may couple transcription elongation to transcript cleavage  
Dependence of Nrd1-Nab3 association with SNR genes on the Paf1 complex and the Ser-2 
CTD kinase has uncovered a role for the Paf1 complex in linking transcription elongation and 
SNR transcript cleavage. This role of the Paf1 complex is not associated with previously ascribed 
functions of the Paf1 complex. For example, the Paf1 complex is important for methylation of 
certain histone H3 lysine residues. The role of these modifications for association of Nrd1-Nab3 
with RNA polymerase II may not be important since mutations in genes that encode these 
methyltransferases do not cause 3'-extended SNR13 transcripts. However, rad6Δ cells, which are 
defective in histone H2B K123 ubiquitylation did exhibit transcription readthrough of snR13 
(Figure 16). Rad6 is an ubiquitin conjugase that has other targets for ubiquitylation besides 
histone H2B K123 that may be relevant for proper 3'-end formation of SNR transcripts. Also, 
other RNA polymerase II-associated factors did not exhibit 3'-extended SNR13 transcripts, 
including proteins with characterized roles in RNA polymerase II elongation or termination 
(Figure 16). A subset of transcription factor mutants did exhibit defects in 3'-end formation of 
snR13 (Figure 16). Deletion of INO80 and ARP8, which code for integral components of the 
INO80 complex resulted in defective 3'-end formation of SNR13 transcripts, but did not exhibit 
3'-extended SNR47 transcripts (Figure 16 and data not shown). Collectively, these observations 
support the idea that the Paf1 complex may be specifically required for Nrd1-Nab3 association 
with SNR genes. The observation that the Paf1 complex is also required for normal levels of 
CTD phosphorylation on Ser-2 over open reading frames of protein-coding genes suggests that 
the Paf1 complex may also recruit or stabilize association of Ctk1 with elongating RNA 
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 polymerase II (Mueller et al., 2004). This idea is consistent with observations that indicate Ctk1 
is required for Nrd1 association with SNR47 (Figure 21A and 21B).  
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 4.0  Chapter 4: Identification of genes regulated by the Paf1 complex through global 
expression analysis of CTR9 and RTF1 deletion mutants  
4.1 Introduction 
Factors involved in modulating transcription can be classified in part by the genes they 
regulate. RNA polymerase II is essential for the transcription of all protein coding genes, snRNA 
genes, and snoRNA genes. However, not all transcription factors are involved in the transcription 
of all RNA polymerase II transcribed genes (Holstege et al., 1998). In fact, global transcription 
profiling studies have demonstrated that different genes have differing requirements for general 
transcription factors, coactivators, and chromatin modification (Holstege et al., 1998). Added to 
this complexity is the observation that several genes require gene-specific activators and/or 
repressors for proper transcriptional activation in response to physiological requirements of the 
cell. 
Imagine the possibility where not only particular genes require a subset of general 
transcription factors and gene-specific activators or repressors for proper initiation of 
transcription, but also require additional signaling through transcription elongation factors. 
Importantly, recent studies indicate that the Ras/PKA signaling pathway targets the transcription 
elongation factor Spt5 in response to control yeast cell growth (Howard et al., 2003). Since the 
Paf1 complex has emerged as an RNA polymerase II-associated factor important for 
coordinating histone modification events during transcription, the possibility exists that some 
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 genes will require the Paf1 complex for proper transcription. Further, deletion of individual Paf1 
complex members results in a range of phenotypes from moderate to severe (Betz et al., 2002; 
Porter et al., 2002). These results lead to the hypothesis that individual Paf1 complex members 
regulate the transcription of different sets of genes. Alternatively, the members of the Paf1 
complex regulate the transcription of the same set of genes. These two hypotheses need not be 
mutually exclusive in that particular genes may require the entire Paf1 complex and different sets 
of genes may require a subset of the Paf1 complex components. 
We chose two complementary approaches to identify genes regulated by the Paf1 complex. 
The first method used genetic interactions between components of the Paf1 complex and 
transcriptional activators identified in a synthetic lethality screen (Costa and Arndt, 2000). The 
rationale was that the Paf1 and SBF were required for the expression of overlapping essential 
transcripts; hence when the function of both complexes are missing cells, will die (Bean et al., 
2005). The second approach was to use microarray analyses to obtain transcriptional profiles for 
each component of the Paf1 complex. Using this approach, the transcriptional profiles could be 
evaluated by computer algorithms to determine which particular subset of the yeast genome 
requires the Paf1 complex for transcription. For example, the use of these algorithms could 
indicate if genes required for cell wall maintenance, sporulation, or other processes with known 
components require the Paf1 complex for regulating their expression. Analysis in this fashion 
could be used to identify genes that require different members of the Paf1 complex for their 
expression.  
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4.2 Methods and materials 
4.2.1 Yeast strains 
As described in section 2.2.1, yeast strains used in this study are isogenic with FY2 (Table 
13). SWI4, SWI6, and MBP1 were replaced with HIS3 using a PCR-based method (Ausubel et 
al., 1988). Strains to be compared in microarrays analyses were isogenic at all loci except the 
deletion strain, where CTR9 was replaced using a PCR-based method with KANMX, which 
confers resistance to the antibiotic G418 (Ausubel et al., 1988).  
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Table 13: Yeast strains used in Chapter 4 
 
 
STRAIN GENOTYPE ORIGIN 
FY118 MATa his4-912δ lys2-128δ leu2Δ1ura3-52 trp1Δ63 Winston lab 
GHY250 MATα  leo1Δ::URA3 his4-912δ lys2-128δ  leu2Δ1ura3-52 Hartzog lab 
GHY972 MATα  his3Δ200 lys2-128δ ura3Δ0 HA3-PAF1 " 
GHY1094 MATα  ctr9Δ::KANMX4 his3Δ200 lys2-128δ leu2Δ1 ura3-52 " 
GHY1177 MATα  his3Δ200 lys2-128δ leu2Δ0 ura3Δ0 trp1Δ63 CTR9-6XMYC::LEU2 " 
KY399 MATa rtf1Δ100:URA3 leu2Δ1 ura3-52 trp1Δ63 pLS21-5[HA3RTF1, TRP1, 
CEN/ARS] 
Arndt lab 
KY452 MATa rtf1Δ100:URA3 his3Δ200 lys2-128δ  leu2Δ1 ura3-52 trp1Δ63 " 
KY453 MATα rtf1Δ100::URA3 his3Δ200 lys2-173R2 leu2Δ1 ura3-52 trp1Δ63 " 
KY508 MATa snf2Δ::HIS3 his3Δ200 lys2-128δ leu2Δ1 ura3-52 " 
KY589 MATα leu2Δ1 trp1Δ63 " 
KY656 MATa rtf1Δ100::URA3 his4-912δ lys2-128δ leu2Δ1 ura3-52 " 
KY661 MATa his3Δ200 his4-912δ lys2-128δ leu2Δ1 ura3-52 " 
KY685 MATα  paf1Δ::URA3 his4-912δ lys2-128δ leu2Δ(0 or 1) ura3(Δ0 or -52) " 
KY687 MATα paf1Δ::URA3 lys2-173R2 leu2Δ(0 or 1) ura3(Δ0 or -52) " 
KY689 MATα cdc73Δ::KANMX4 lys2Δ0 leu2Δ0 " 
KY980 MATα his4-917δ lys2-173R2 leu2Δ1 ura3-52 trp1Δ63 HA3-RTF1 " 
KKY5 MATα mbp1Δ::HIS3 his3Δ200 lys2-128δ leu2Δ1 ura3-52 trp1Δ63 " 
KKY11 MATα swi4Δ::HIS3 his3Δ200 lys2-128δ leu2Δ1 ura3-52 trp1Δ63 " 
KKY13 MATα swi6Δ::HIS3 his3Δ200 lys2-128δ leu2Δ1 ura3-52 adr8 " 
KRY2 MATa rtf1Δ100::URA3 his3Δ200 his4-912δ  lys2-173R2 leu2Δ1 ura3-52 " 
PCY431 MATa rtf1Δ101::LEU2 his4-912δ  lys2-128δ leu2Δ1 ura3-52 trp1Δ63 leu2Δ1 
ura3-52 trp1Δ63 
" 
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 4.2.1.1 Analysis of IMD2 induction 
Cells were grown to approximately 1x107 cells/ml in SC-Ura media and divided. 6AU was 
added to a final concentration of 75μg/ml to one half of the culture and both cultures were grown 
at 30°C for the indicated times in hours prior to RNA isolation. Cells were harvested, RNA was 
isolated and Northern analysis was performed as described previously (Stolinski et al., 1997). 
Hybridization probes were prepared by random-prime labeling of PCR-generated DNA 
fragments containing IMD2 and SED1. Oligonucleotides used for the PCR were as described by 
Shaw and Reines (2000}. 
4.2.1.2 Northern blotting analysis.  
Aliquots of 10μg of the indicated RNAs were resuspended in RNA sample buffer (50% 
deionized formamide; 1X MOPS; 2.12M formaldehyde; 0.5mg/ml ethidium bromide), 
electrophoresed through a 1.5% denaturing agarose gel, and photographed with the 440CF digital 
imaging station (Kodak). Genescreen filters (PerkinElmer Life Sciences Inc,) were hybridized 
with random-prime labeled probes containing [α-32P]dATP (Dupont NEN) and/or [α-32P]dCTP 
(Dupont NEN), using PCR-amplified coding sequences of ARG1, SER3 and SED1 (Squazzo et 
al., 2002). The blots were exposed to both phosphorimaging screen and film (Kodak). 
4.2.2 Chromatin immunoprecipitation (ChIP) analysis 
Cells were grown in YPD to 1-2x107 cells/ml.  ChIP assays and immunoprecipitations with 
anti-Myc antibody or anti-HA antibody conjugated to agarose beads (Santa Cruz Biotechnology) 
were performed as described (Komarnitsky et al., 2000; Simic et al., 2003).  To confirm signal 
linearity, quantitative PCR was performed on two dilutions of input and immunoprecipitated 
DNA using [α-32P]dATP, and relative ChIP signals were calculated as described in the figure 
legends. Table 14 lists the oligonucleotides used for ChIP at the ARG1 and SRG1-SER3 loci. 
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 Oligonucleotides amplified sequences relative to +1 of either ARG1 or SER3 (per Saccharomyces  
Genome Database).  
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Table 14: Oligonucleotide sequences used for ChIP in Chapter 4 
 
 
Oligonucleotide Name 5'-Oligonucleotide Sequence Hybridizes Relative to +1 
KKO84 TGGTTAAGCAGTTAGGCT -424 SER3 
KKO85 TTTCCTTATCCTCTGCTCCC -123 SER3 
KKO86 CGTTCCACAGCGCTTGAATGCTG -149 SER3 
KKO87 GCTGGTAGCGTAGTCTAAGTCAAC +143 SER3 
KKO88 GTGACACTACATGTACCAGC +760 SER3 
KKO89 GCCACCAATGTGTGGTGTCAAG +1050 SER3 
KKO125 CCCATTGTGCAGCGATAAGG -75 ARG1 
KKO126 GGCCTTTTCCTTGGCGGC +150 ARG1 
KKO127 CCCCACCAAAGGACATGTGG +599 ARG1 
KKO128 CCTTGCTAAGTTGGATGCGG +787 ARG1 
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4.2.2.1 Harvesting yeast cultures for microarray analysis 
Growth of cultures for use in microarray analysis differed as described below from standard 
techniques. Liquid microarray YPD (maYPD) was prepared in glass flasks and graduated 
cylinders that had been well washed with double distilled water, at least four times to remove 
residual detergents left over from cleansing. Standard 5ml saturated overnight cultures were 
inoculated in maYPD with strains that were freshly struck out from the freezer with verified 
markers, in 15ml sterile conical tubes (Falcon) and incubated at 30°C. Dilution of overnight 
cultures was performed as usual except sterile, plastic pipets (Sarstedt) were used to transfer 
overnight culture to 1.5ml centrifuge tubes. Log phase overnight cultures were inoculates into 
250ml of maYPD with a dilution of overnight culture using sterile micropipettor tips and 
incubated at 30°C overnight. Log phase cultures were harvested between 1-2x107 cells/ml. The 
cells were harvested in pre-washed GS3 bottles in the RC-5B centrifuge for 10 minutes at 4K 
rpm, washed one time with water, transferred to pre-washed Oakridge tubes, and pelleted in the 
SA-600 centrifuge for 5 minutes at 4K rpm. After the water was decanted from the cells, they 
were quick frozen in liquid nitrogen and stored at -70°C. 
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4.2.3 RNA isolation for microarray analysis 
After cell pellets were harvested as described in section 4.2.1., RNA was isolated using the 
hot-acid phenol extraction method as in (A. M. Dudley and G. M. Church, personal 
communication). Briefly, the thawed cell pellets were resuspended in TES solution (10mM Tris-
HCl, pH 7.5; 10mM EDTA, pH 8.0; 0.5% SDS w/v). An equal volume of acid phenol pre-
warmed to 65°C was added to the suspension, which was subsequently agitated in a vortex mixer 
at maximum speed for 10 seconds. The suspension was incubated for 1 hour at 65°C, with 
vortexing every ten minutes. Importantly, the neutralizing component shipped with the phenol 
(Sigma, # P-4557) was not used, leaving the pH of the phenol to be acidic. The permeabilized 
cells were incubated on ice for 5 minutes prior to centrifugation in the SA-600 rotor at 10K rpm 
in the RC-5B centrifuge for 5 minutes at 4°C. The aqueous layer was extracted again with room 
temperature acid phenol followed by a chloroform extraction using 12ml of chloroform, agitated 
in a vortex mixer and centrifugation. The aqueous layer was subjected to ethanol precipitation 
using 1.2ml 3M NaOAc, pH5.2, and 32.5ml 100% ethanol, inversion of the suspension followed 
by centrifugation at 4°C for 20 minutes at 10K rpm. Precipitated RNAs were washed two times 
with 25ml 70% ethanol. RNA was air-dried on the bench prior to suspension in 4ml water. Total 
RNA was column purified and subjected to DNase I digestion using RNeasy maxi preps and 
DNase I (Qiagen) according to the total RNA cleanup procedure developed by Qiagen. Column 
purified total RNA was subjected UV analysis to determine RNA concentration, agarose gel 
electrophoresis to analyze rRNA integrity, and in some cases RT-PCR to determine the relative 
level of genomic DNA contamination. Aliquots of 20μg of RNA from either CTR9 or ctr9Δ cells 
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 were pipeted into pre-labeled 1.5ml microcentrifuge tubes and stored at -70°C for downstream 
applications.  
 
4.2.4 Microarray analysis 
4.2.4.1 cDNA preparation 
The cDNA preparation protocol was followed according to the Atlas Glass Fluorescent 
Labeling kit (http://www.clontech.com/clontech/techinfo/manuals/PDF/PT3452-1.pdf, BD 
Biosciences).  Briefly, equivalent amounts of total RNA derived from CTR9 and ctr9Δ strains 
was thawed at 70°C for 1-2 minutes and cooled on ice for 1-2 minutes. Contents were collected 
by centrifugation in a microcentrifuge and returned to ice. The annealing reaction was performed 
in a total volume of 25μl with 7μg of oligonucleotide dT (N=18) and 20μg of total RNA. Samples 
were incubated at 70°C for 5 minutes and transferred to 48°C for 5 minutes. While the 
oligonucleotides were annealing, 2X reverse transcription master mix was prepared at room 
temperature. 2X master mix contained the following reagents supplied with the labeling kit: 10μl 
5X cDNA synthesis buffer, 5μl 10X dNTP mix that includes aminoallyl-dUTP, 7.5μl water, and 
80 units of MMLV. Annealing reactions were cooled on ice for 2 minutes, microcentrifuged to 
collect contents, added to 25μl of 2X RT-PCR master mix and pipeted gently to mix reagents. 
RT-PCR proceeded for 30 minutes at 48°C, incubated at 70°C for 5 minutes, followed by 
incubation at 37°C with 5 units RNaseH for 15 minutes to degrade RNA hybridized to cDNA.  
cDNAs were treated with Quickclean Purification Resin as directed by the manufacturer 
(Clonetech), where 5μl of resin was vortexed with the products of the RT-PCR reactions. This 
step removes proteins and is a substitute for phenol/chloroform extraction. Resin was separated 
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 from the cDNAs using 0.45μm spin filters and collection tube provided by BD Biosciences, 
where the suspension was transferred to the filter column and microfuged at maximum rpm for 1 
minute. cDNAs were precipitated using manufacturer provided 3M sodium acetate (Clonetech) 
and 137.5μl 100% ethanol, inverted, and incubated at -20°C for a minimum of 1 hour.  
4.2.4.2 Cy dye incorporation/probe clean up 
Precipitated cDNAs from section 4.2.4.2. were microcentrifuged at maximum speed for 20 
minutes at 4°C. The pellets were washed with 70% ethanol and centrifuged for 5 minutes at 
maximum speed at 4°C. The remove supernatant was removed. The cDNA pellet was 
resuspended in 10μl of 2X Fluor-labeling buffer and 10μl of either Cy3 or Cy5 dye suspension 
was added; the Cy dye suspension was created by mixing 45μl of manufacturer supplied DMSO 
with a vial of Cy3 Mono-reactive dye (Amersham Pharmacia #PA23001) or Cy5 Mono-reactive 
dye (Amersham Pharmacia #PA25001). Dye coupling proceeded in the dark for 30 minutes. 
Labeled cDNA was precipitated with manufacturer provided 3M sodium acetate and 30μl 100% 
ethanol, inverted, and incubated at -20°C for a minimum of 1.5 hours. Precipitates were washed 
with 70% ethanol prior to resuspension in 100μl water. Unincorporated dye was removed using 
the Atlas NucleoSpin column extraction kit according to the manufacturer's instructions supplied 
with the Atlas Glass Fluorescent Labeling Kit (Clonetech). Samples were combined and 
concentrated to 36μl using Microcon 30 filters with microcentrifugation for 6-8 minutes at 10K 
rpm. Filters were inverted and contents were collected by centrifugation for 2 minutes at 10K 
rpm (Amicon).  
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 4.2.4.3 Hybridization 
In preparation for competitive hybridization of labeled cDNA, 2X hybridization buffer  
(250μl  formamide (F-5786, Sigma Ultra), 250μl 20XSSC, and 10μl 10% SDS) was prepared 
and prewarmed to 42°C. To the concentrated samples, 2μl 10mg/ml sonicated salmon sperm 
DNA and 2μl 10mg/ml polyadenylic acid were added to reduce nonspecific hybridization. 
Samples were incubated at 90°C for 2 minutes to denature labeled cDNAs. An equal volume of 
2X hybridization buffer was mixed with denatured cDNAs and applied to microarray slides 
(Microarray Centre (http://www.microarrays.ca), University Health Network, Toronto, Canada) 
covered with Lifterslips (Erie Scientific Company). Microarray slides were sealed in either 
microarray chambers with a drop of 3XSSC buffer for humidity or within P-1000 tip boxes that 
contained paper towels and water for humidity for 16 hours at 42°C.   
4.2.4.4 Microarray scanning and image analysis 
Following hybridization, three microarray wash solutions were prepared. All washes were 
performed at room temperature for 5 minutes in volumes large enough to fill washed P-1000 tip 
boxes (500ml) with gentle shaking. Microarrays were quickly removed from the hybridization 
chambers, placed in slide racks, and submerged in wash buffer one composed of 0.2XSSC/0.1% 
SDS. Slides were subsequently transferred to wash buffer two 0.2XSSC and then to wash buffer 
three 0.1XSSC. Finally, microarray slides were quickly plunged into 0.01XSSC and dried by 
centrifugation for 5 minutes at 800rpm.  
Hybridized and washed microarray slides were stored in microscope slide boxes to prevent 
exposure to light prior to array scanning. Microarrays were scanned using the Affymetrix 
Genetic Microsystem 418 array scanner (Department of Biological Sciences, University of 
Pittsburgh). Slides were scanned individually first with a laser set to 635nm to excite the Cy5 
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 fluor within the cDNA. Emissions were collected by the photomultiplier tube (PMT) in order to 
produce an image. Once data acquisition for the Cy5 labeled cDNA was complete, a laser set to 
532nm excited the Cy3 fluor and the emissions were collected. The images were assigned a false 
color based on the wavelength of the scanner and were superimposed using GenepixPro 4.0 
image analysis software (Axon Instruments). 
4.2.5 Statistical analysis  
4.2.5.1 Dye normalization 
Identities of the printed genes or features were identified by applying the array list settings 
provided by the Microarray Centre to the merged features. The settings are locked onto the 
image and GenepixPro 4.0 determined the intensities of individual pixels within the features and 
the background intensity of the pixels for each channel, either 532nm for Cy3 or 635nm for Cy5. 
With this information the Genepix Pro 4.0 software calculated several values that were used to 
determine the median intensity in each channel for each feature and the log2 (635/532) ratio for 
each feature. The median intensity in each channel was summed. Ideally, the sums for Cy3 and 
Cy5 intensity should be equal since 20μg of total RNA was used for preparing labeled cDNA 
and equivalent amounts of Cy3 and Cy5 dye were used in the dye coupling reaction. However, 
variation in total intensity was used to normalize the signals. The ratio of Cy3 to Cy5 was used to 
configure the wavelength-based normalization feature within GenepixPro 4.0 and the 
normalization was applied to every feature, resulting in a dye-normalized log2 (635/532) ratio. 
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4.2.5.2 Statistical analysis 
The dye normalized log2 (635/532) ratios were exported into Excel (Microsoft) along with 
gene name, ORF designation, and unique feature indicator number. Log2 (635/532) ratios from 
individual replicates can be extracted from GenepixPro 4.0 and cataloged by their microarray 
slide number side by side with the data from other replicates. For the CTR9 versus ctr9Δ 
microarray experiments, data from four total biological replicates and data from four reciprocal 
dye labeling experiments were ordered into Excel. Preliminary statistical analysis was performed 
by calculating the average and standard deviation of the log2 (635/532) for each feature across all 
eight experiments.  
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4.3 Results 
4.3.1 The Paf1 complex and SBF may coordinately regulate transcription during the G1/S 
phase of the cell cycle 
Initial attempts to identify genes regulated by the Paf1 complex relied on genetic 
interactions among components of SBF and MBF and members of the Paf1 complex. In 
particular, mutations in SWI4 and SWI6 were isolated in a synthetic lethal screen using an rtf1Δ 
strain (Costa and Arndt, 2000). Mutations in mbp1 were not recovered in this genetic screen. We 
verified the synthetic lethal interactions by producing deletions in SWI4, SWI6, and MBP1 and 
crossing them by an rtf1Δ strain (Figure 28). Double mutant combinations were recovered for 
mbp1Δ rtf1Δ, but not for swi4Δ rtf1Δ and swi6Δ rtf1Δ  (Figure 28). The lethality observed for 
swi4Δ rtf1Δ and swi6Δ rtf1Δ could manifest from the absence of transcriptional activation 
combined with a defect in transcription elongation. The Paf1 complex together with SBF were 
implicated in co-regulating the transcription of gene products required for the G1/S phase 
transition in the cell cycle. Therefore, we attempted to identify Rtf1-regulated genes with 
Northern analysis using total RNA isolated from wild-type, rtf1Δ, swi4Δ, swi6Δ, mbp1Δ strains. 
Transcript abundance levels for CLN1, CLN2, and CLN3 were analyzed; however the results 
from these experiments did not conclusively establish a role for the Paf1 complex in regulating 
G1 cyclins or other targets of SBF (data not shown). These results could be due to the possibility 
that Rtf1 doe not have a significant role in G1 cyclin expression because the cultures were grown 
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 asynchronously rather than synchronously thereby reducing the opportunity to observe the 
lowered transcript levels in rtf1Δ cells. However, two groups did demonstrate a role for the Ctr9 
and Paf1 members of the Paf1 complex in regulating the transcription of a subset of genes 
expressed during the G1/S phase of the cell cycle. First, in a screen to identify mutations that 
failed to activate the transcription of G1 cyclins, a mutation in CTR9 was recovered (Koch et al., 
1999). Interestingly, ctr9Δ and paf1Δ cells but not cdc73Δ cells were defective in the 
transcription of a G1 cyclin CLN2 (Koch et al., 1999). Second, microarray analyses using 
Affymetrix oligonucleotide arrays and differential display identified genes regulated by Paf1 and 
Ctr9 complex Jaehning lab (Penheiter et al., 2005; Porter et al., 2002). These studies revealed 
that Paf1 and Ctr9 were important for the transcription of cell cycle-regulated genes. 
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Figure 28:  RTF1 interacts genetically with SWI4 and SWI6 but not MBP1 
Genetic interactions between RTF1 and components of SBF. Crosses of rtf1Δ (KY452) X swi4Δ 
(KKY11), rtf1Δ (KY452) X swi6Δ (KKY13), and rtf1Δ (KRY2) X mbp1Δ (KKY5) cells were 
performed followed by tetrad dissection. The genotypes were inferred from phenotypic analysis 
and identified wild-type, single and double mutants as indicated by color-coded spores.  
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4.3.2 IMD2 transcription induction is impaired in Paf1 complex member mutants 
As previously described mutations within the Paf1 complex and other elongation factors 
often results in sensitivity to the base analog 6AU (Exinger and Lacroute, 1992; Shaw and 
Reines, 2000). However, sensitivity of 6AU is frequently but not always indicative of defects in 
transcription elongation (Exinger and Lacroute, 1992; Shaw and Reines, 2000). Shaw and Reines 
demonstrated that IMD2/PUR5, which encodes inosine monophosphate dehydrogenase, is 
transcriptionally induced by exposure of yeast cells to 6AU (Squazzo et al., 2002). Mutations 
that cause transcription elongation defects and 6AU sensitivity also prevent the induction of 
IMD2 transcription in response to 6AU treatment. In contrast, mutations that cause 6AU 
sensitivity but do not affect transcription elongation do not interfere with IMD2 induction. Thus, 
a 6AU-sensitive phenotype coupled with the inability to induce IMD2 in response to 6AU is 
suggestive of a defect in transcription elongation. We therefore isolated RNA from wild type, 
rtf1Δ, and paf1Δ cells before and after 6AU treatment and performed a Northern analysis of 
IMD2 levels (Figure 29). This analysis showed that deletion of PAF1 or RTF1 significantly 
reduces IMD2 induction, and therefore suggests that the Paf1 complex may play a role in 
transcription elongation. The expression analysis also indicated that under non-inducing 
conditions the absence of either Paf1 or Rtf1 resulted in increased transcription of IMD2 
message. This result suggests that the Paf1 complex may regulate the expression of IMD2 under 
normal growth conditions (Figure 29). One of the caveats of this experiment is that any phase of 
the transcription cycle including initiation or elongation could result in impaired IMD2 
expression in the presence of 6AU.  Therefore, impaired ability of rtf1Δ and paf1Δ cells to 
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 induce IMD2 expression cannot serve as the only evidence implicating members of the Paf1 
complex in transcription elongation. Rather, impaired IMD2 induction together with genetic, 
physical, and chromatin interaction data implicating the Paf1 complex in elongation should be 
considered when attempting to describe the function of the Paf1 complex in transcription.  
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Figure 29: rtf1Δ and paf1Δ cells are defective in IMD2 induction 
rtf1Δ and paf1Δ strains are defective in IMD2 induction. Northern analysis of IMD2 transcription 
was performed on total RNA samples prepared from wild-type (KY589), rtf1Δ (KY453), and 
paf1Δ (KY687) cells. The strains were grown to ~1x107 cells/ml in SC-Ura media and then 
divided. 6AU was added to a final concentration of 75μg/ml to one half of the culture and both 
cultures were grown at 30°C for the indicated times, in hours, prior to RNA isolation. Each lane 
contained 10μg of total RNA. The same filters that were probed for IMD2 transcript were 
stripped and reprobed for SED1 mRNA to serve as a loading control. 
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4.3.3 Differential expression analysis to identify genes regulated by the Paf1 complex 
In an effort to identify genes regulated by the Paf1 complex, microarray analysis was 
performed. Total RNA was isolated from CTR9 and ctr9Δ cells and cDNA was prepared using a 
two-step labeling protocol in which reverse transcription was followed by Cy dye incorporation.  
Identification of differentially expressed genes involved competitive hybridization to glass 
microarrays, image analysis and preliminary statistical analyses. The microarrays were obtained 
from the Microarray Centre. Microarray slides contained approximately 6,000 cDNAs 
representative of the transcriptome of S. cerevisiae, spotted in duplicate. Northern analyses were 
used to verify changes observed between the transcription profiles of CTR9 and ctr9Δ cells for 
genes exhibiting differential expression in strains deleted for individual Paf1 complex members. 
Finally, ChIP (ChIP) analysis was performed to determine whether components of the Paf1 
complex are directly or indirectly involved in regulating the genes identified using microarray 
analysis. 
Four biological replicate microarray experiments were performed using RNA isolated from 
CTR9 and ctr9Δ cells. In these experiments, cDNA prepared from CTR9 total RNA was labeled 
with Cy3 dye while cDNA prepared from ctr9Δ total RNA was labeled with Cy5 dye. To 
account for potential differences in labeling efficiency and differential oxidation of the Cy fluors, 
four reciprocal labeling experiments were also performed. Upon image analysis, dye 
incorporation normalization and data extraction, the eight sets of microarray data were used to 
calculate the average log2 ratio and standard deviation for each representative gene. Table 15 and 
Table 16 contain Ctr9-regulated genes; Table 15 contains 2.5% of the genes in S. cerevisiae 
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 genome that require Ctr9 for transcription while Table 16 contains 2.5% of the genes in S. 
cerevisiae genome that require Ctr9 for their repression. Out of the many genes that were 
potentially regulated by Ctr9, we focused on SER3 and ARG1, these genes are highlighted in 
yellow in Table 16. ACO1 is highlighted in pink (Table 16). Evidence from microarrays 
performed in our laboratory indicate that the Paf1 complex may negatively regulate ACO1 
transcription (Table 16). 
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Table 15:  2.5% of 6200 genes that require Ctr9 for their transcription 
 
 
Open Reading frame Gene name Average log2 ratio Standard deviation 
YJL196C ELO1 -2.50 1.65 
YDR139C RUB1 -2.49 5.16 
YGL117W NA -2.41 1.16 
YGR049W SCM4 -2.30 2.57 
YJR147W HMS2 -2.24 1.62 
YDR525W API2 -2.21 2.04 
YER091C MET6 -2.09 1.10 
YKL069W NA -2.05 1.07 
YAR071W PHO11 -2.03 0.69 
YDR469W SDC1 -2.02 4.04 
YMR195W ICY1 -2.00 0.58 
YJR025C BNA1 -1.99 1.39 
YCR071C IMG2 -1.98 4.92 
YFR047C BNA6 -1.95 1.40 
YGR177C ATF2 -1.93 1.35 
YGR018C NA -1.92 4.73 
YKL091C NA -1.92 1.06 
YEL059W NA -1.89 4.87 
YNL129W NA -1.86 0.70 
YLR156W NA -1.86 6.14 
YPL250C ICY2 -1.84 0.78 
YLR364W NA -1.83 2.61 
YGR163W GTR2 -1.83 0.84 
YGL039W NA -1.83 0.69 
YOR236W DFR1 -1.81 0.70 
YER062C HOR2 -1.77 0.96 
YML113W DAT1 -1.75 4.10 
YOL014W NA -1.74 0.30 
YLR118C NA -1.74 2.64 
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 Table 15 (continued) 
YDL198C YHM1 -1.72 2.33 
YGL155W CDC43 -1.72 4.96 
YLR348C DIC1 -1.72 0.95 
YDL241W NA -1.70 0.59 
YDL022W GPD1 -1.69 0.83 
YHL041W NA -1.68 4.46 
YIL119C RPI1 -1.68 0.79 
YPL014W NA -1.67 1.80 
YGR131W NA -1.65 0.82 
YJR024C NA -1.65 2.27 
YER032W FIR1 -1.64 0.42 
YPL099C NA -1.63 0.36 
YDR270W CCC2 -1.63 4.91 
YKR074W NA -1.60 0.35 
YLR268W SEC22 -1.59 0.81 
YGL159W NA -1.59 2.04 
YIL086C NA -1.59 1.47 
YER067W NA -1.58 0.84 
YDR367W NA -1.57 0.44 
YER053C NA -1.56 2.83 
YOR344C TYE7 -1.54 0.68 
YGL080W NA -1.54 1.59 
YMR141C NA -1.54 2.26 
YLR349W NA -1.54 1.82 
YMR022W QRI8 -1.53 4.99 
YDR491C NA -1.52 4.53 
YMR317W NA -1.51 1.54 
YPR116W NA -1.51 2.47 
YKL096W CWP1 -1.51 0.28 
YCL018W LEU2 -1.51 0.71 
YER093C-A NA -1.50 1.28 
YOR163W DDP1 -1.50 0.45 
YMR284W YKU70 -1.49 4.18 
YDR126W PSL10 -1.48 1.27 
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 Table 15 (continued) 
YMR030W NA -1.48 4.84 
YLR228C ECM22 -1.48 4.76 
YHR049C-A NA -1.46 4.80 
YDL049C KNH1 -1.46 1.17 
YML075C HMG1 -1.46 2.73 
YNL288W CAF40 -1.46 4.87 
YER037W PHM8 -1.46 1.28 
YOR095C RKI1 -1.45 0.46 
YCR090C NA -1.45 0.51 
YGR033C NA -1.45 1.72 
YBR022W NA -1.44 1.78 
YCLX09W NA -1.44 2.42 
YHL009C YAP3 -1.44 1.17 
YJL161W NA -1.43 0.77 
YMR157C NA -1.43 5.06 
 Open reading frames with NA indicate these genes are unannotated as per SGD. 
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 ARG1 and SER3 are involved in the biosynthesis of arginine and serine, respectively. 
Interestingly, our microarray data indicated that Ctr9 is required for repression of ARG1 and 
SER3 in rich medium (Table 16), which indicates that members of the Paf1 complex may 
negatively regulate the expression of certain genes. Northern analysis revealed that Paf1 complex 
members were required for repression of ARG1 transcription (Figure 30A and 30; Crissuci and 
K. M. Arndt, unpublished observations). ChIP analysis using antibodies directed against epitope-
tagged forms of Rtf1 and Ctr9 revealed that both proteins associate with the 5' and 3' regions of 
ARG1 when cells are grown in rich medium (Figure 30B-30D). The data presented in Figure 30 
is consistent with results from the Hinnebusch lab where they show ARG1 transcription is 
increased in paf1Δ cells and that Paf1 localizes to the ARG1 UAS. These results are of interest 
since some transcription factors are known to positively and negatively regulate the transcription 
of certain genes. The ARG1 locus is desirable for studying the mechanism of possible repression 
through the Paf1 complex for many reasons. First, manipulation of ARG1 transcription is 
dependent on the presence of arginine in the cell. For example, ARG1 transcription is induced in 
the absence of arginine in the growth medium and transcription is repressed when arginine is 
present. Second, many transcription factors involved in regulating ARG1 expression in response 
to limiting levels of arginine are known. Therefore, the use of ARG1 as a model gene could 
provide insight into the mechanism by which the RNA polymerase II-associated Paf1 complex 
may repress ARG1 transcription.  
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Table 16: 2.5% of 6200 genes that require Ctr9 for their repression 
 
 
Open reading frame Gene name Average log2 ratio Standard deviation 
YER081W SER3 3.07 0.54 
YMR096W SNZ1 2.68 1.03 
YOL058W ARG1 2.58 1.33 
YKR039W GAP1 2.58 1.05 
YLR259C HSP60 2.53 1.87 
YLR237W THI7 2.47 1.81 
YLL034C NA 2.46 4.55 
YGL255W ZRT1 2.37 1.17 
YLR007W NA 2.22 4.75 
YMR026C PEX12 2.17 5.01 
YPL278C NA 2.11 4.73 
YOR192C NA 2.04 1.48 
YDR473C PRP3 2.03 2.91 
YNR039C ZRG17 1.95 4.44 
YPL154C PEP4 1.78 0.89 
YGL222C EDC1 1.77 5.58 
YIL082W-A NA 1.75 4.81 
YPL274W SAM3 1.74 2.15 
YLR382C NAM2 1.74 4.34 
YPL227C ALG5 1.74 4.58 
YDR443C SSN2 1.73 4.57 
YGR223C NA 1.72 4.97 
YKL155C RSM22 1.71 4.58 
YLL004W ORC3 1.69 4.66 
YLR330W CHS5 1.66 4.45 
YDL109C NA 1.65 4.60 
YJR121W ATP2 1.62 1.49 
YNL061W NOP2 1.61 2.40 
YJR045C SSC1 1.61 1.59 
YOR375C GDH1 1.58 0.69 
 227
 Table 16 (continued) 
YPL038W MET31 1.58 3.30 
YBR131W CCZ1 1.57 4.57 
YDR019C GCV1 1.56 1.48 
YNR068C NA 1.55 5.12 
YGL113W SLD3 1.51 4.82 
YLL060C GTT2 1.51 0.75 
YLL022C HIF1 1.50 3.24 
YIR034C LYS1 1.49 0.85 
YGR157W CHO2 1.48 0.91 
YMR017W SPO20 1.48 4.81 
YOR379C NA 1.47 4.99 
YLR304C ACO1 1.44 0.82 
YMR173W-A NA 1.43 0.54 
YKR080W MTD1 1.43 1.15 
YOR027W STI1 1.43 1.84 
YER099C PRS2 1.43 4.85 
YHR105W NA 1.42 2.81 
YNL033W NA 1.42 2.13 
YHR064C SSZ1 1.41 1.34 
YOR389W NA 1.40 1.17 
YMR173W DDR48 1.40 0.53 
YLL051C FRE6 1.40 5.06 
YPL003W ULA1 1.39 5.04 
YGL079W NA 1.39 2.75 
YKR048C NAP1 1.37 1.82 
YOL036W NA 1.37 0.95 
YJL034W KAR2 1.37 0.46 
YOR023C AHC1 1.35 1.70 
YGR110W NA 1.35 0.69 
YKL145W RPT1 1.35 1.11 
YER176W ECM32 1.33 1.16 
YOR048C RAT1 1.33 3.22 
YDL090C RAM1 1.33 4.78 
YMR265C NA 1.32 1.88 
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 Table 16 (continued) 
YJR065C ARP3 1.32 1.16 
YNL158W NA 1.31 1.63 
YGL230C NA 1.30 2.85 
YHL017W NA 1.30 1.60 
YKR079C NA 1.30 1.82 
YDR438W NA 1.30 4.57 
YNL202W SPS19 1.29 1.85 
YLR224W NA 1.29 0.82 
YPR191W QCR2 1.28 0.53 
YDR311W TFB1 1.28 4.51 
YIL138C TPM2 1.28 0.52 
YNL165W NA 1.27 1.17 
YJR062C NTA1 1.27 1.35 
YJL002C OST1 1.27 0.93 
Open reading frames with NA indicate these genes are unannotated as per SGD. 
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Figure 30: The Paf1 complex directly regulates the transcription of ARG1 
Expression analysis of ARG1. (A) Northern analysis was performed with 10μg of total RNA 
isolated from the indicated strains: wild-type (KY661), rtf1Δ (KY656), paf1Δ (KY685), ctr9Δ 
(GHY1094), cdc73Δ (KY689), leo1Δ (GHY250), snf2Δ (KY508). ARG1 cDNA random-prime 
labeled was used to probe filters for ARG1 transcripts. (B) Diagram of the ARG1 locus. Primer 
pairs amplifying ARG1p (-75 to +150) and ARG1c (+599 to +787) and their positions relative to 
the ATG +1 are indicated. (C) ChIP analysis over the ARG1 locus was performed with RTF1 
(FY118), HA3-RTF1 (KY399 or PCY431 grown in SC-Trp), CTR9 (FY118) and CTR9-6XMYC 
(GHY1177) strains. Chromatin was precipitated with antibodies against the HA or Myc epitope. 
Two amounts of immunoprecipitated (IP) DNA (2μl and 4μl) and input (In) DNA (4μl of 1:125 
and 1:250 dilutions) were analyzed by PCR. The reactions included the ARG1 primer pair 
specified adjacent to each panel as in (B) and primer pairs that amplifies a subtelomeric region of 
chromosome VI (TELVI), which does not contain genes transcribed by RNA polymerase II. (D) 
The relative occupancy of tagged and untagged forms of Rtf1 and Ctr9 was determined by 
calculating the ratio of IP to In for primer pairs spanning ARG1 and normalizing to the IP to In 
ratio for the telomere signal. Relative ChIP was plotted graphically with the untagged strain 
represented by gray bars and the tagged strain represented by black bars. 
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Microarray analysis also indicated that SER3 is repressed by the Paf1 complex when serine 
was not limiting. Northern analysis was performed with total RNA isolated from strains lacking 
individual members of the Paf1 complex (Figure 31A). Included in this Northern analysis, was 
RNA isolated from a snf2Δ strain since SWI/SNF was necessary for mediating SER3 repression 
in rich medium (Martens and Winston, 2002). ChIP experiments were performed on the SER3 
gene using primer pairs that amplified the promoter region, the 5' open reading frame, or 3' end 
of SER3 (Figure 31B-31D). Using epitope-tagged forms of Rtf1 and Ctr9 we observed 
enrichment of the Paf1 complex over the promoter and 5' region of SER3 (Figure 31B-31D). 
Density of both Ctr9 and Rtf1 was severely reduced to near background levels toward the 3' end 
of SER3 (Figure 31C and 31D). The pattern of Paf1 complex localization over SER3 was 
different from what we had observed for ARG1, therefore it was possible that the mechanism by 
which the Paf1 complex acted to repress SER3 was different for the mechanism the Paf1 used to 
repress ARG1. However, the preliminary ARG1 ChIP experiments must be repeated because we 
have observed variation in ARG1 derepression dependent upon the auxotrophic markers of the 
particular strain (Crissuci and K. M. Arndt, unpublished observations). The Winston lab 
communicated to us that they had identified a gene within the promoter of SER3 that had been 
unannotated in the yeast genome (Martens et al., 2004). The gene within the SER3 promoter was 
designated SER3 regulatory gene 1 or SRG1 (Martens et al., 2004). Transcription from SRG1 
results in the expression of a noncoding RNA (Martens et al., 2004). In fact, expression of SRG1 
serves to repress transcription of SER3 by a transcriptional interference mechanism (Martens et 
al., 2004). SRG1 produces a transcript of approximately 551 nt in length according to SGD, 
however the 3'-end of the SRG1 transcript has not been mapped. Therefore, the 3’ region of the 
SRG1 gene could potentially overlap with the 5’ region of SER3 (Figure 31B). Our ChIP results 
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 support the idea that the Paf1 complex may be important for the transcription of SRG1 and serve 
to regulate SER3 transcription through the transcriptional interference mechanism.  
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Figure 31: The Paf1 complex directly regulates the transcription of SER3 
Expression analysis of SER3. (A) Northern analysis was performed with 10μg of total RNA 
isolated from the indicated strains: wild-type (KY661), rtf1Δ (KY656), paf1Δ (KY685), ctr9Δ 
(GHY1094), cdc73Δ (KY689), leo1Δ (GHY250), snf2Δ (KY508). RNA isolated from snf2Δ 
cells served as a positive control for derepression of SER3 (Martens and Winston, 2002). A 
random-prime labeled SER3 probe was used to probe filters for SER3 transcripts. The blots were 
stripped and reprobed with labeled SED1 cDNA as an internal control (B) Diagram of the SRG1-
SER3 locus. Primer pairs amplifying SRG1 (-424 to -123), the SER3 promoter (SER3p; -149 to 
+143), and the SER3 coding region (SER3c; + 760 to +1050) and their positions relative to the 
ATG (+1) are indicated. (C) ChIP analysis over the SER3 locus was performed with RTF1 
(FY118), HA3-RTF1 (KY399 or PCY431 grown in SC-Trp), CTR9 (FY118) and CTR9-6XMYC 
(GHY1177) strains. Chromatin was precipitated with antibodies against the HA or Myc epitope. 
Two amounts of immunoprecipitated (IP) DNA (2μl and 4μl) and input (In) DNA (4μl of 1:125 
and 1:250 dilutions) were analyzed by PCR. The reactions included the SER3 primer pair 
specified adjacent to each panel as in (B) and a primer pair that amplifies a subtelomeric region 
of chromosome VI (TELVI), which does not contain genes transcribed by RNA polymerase II. 
(D) The relative occupancy of tagged and untagged forms of Rtf1 and Ctr9 were determined by 
calculating the ratio of IP to In for primer pairs spanning SER3 and normalizing to the IP to In 
ratio for the telomere signal. Relative ChIP was plotted graphically with the untagged strain 
represented by gray bars and the tagged strain represented by black bars. 
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4.4 Conclusions 
4.4.1 Combined approaches of genetics and microarray analyses identify genes regulated 
by the Paf1 complex 
Deletion of individual members of the Paf1 complex causes defects in the transcription of 
genes. Genetic interactions between members of the Paf1 complex and SBF provided support to 
the idea that the Paf1 complex may be involved in regulating a subset of SBF-regulated genes. 
While Northern analysis with total RNA isolated from rtf1Δ strains did not exhibit defects in the 
transcription of SBF-regulated target genes, only a small subset of SBF target genes was 
analyzed (data not shown). Differential display and microarray analysis identified transcriptional 
targets of Paf1 and Ctr9 in the Jaehning lab and revealed a role for the Paf1 complex in 
regulating the transcription of genes that are expressed during the G1/S phase of the cell cycle. 
Inspection of the genes that require SBF, Ctr9 and Paf1 for proper transcription combined with 
Northern analysis using total RNA isolated from strains deleted for individual members of the 
Paf1 complex could reveal whether Rtf1, Cdc73 or Leo1 are also important for the transcription 
of the genes regulated by SBF, Ctr9, and Paf1. 
Microarray studies performed to identify Ctr9 target genes revealed a direct role for the 
Paf1 complex in regulating genes in the arginine and serine biosynthetic pathways. Expression 
analyses of ARG1 indicated that individual Paf1 complex members are required for repression of 
ARG1 under noninducing conditions (Figure 30A-30D). Moreover, Paf1 and Ctr9 associated 
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 directly with the length of the ARG1 open reading frame suggesting that the Paf1 complex is 
actively involved in repressing ARG1 transcription in the presence of arginine (Figure 30A-30D). 
Again, observations from our laboratory and communication with the Hinnebusch laboratory 
suggest that strains with certain auxotrophic makers may derepress ARG1 through general amino 
acid control (Hinnebusch, 2005). Therefore, the ARG1 Northerns and ChIP experiments must be 
repeated with strains that do not cause the induction of general amino acid control. The 
mechanism through which Paf1 acts to repress transcription of ARG1 is not clear. However, the 
mechanism of Paf1 complex-dependent repression at ARG1 is probably distinct from the 
repressive mechanism occurring at SER3. SER3 transcription is regulated by transcriptional 
interference caused by the transcription of SRG1 (Martens et al., 2004). A role for the Paf1 
complex in regulating SRG1 transcription has not been directly tested, however, ChIP analysis 
using epitope-tagged versions of Rtf1 and Ctr9 over the SRG1-SER3 region suggests the Paf1 
complex associates with SRG1 while association of the Paf1 complex is reduced over the 3' 
region of SER3 (Figure 31B-31D). This pattern of Paf1 complex occupancy is consistent with the 
Paf1 complex regulating SRG1 expression and indirectly regulating SER3 expression via 
transcriptional interference.  
Impaired IMD2 induction is a hallmark of elongation factor mutants. Deletion of DST1 the 
gene that codes for the well-characterized elongation factor TFIIS results in impaired IMD2 
induction in the presence of 6AU (Shaw and Reines, 2000). Analysis of IMD2 induction in 
paf1Δ and rtf1Δ cells revealed a defect in IMD2 induction similar to dst1Δ cells (Figure 28). 
Interestingly, deletion of DST1 suppresses the Spt- phenotype of rtf1Δ cells and triple mutant 
cells deleted for DST1, SPT4, and RTF1 are inviable (Costa and Arndt, 2000). Overall, these 
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 observations suggest that TFIIS, Spt4, and the Paf1 complex may be important for regulating 
transcription elongation. 
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 5.0  Chapter 5:  Discussion 
5.1 Introduction 
To address possible functions of Rtf1 and members of the Paf1 complex in cells I combined 
conventional genetic approaches with genome-wide expression analyses for my thesis research. 
The two approaches are complementary to each other. For instance, discovery of multicopy 
suppressors of point mutations within RTF1 could identify novel genetic interactions with 
implications for regulating RNA polymerase II transcription. On the other hand, the use of DNA 
microarrays to identify genes directly and differentially regulated by the Paf1 complex could be 
used to uncover and/or further dissect transcription regulatory networks. A discussion of the 
success of these approaches follows. 
5.2 What have we learned about Rtf1 and the Paf1 complex by analyzing the rtf1 point 
mutants? 
5.2.1 Can the rtf1 missense mutations provide insight into Rtf1 activity? 
Multiple genetic tools to clarify the function of RTF1 in the cell were constructed in the 
Arndt lab after the initial isolation of rtf1-1, a mutation that restored the Spt+ phenotype of a TBP 
mutant (Stolinski et al., 1997). The rtf1Δ mutant and a series of small deletions within RTF1 
have contributed greatly to our understanding of Rtf1 in transcription. For example, a genetic 
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 screen with rtf1Δ cells identified genes that become essential in the absence of Rtf1 (Costa and 
Arndt, 2000). The identity of these mutations revealed the first link between Rtf1 and factors 
involved in the transition from transcription initiation to elongation (Costa and Arndt, 2000). The 
RTF1 deletion series in combination with primary amino acid alignments among Rtf1 homologs 
provided information regarding the function of different regions within Rtf1. For example, 
deletions within the central region of Rtf1 confer 6AUS and Spt- phenotypes. Interestingly, the 
central region of the protein is among the most conserved across eukaryotes, suggesting strongly 
that this portion of Rtf1 is critical for its function.   
Additional analysis on the internal RTF1 deletion series has provided information regarding 
the function of Rtf1 and which regions of Rtf1 are important for known physical, biochemical, 
and genetic relationships. Not surprisingly, different regions are responsible for the diverse roles 
ascribed to Rtf1. For example, the N-terminal region encompassing amino acid residues 3-30 of 
Rtf1 is important for association with the chromatin remodeling factor Chd1 (K. L. Roinick and 
K. M. Arndt, unpublished observations). Deletion of residues 62-109 and 111-152 and to a lesser 
extent deletion of the conserved region of Rtf1 result in a significant reduction in global levels of 
histone H3 trimethylation that is associated with transcriptionally active genes (M. H. Warywoda 
and K. M. Arndt, unpublished observations). The rtf1 point mutants do not cause defects in 
histone H3 K4 trimethylation even at elevated temperatures. Taken together, the above 
observations strongly suggest the conserved, central region of Rtf1 is associated with chromatin 
dynamics. 
In an effort to learn more about Rtf1, we sought conditional mutations within RTF1. 
Mutagenic PCR and screening for 6AUS and Spt- phenotypes at elevated temperatures lead to the 
identification of several conditional RTF1 mutations. These alleles contained multiple mutations, 
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 increasing the likelihood that these phenotypes arose from a combination of one or more 
mutations within the gene. To isolate single missense mutations conferring conditional 
phenotypes and to determine the contribution of each mutation, individual mutations were 
separated by subcloning or singly introduced using site-directed mutagenesis. We uncovered 
three point mutants that exhibited conditional phenotypes. The rtf1 allele within parent plasmid 
pDM1 contained two mutations, the first resulted in an E264D substitution and the second 
resulted in a V274D substitution. The  valine to aspartic acid substitution is a striking change as 
compared to the more conservative glutamic acid to aspartic acid substitution. Both of these 
point mutations reside in the central conserved region of Rtf1 that is essential for function since 
deletion of residues 251-300 results in both 6AUS and Spt- phenotypes. The phenotypes of the 
individual point mutants were analyzed and indicated that the conditional 6AUS and weak Spt- 
phenotypes were the result of the V274D substitution in rtf1-105. The E264D substitution within 
the central conserved region of Rtf1 did not greatly affect the function of Rtf1 at either the 
permissive or restrictive temperatures indicating that this position could be occupied by a less 
bulky, but acidic residue. If the change had been more severe, it is likely that mutant phenotypes 
would have been observed. As for V274D, valine is a small, nonpolar amino acid that likely 
resides within the hydrophobic core of the protein, replacing valine with aspartic acid, a charged 
amino acid, could impact the folding of Rtf1. The substitution of a nonpolar amino acid with a 
charged amino acid could force a residue that is normally within the protein into a more solvent 
exposed position resulting in reduced protein activity at higher temperatures.  
Two mutations were observed in RTF1 within parent plasmid pDM6. The first caused the 
substitution of methionine 289 to lysine, which replaces a nonpolar amino acid with a basic 
charged residue. The second mutation introduces a stop codon at amino acid 495. Since deletion 
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 of either 491-535 or 536-558 of Rtf1 does not result in either 6AUS of Spt- phenotypes, we 
reasoned that the missense mutation contributed more to the phenotype than the deletion at the 
C-terminus. rtf1-107 (M289K) was analyzed for conditional phenotypes. This mutant exhibited a 
conditional 6AUS phenotype and a weak Spt- phenotype at the permissive temperature but 
mutation did not severely affect function of Rtf1 at the permissive temperature. Replacing a 
nonpolar residue with lysine could disrupt nonpolar interactions within the protein that are 
important for Rtf1 stability, while potentially changing the path of the amino acid backbone to 
accommodate a charged side chain.  
Identification of the point mutation(s) that caused the phenotype of the rtf1 allele on parent 
plasmid pDM3 was more challenging. Sequence analysis uncovered 3 mutations that resulted in 
the following amino acid substitutions: Q172R, K246E and Y341F. The latter two mutations 
reside in the conserved region of Rtf1 important for its function, however the mutation that 
causes the Q172R substitution resides within a region of RTF1 that when deleted confers a Spt- 
phenotype.  Interestingly, the three mutations appear to have contributed to the Spt- phenotype of 
pDM3 because this plasmid conferred a strong Spt- phenotype at 30° and 37°C. At the 
permissive temperature the separated mutations did not cause a Spt- phenotype, however at 
elevated temperatures the Q172R substitution resulted in a strong Spt- phenotype while the other 
substitutions caused substantially weaker phenotypes. The error-prone PCR screen for 
conditional RTF1 mutations identified pDM3 in a selection for mutants that at 30°C were 
resistant to 6AU but at 37°C exhibited sensitivity to 6AU. Surprisingly, strains containing the 
individual point mutations were just as resistant as wild-type strains to 6AU at the elevated 
temperature. 
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 5.2.2 Multicopy suppressors of an rtf1 point mutant suggest a role for the Paf1 complex 
in transcription termination 
The goal of the high-copy-number suppressor screen was to identify new RTF1 interacting 
genes that in increased dosage suppressed the phenotypes of an rtf1 mutant. This strategy could 
provide additional evidence for the previously recognized genetic and/or biochemical 
interactions between RTF1 and genes involved in transcription. However, it was the possibility 
of identifying novel RTF1-interacting genes that stimulated this study. The dosage suppression 
screen was successful in that several candidates that suppressed the phenotypes of rtf1-107 were 
identified. For example, we identified library plasmids that contained RTF1, genes known to 
reverse sensitivity to 6AU and genes that could be functionally linked to RTF1.  In particular, the 
genomic insert of library plasmid 305 contained NAB3 and could suppress the Spt- phenotype of 
rtf1-107. NAB3 subcloned into a 2-micron vector alone suppressed the Spt- phenotype of all rtf1 
point mutants, but not an rtf1Δ strain. This result was further supported by the enhancement of 
the nrd1-5 temperature sensitivity phenotype that occurred when the nrd1-5 allele was combined 
with deletions of individual Paf1 complex members.  
What are the functional implications for Rtf1 and the Paf1 complex in the case of dosage 
suppression by NAB3? In order for NAB3 to be a bypass suppressor of RTF1, overexpression of 
NAB3 in rtf1Δ cells must reverse the rtf1Δ mutant phenotypes. This is not the case because 
multicopy NAB3 did not suppress the phenotypes of the rtf1Δ strain (Figure 9). Since NAB3 is 
not a bypass suppressor of rtf1, it is likely Nab3 does not activate a parallel pathway required in 
the absence of Rtf1 or the Paf1 complex. Moreover, the combined genetic observations reported 
here more strongly support a model where Rtf1 and the Paf1 complex are required in order for 
Nab3 and Nrd1 to perform their function in the cell. Nab3 and Nrd1 participate in terminating 
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 snRNAs and snoRNAs that are transcribed by RNA polymerase II (Carroll et al., 2004; Conrad 
et al., 2000; Steinmetz et al., 2001). Therefore, Rtf1 and the Paf1 complex could be involved in 
transcription termination of RNA polymerase II messages.   
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5.3 Novel genetic interactions implicate the Paf1 complex in 3'-end formation 
5.3.1 Enhancement of nrd1 phenotypes in Paf1 complex member deletion mutants 
The observation that deletion of individual members of the Paf1 complex: PAF1, CTR9, 
CDC73, or RTF1 in combination with nrd1-5 enhanced the temperature sensitivity of the nrd1-5 
cells provided additional support for non-bypass, multicopy suppression of point mutations in 
RTF1 by NAB3 (Figure 11 and data not shown). Nrd1 and Nab3 are reported to associate by Co-
IP experiments (Conrad et al., 2000). Importantly, the interaction between Nrd1 and Nab3 is 
functionally significant since they are required for proper transcription termination of 
sn/snoRNAs transcribed by RNA polymerase II (Carroll et al., 2004; Sheldon et al., 2005; 
Steinmetz et al., 2001). The involvement of the Paf1 complex in 3'-end formation of certain 
snoRNA transcripts taken together with previous observations strongly suggest a functional 
genetic link among members of the Paf1 complex with Nrd1 and Nab3. 
While the leo1Δ nrd1-5 double mutant was not analyzed for enhanced temperature 
sensitivity the cdc73 nrd1-5 strain was tested and did exhibit synthetic enhancement of the nrd1-
5 temperature sensitive phenotype (Figure 11). The LEO1 and CDC73 deletion strains did not 
exhibit 3'-extended SNR13 or SNR47 transcripts, in contrast to cells with deletions in PAF1, 
CTR9, or RTF1 (Figure 13 and Figure 17). Therefore, the possibility remains that leo1 nrd1-5 
cells would exhibit enhanced temperature sensitivity that is greater than the sensitivity of nrd1-5 
alone. However, one explanation for the enhanced temperature sensitivity of cdc73Δ nrd1-5 
mutant is that Cdc73, and perhaps Leo1, is responsible for the 3'-end formation of snRNAs or 
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 snoRNAs other than SNR13 or SNR47. Another explanation for the synthetic interactions 
between cdc73Δ and nrd1-5 is that Cdc73, perhaps Leo1 too, could participate in the 3'-end 
formation of polyadenylated transcripts and not snRNAs or snoRNAs. Alternatively, Cdc73 and 
Leo1 may not have a direct role in forming 3'-ends of any transcripts. In this situation the genetic 
interactions between cdc73Δ and nrd1-5 could be caused by compromised Paf1 complex 
function since deletion of CDC73 reduces the association of the Paf1 complex with chromatin 
(Mueller et al., 2004).   
5.3.2 Overexpression of NAB3 causes sickness in cells deleted for certain Paf1 complex 
components 
Further genetic analyses were performed with deletions of individual Paf1 complex 
members and NAB3. Overexpression of NAB3 in cells lacking components of the Paf1 complex 
revealed different levels of synthetic phenotypes that ranged from mild to severe. ctr9Δ cells 
transformed with a high-copy-number NAB3 plasmid grew poorly as compared to wild-type 
control cells or ctr9Δ strains with vector alone (Table 9). paf1Δ cells containing high-copy-
number NAB3 were too sick to analyze as compared to paf1Δ cells with vector alone, which is 
consistent with the idea that multicopy NAB3 exacerbates the growth phenotypes of paf1Δ 
strains. In contrast, increased dosage of NAB3 did not aggravate the growth defects of leo1Δ, 
cdc73Δ, or rtf1Δ to the level of paf1Δ or ctr9Δ cells (Table 9). However, the growth phenotypes 
of leo1Δ, cdc73Δ, or rtf1Δ cells with multicopy NAB3 were increased as compared to isogenic 
strains with vector or wild-type strains with high-copy-number NAB3 (Table 9). These results 
provide additional support that high-copy-number NAB3 is not a bypass suppressor of point 
mutations within RTF1. Moreover, these observations suggest that the Paf1 complex may be 
functionally linked to Nab3. 
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 The phenotypes conferred by overexpression of NAB3 in Paf1 complex deletion mutants 
mirror closely the severity of phenotypes previously reported for deletion of individual Paf1 
complex components. For example, the most severe phenotypes are observed in paf1Δ and ctr9Δ 
strains and include sensitivity to hydroxyurea and caffeine while rtf1Δ, cdc73Δ, and leo1Δ are 
resistant to these chemicals (Betz et al., 2002; Porter et al., 2002). Deletion of individual Paf1 
complex members do have two phenotypes in common, sensitivity to the base analog 6AU and 
the Spt- phenotype (Squazzo et al., 2002). Both phenotypes are associated with defects in 
transcription elongation, which suggests all members of the Paf1 complex are important for 
event(s) occurring during elongation. 
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5.4 In vivo and in vitro analyses support the role of the Paf1 complex in proper 3'-end 
formation 
The genetic interactions that were observed between members of the Paf1 complex and 
Nrd1-Nab3 indicated these proteins may functionally interact. Nab3 and Nrd1 are required for 3'-
end formation of snRNAs and snoRNAs, which are nonpolyadenylated RNA polymerase II 
transcripts (Steinmetz and Brow, 2003; Steinmetz et al., 2001). Therefore, the hypothesis that the 
Paf1 complex was required for proper 3'-end formation of snRNAs and snoRNAs was tested.  
5.4.1 SNR13 transcripts are extended in Paf1 complex mutants 
Since the Paf1 complex was postulated to functionally interact with Nrd1 and Nab3 in 3'- 
end formation, the possibility that the Paf1 complex was involved in forming 3'-ends of certain 
RNA polymerase II transcripts was tested. Denaturing gel electrophoresis was performed on total 
RNA isolated from strains lacking individual members of the Paf1 complex and the resolved 
RNAs were probed with labeled TRS31 DNA to identify 3'-extended SNR13 transcripts (Figure 
13). Consistent with the hypothesis that the Paf1 complex is important for 3'-end formation of 
snoRNAs, extended SNR13 transcripts were identified in samples isolated from strains lacking 
PAF1, CTR9, and RTF1 (Figure 13). Transcriptional readthrough of SNR13 transcripts in these 
Paf1 complex mutants was observed, however the level of readthrough in these cells was less 
than readthrough levels attained in cells with mutations in nrd1 and nab3 (Steinmetz et al., 
2001).  
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 In a complementary approach to determine the participation of the Paf1 complex in 3'-end 
formation of SNR13, an in vivo reporter assay was performed. The ACT1-CUP1 reporter 
construct consists of the TDH3 promoter driving the expression of ACT1 where the ACT1 intron 
is replaced with the sequences sufficient for 3'-end formation of SNR13 (Steinmetz and Brow, 
2003; Steinmetz et al., 2001). Downstream of the modified ACT1 intron is the CUP1 gene that 
when expressed in cup1Δ cells confers resistance to Cu2+ (Steinmetz and Brow, 2003; Steinmetz 
et al., 2001). When the ACT1-CUP1 plasmid is transformed into wild-type cells lacking an 
endogenous copy of CUP1, the cells will not grow in the presence of Cu2+ due to the sequence 
that directs 3'-end formation of SNR13 within the ACT1 intron. Alternatively, we predicted that 
paf1Δ or ctr9Δ cells transformed with the ACT1-CUP1 reporter construct would be resistant to 
Cu2+ since these cells would not respond normally to the termination sequences that replaced the 
ACT1 intron. As was predicted, wild-type cells were sensitive to Cu2+ while cells lacking PAF1 
or CTR9 exhibited increased resistance to Cu2+ (Figure 14). The nrd1-5 cells transformed with 
the ACT1-CUP1 reporter exhibited the greatest Cu2+ resistance and this result correlates well 
with the TRS31  Northern analyses (Figure 13 and Figure 14), where increased Cu2+ resistance of 
nrd1-5 cells is in agreement with the high ratio of 3'-extended SNR13 to normal SNR13 
transcripts. The moderate Cu2+ resistance of either paf1Δ or ctr9Δ cells in this assay correlates 
well with the intermediate levels of 3'-extended SNR13 transcripts in these cells (Figure 13 and 
Figure 14). 
One explanation for the greater ratio of 3'-extended SNR13 to normal SNR13 transcripts in 
nrd1 and nab3 cells as compared to strains lacking individual Paf1 complex components is that 
Nab3 and Nrd1 play a more integral role in 3'-end formation. In support of this idea it should be 
noted that NAB3 and NRD1 are essential genes while PAF1, CTR9, and RTF1 are not in S. 
 249
 cerevisiae. Also consistent with this notion is that evidence implicates both Nrd1 and Nab3 in 
transcription termination of snRNA and snoRNA transcript (Conrad et al., 2000; Steinmetz and 
Brow, 1996; Steinmetz and Brow, 2003; Steinmetz et al., 2001). Alternatively, use of the TRO 
assay with cells lacking PAF1 did not provide evidence to indicate that the Paf1 complex is 
clearly involved in transcription termination (Figure 26A-26D). Since 3'-end formation is 
intimately linked with transcription termination it is possible that cells with defects in 
transcription termination, have more severe phenotypes than cells with defects in 3'-end 
formation and this causes the difference in the ratios of 3'-extended SNR13 to normal SNR13 
transcripts observed for nab3 and nrd1 mutants as compared to Paf1 complex mutants. While 
these two explanations are not necessarily mutually exclusive it is noteworthy that most genes 
encoding known termination factors in S. cerevisiae are essential while the genes encoding 3'-
end formation factors can be either essential or nonessential (Cheng et al., 2004; Dheur et al., 
2003). 
The Paf1 complex has been classified as an elongation complex due to its association with 
actively transcribed genes through ChIP analyses and affinity purification experiments where 
RNA polymerase II is immunoprecipitated in complex with epitope-tagged versions of different 
Paf1 complex members (Krogan et al., 2002; Mueller and Jaehning, 2002; Pokholok et al., 2002; 
Squazzo et al., 2002). However, there is no evidence to indicate whether the Paf1 complex is 
required to improve RNA polymerase II processivity or enhance the efficiency of the enzyme 
(Mason and Struhl, 2005). The Paf1 complex is not the only RNA polymerase II-associated 
complex implicated in elongation without direct evidence in support of improved processivity or 
efficiency of RNA polymerase II on the template (Mason and Struhl, 2005). In fact, several RNA 
polymerase II-associated factors are involved in different aspects of transcription including CTD 
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 phosphorylation, histone modification, nucleosome remodeling, nucleosome disruption and 
nucleosome assembly (Gilbert et al., 2004; Krogan et al., 2002; Lindstrom et al., 2003; Mueller 
and Jaehning, 2002; Otero et al., 1999; Pokholok et al., 2002; Squazzo et al., 2002). However, 
many of these elongation factors also localize to active genes by ChIP experiments and/or co-
precipitate with RNA polymerase II. The hypothesis that RNA polymerase II-associated proteins 
and/or factors involved in chromatin structure are required for 3'-end formation of 
nonpolyadenylated transcripts is testable using the TRS31 Northern as a readout for improper 3'-
end formation of SNR13. Strains lacking many genes involved in histone modification (SET1, 
SET2, DOT1, BRE1 and GCN5), chromatin remodeling (ISW1, ISW2, SNF2, SWR1 and ARG82), 
transcriptional activation (SWI4, SWI6, and MBP1) did not exhibit 3'-extended SNR13 transcripts 
in this assay (Figure 16 and data not shown). However, improper 3'-end formation of SNR13 
transcripts was observed in strains lacking RAD6, INO80 and ARP8 (Figure 16). Rad6 is an E2-
ubiquitin conjugase enzyme that is required for histone H2B ubiquitylation at lysine residue 123 
(Ng et al., 2002; Wood et al., 2003; Wood et al., 2003). Histone H2B ubiquitylation is a 
prerequisite for histone H3 trimethylation on lysine 4 that is associated with active transcription 
on genes transcribed by RNA polymerase II (Ng et al., 2003; Ng et al., 2003). Ino80 and Arp8 
are components of the INO80 chromatin remodeling complex (Ebbert et al., 1999; Jin et al., 
2005; Shen et al., 2000; Shen et al., 2003). Arp8 is an integral component of INO80 and Ino80 is 
a Swi/Snf-related protein that catalyzes ATP-dependent chromatin remodeling (Shen et al., 
2003). Taken together, the Paf1 complex, Rad6, and components of INO80 are required for 
proper 3'-end formation of SNR13; however not all RNA polymerase II-associated proteins are 
involved in regulating 3'-end formation of this nonpolyadenylated transcript. 
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 The requirement for the Paf1 complex in 3'-end formation of SNR13 transcripts could either 
be direct or indirect. Since the Paf1 complex is implicated in transcription it is formally possible 
that the Paf1 complex is required for the transcription of a gene whose protein product is 
involved in 3'-end formation of snR13 and not the Paf1 complex. Evidence in support of direct 
involvement of transcription factors has been obtained using inducible genes. For example, ChIP 
experiments were used to demonstrate that occupancy of Chd1 is greatly increased upon GAL 
gene induction (Simic et al., 2003). In order to test if the Paf1 complex is directly involved in 3'-
end formation, ChIP experiments with epitope-tagged versions of Paf1 were performed (Figure 
19). Initial experiments provided support for a direct role of the Paf1 complex in forming normal 
3'-ends of SNR13. These analyses were complicated due to the close proximity of the TRS31 
genes adjacent to the SNR13 gene. Interfering in the analysis is the possibility that epitope-
tagged Paf1 may associate with both SNR13 and TRS31, since both are RNA polymerase II 
transcribed genes. Immunoprecipitated chromatin is sonicated to an average size of 500 bp and 
the distance between SNR13 and TRS31 is just under 300 bp. Therefore, distinguishing between 
the occupancy signal contributed by epitope-tagged Paf1 at either gene would be nearly 
impossible. 
 
5.4.2 SNR47 transcripts readthrough into downstream YDR042c in cells lacking 
individual Paf1 complex members 
The Paf1 complex was postulated to functionally interact with Nrd1 and Nab3 do to the 
amassed genetic observations described herein, and because of the role for the Paf1 complex in 
forming 3'-ends of a particular RNA polymerase II transcript (Figure 13 and Figure 14). The next 
hypothesis to test was whether the Paf1 complex is involved in forming proper 3'-ends of other 
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 snoRNAs. To test this hypothesis we performed Northern analyses on total RNA isolated from 
individual Paf1 complex member mutants and probed filters with labeled YDR042c DNA (Figure 
17). The YDR042c gene lies downstream of the snoRNA gene SNR47 and therefore measures 
transcriptional readthrough of RNA polymerase II molecules from SNR47 to YDR042c. Northern 
analysis using YDR042c revealed that the YDR042c transcript is not produced under the growth 
conditions used. Instead a transcript of the size estimated for transcriptional readthrough 
occurring at SNR47, SNR47-YDR042c, was identified in strains lacking PAF1, CTR9, RTF1 or 
cells containing the nrd1-5 or ctk1Δ mutations (Conrad et al., 2000). Consistent with this result 
Northern analyses performed with labeled SNR47 DNA detected a transcript of the same size as 
that detected with the labeled YDR042c probe (Figure 17). Together, Northern analyses using 
SNR47 or YDR042c revealed a chimeric transcript that is formed by transcriptional readthrough 
indicative of improper 3'-end formation of snR47. 
To verify the 3'-extended SNR47 transcripts in another context, in vivo reporter analyses 
were performed. For this experiment, a control and experimental plasmid construct were used. 
The control construct consisted of the HIS3 gene driven by the ADH1 promoter with the CYC1 
terminator downstream of HIS3 for proper 3'-end formation and polyadenylation (Carroll et al., 
2004). When this construct is transformed into his3Δ strains, cells grown under selection for the 
plasmid but in the absence of exogenous histidine will grow. The experimental construct is 
identical to the control plasmid but the sequences sufficient for 3'-end formation of SNR47 are 
inserted between the ADH1 promoter and the HIS3 gene (Carroll et al., 2004). When this 
construct is transformed into RTF1 cells, the transcription machinery is predicted to engage the 
sequences for 3'-end formation and terminate transcription prior to producing the HIS3 transcript 
(Figure 18). Alternatively, when transformed into rtf1Δ cells, it is predicted that if Rtf1 is 
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 involved in 3'-end formation of SNR47, then the transcription machinery will not engage the 
sequences required for 3'-end formation and the cells will grow in the absence of histidine 
(Figure 18). As predicted, wild-type and rtf1Δ cells transformed with the control construct grew 
on medium lacking histidine (Figure 18). Also, rtf1Δ but not wild-type cells grew in the absence 
of histidine when transformed with the experimental reporter plasmid (Figure 18). The SNR47 
termination sequence reporter assays taken together with the SNR47 and YDR042c Northern 
analyses provides evidence that Rtf1 and other members of the Paf1 complex are required for 
proper 3'-end formation of snR47.  
To this point, observations in support of the Paf1 complex in 3'-end formation of certain 
RNA polymerase II transcripts have come from two different snoRNA genes. Importantly, 3'-
extended SNR47 transcripts were identified in paf1Δ, ctr9Δ, and rtf1Δ cells, similar to nrd1-5 
mutant strains (Figure 17). Again, it is possible that the Paf1 complex is participating indirectly 
in 3'-end formation of SNR47 transcripts. To begin to establish if the Paf1 complex directly 
participates in 3'-end formation of SNR47, ChIP analysis was performed. Therefore, a set of 
primer pairs was designed to amplify DNA along the SNR47 locus and within the open reading 
frame of YDR042c to test for the occupancy of Paf1 complex members (Figure 12 and Figure 
20). The SNR47 locus differs from the SNR13 locus in that DNA surrounding SNR47 is less 
gene-dense than that of SNR13. Furthermore, the nearest upstream gene of SNR47 is NRG1 and it 
is 930 bp upstream of SNR47 while YDR042c is 444 bp downstream of SNR47 so the 
transcription of genes surrounding SNR47 are less likely to complicate ChIP analyses. Using the 
8WG16 antibody that is specific for the CTD of RNA polymerase II, DNA that was associated 
with RNA polymerase II was immunoprecipitated. The result of this ChIP analysis indicated that 
RNA polymerase II associated strongly with SNR47 and regions downstream of SNR47 required 
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 for transcription termination of the snoRNA message (Carroll et al., 2004) (Figure 20). 
Inspection of the 5' open reading frame of YDR042c indicated that RNA polymerase II density 
was reduced in agreement with Northern assay experiments that provided evidence that 
YDR042c was not transcribed to detectable levels under the growth conditions used (Figure 20B 
and 20C). Moreover, ChIP assays revealed that the occupancy of Paf1 over the SNR47 locus 
mirrored that of RNA polymerase II; the Paf1 signal was strongest over SNR47 and the 
downstream DNA sequences required for 3'-end formation of snR47 (Figure 20B and 20C 
compare to 20D and 20E). Additionally, Paf1 density was greatly reduced over the 5' region of 
YDR042c as was observed for RNA polymerase II (Figure 20B-20E). The observation for 
epitope-tagged Paf1 can be extrapolated to the other members of the Paf1 complex, since Paf1 
has been shown to be an integral member of the complex (Mueller et al., 2004). The co-
localization pattern of RNA polymerase II and Paf1 at SNR47 strongly indicates that the Paf1 
complex is directly involved in the transcription and 3'-end formation of SNR47 (Figure 20A-
20E).  
The Greenblatt lab demonstrated that both Nrd1 and Nab3 associated with SNR13 by ChIP 
analysis (Morlando et al., 2004). Given the transcriptional context of SNR13 relative to TRS31 
and since the 3'-extended SNR13 and SNR47 transcripts were identified in paf1Δ, ctr9Δ, and 
rtf1Δ as well as strains with mutations in either NRD1 or NAB3, the association of these 
transcription termination factors along the SNR47 locus was important to map. Using ChIP 
analysis, the occupancy of Nrd1 and epitope-tagged Nab3 was mapped to the SNR47 locus 
(Figure 12; Figure 21A and 21B; Figure 22A and 22B). The density of Nrd1 and Nab3 
overlapped with the previously determined densities of RNA polymerase II and Paf1 (Figure 
20A-20E; Figure 21A and 21B; Figure 22A and 22B). The SNR47 association data for Nrd1 and 
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 Nab3 are also in agreement with TRO analyses where Nrd1 and Nab3 were required for proper 
transcription termination (Steinmetz et al., 2001). Taken together, RNA polymerase II, Paf1, 
Nrd1, and Nab3 associate with SNR47 and the DNA elements associated with normal 3'-end 
formation of snR47 and signal intensities drop significantly over the 5' open reading frame of 
YDR042c (Figure 12; Figure 20A-20E; Figure 21A-21C; Figure 22A and 22B). 
A possible explanation for the observed 3'-end formation defect of snoRNAs in Paf1 
complex member mutants is that the Paf1 complex is required for the association of Nrd1 and/or 
Nab3 with transcribing RNA polymerase II. To test this hypothesis, chromatin isolated from 
PAF1 and paf1Δ cells was immunoprecipitated with antibodies toward Nrd1 or epitope-tagged 
Nab3. Quantitative PCR across the SNR47 locus indicated a modest decrease in Nab3 density 
over SNR47 with primer pair 2 in paf1Δ cells as compared to PAF1 cells (Figure 22A and 22B). 
Analysis of Nrd1 occupancy over SNR47 revealed a more dramatic decrease in Nrd1 occupancy 
over SNR47 at primer pair 2 in paf1Δ as compared to PAF1 cells (Figure 21A and 21B). 
Significantly, Nrd1 and Nab3 did associate with SNR47 DNA in paf1Δ cells but to lower levels 
as compared to signal intensity in PAF1 cells. Together, these results indicated the Paf1 complex 
is required in part for the association of Nrd1 and Nab3 with RNA polymerase II at the SNR47 
locus.  
Normal levels of Nab3 and Nrd1 association with the SNR47 gene may be partially 
dependent on the Paf1 complex (Figure 21A and 21B; Figure 22A and 22B). However, reduction 
in Nrd1 and Nab3 signal observed using ChIP experiments could be the result of epitope 
masking within the triple HA-tagged Nab3 and Nrd1 proteins during the immunoprecipitation. 
Furthermore, the level of Nrd1 and Nab3 association with SNR47 in PAF1 chromatin extracts 
closely matches peak association with RNA polymerase II and Paf1 (Figure 20A-20D; Figure 
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 21A and 21B; Figure 22A and 22B). The low signal levels of Nrd1 and Nab3 over the SNR47 
gene could be a result of reduced RNA polymerase II across SNR47 since Nrd1 associates with 
RNA polymerase II via two-hybrid interaction. To rule out this possibility, ChIP experiments 
were performed with antibodies toward an HA-tagged version of Rbp3, a subunit of RNA 
polymerase II with chromatin isolated from paf1Δ and PAF1 cells (Figure 21C). The results of 
these experiments suggested that RNA polymerase II association with SNR47 is independent of 
the Paf1 complex. Another possibility regarding the lower levels of Nrd1 and Nab3 on chromatin 
in paf1Δ is that the Paf1 complex is required for normal levels of Nrd1 and Nab3 proteins. 
However, immunoblot analysis of extracts prepared form PAF1 and paf1Δ cells revealed no 
difference is expression of Nrd1 or Nab3 (Figure 23A and 23B). The most likely explanation for 
reduced association of Nrd1 and Nab3 with SNR47 in paf1Δ cells is that the Paf1 complex 
recruits or stabilizes association of these transcription termination factors with RNA polymerase 
II on snoRNA genes. 
The reduced Nrd1 and or Nab3 association with RNA polymerase II at snoRNA genes in 
paf1Δ cells may be directly responsible for the 3'-end formation defect observed in the Paf1 
complex mutant strains. The prediction that the Paf1 complex is the only RNA polymerase II-
associated complex required for the stable association of Nrd1 and Nab3 at snoRNA genes is 
unlikely since Nrd1 and Nab3 are essential proteins and Paf1 complex members are not. 
Consistent with this argument the possibility exists that the Paf1 complex may act redundantly 
with other RNA polymerase II-associated proteins in stabilizing associations of Nrd1 and Nab3 
with transcribing RNA polymerase II. Based on preliminary TRS31 Northern analyses with RNA 
isolated from transcription-associated mutants, Spt5, Ino80 and Arp8, as well as Rad6 may 
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 function redundantly in 3'-end formation at SNR13 with the Paf1 complex in recruitment and 
stabilization of Nrd1 and Nab3 with elongating RNA polymerase II.  
Several lines of evidence indicate the Paf1 complex associates with Nrd1 and Nab3 in vivo. 
First, Nab3 and Nrd1 co-localize to SNR47 with RNA polymerase II and the Paf1 complex. 
Second, Nrd1 and Nab3 depend on a functional Paf1 complex for proper recruitment to SNR47. 
Finally, both Nrd1 and the Paf1 complex are RNA polymerase II-associated proteins (Conrad et 
al., 2000; Sheldon et al., 2005). Therefore, Co-IP experiments addressed the hypothesis that 
Nrd1 and/or Nab3 physically associate with members of the Paf1 complex in vivo. Protein 
extracts were prepared from strains that contained either CTR9-Myc9 HA3-RTF1 or CTR9-Myc9 
HA3-PAF1 and immunoprecipitation studies were performed (Figure 24). While 
immunoprecipitation efficiency was optimal for Ctr9, Rtf1, Paf1, and Nrd1, there was no 
evidence of strong association between members of the Paf1 complex and Nrd1 (Figure 24). 
Low salt concentrations were utilized in the immunoprecipitation reactions to address the 
possibility of weak associations existed between Nrd1 and the Paf1 complex. The possibility 
remains that associations occur between Nrd1 and the Paf1 complex since they co-localize to 
actively transcribed region of snoRNA genes. Only the soluble protein extracts and not insoluble 
fraction, were tested for the Nrd1-Paf1 complex interaction so it is formally possible that Nrd1-
Paf1 complex interactions occur only in the presence of DNA or RNA.  
How did the observation that multicopy NAB3 suppression of the Spt- phenotype of rtf1-
107 lead to a role for the Paf1 complex in 3'-end formation of nonpolyadenylated RNA 
polymerase II transcripts?  The genetic evidence obtained from the high-copy-number genetic 
screen revealed a second novel genetic interaction between deletion of individual Paf1 complex 
members and the Nab3 associated factor Nrd1. 3'-extended snoRNA transcripts discovered in 
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 paf1Δ, ctr9Δ, and rtf1Δ by Northern blot analyses is a defect that occurs in nrd1 and nab3 mutant 
strains (Carroll et al., 2004; Sheldon et al., 2005; Steinmetz et al., 2001). Further, ChIP 
experiments indicated the Paf1 complex is necessary for the recruitment or stabilization of Nrd1 
and Nab3 with transcribing RNA polymerase II. Therefore, how can we reconcile the genetic 
observations and co-localization to SNR47 without the physical association of Nrd1 and Nab3 
with the Paf1 complex? The explanation may require two answers that are not mutually 
exclusive. First, one plausible explanation is that the Nrd1-Nab3 module associates with one 
region of RNA polymerase II and the Paf1 complex associates with another region. In support of 
this idea, the primary amino acid sequence analysis of Nrd1 indicates that this protein may 
directly interact with the CTD of RNA polymerase II (Meinhart and Cramer, 2004). Further, the 
CTD is adjacent to the RNA exit channel and since Nrd1 and Nab3 each contain an RRM that 
specifically recognizes a different four nucleotide motif within the nascent RNA, the likelihood 
these factors are localized to this region of RNA polymerase II is high (Carroll et al., 2004). The 
largest subunit of RNA polymerase II co-purifies with individual members of the Paf1 complex, 
however the precise subunit or domain of RNA polymerase II required for this interaction is not 
known. The possibility remains that RNA polymerase II does not directly interact with individual 
members of the Paf1 complex rather another RNA polymerase II-associated factor is required for 
the co-precipitation of the Paf1 complex with RNA polymerase II. Perhaps RNA mediates the 
association of the Nrd1-Nab3 module with the Paf1 complex and an RNA of a particular length 
is required for the interaction. Once the message attains the appropriate length it facilitates the 
exchange of the Paf1 complex for Nrd1 and Nab3. Alternatively, the phosphorylation state of the 
CTD may mediate an exchange of factors associated with RNA polymerase II as first postulated 
by the Buratowski lab in the case of polyadenylated transcripts (Kim et al., 2004).  
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 Second, as far as reconciling the genetic observations with the association of transcription 
factors to SNR47 in the absence of physical interactions the effect of NAB3 overexpression on 
individual Paf1 complex deletion mutants was quite striking. The observation that multicopy 
NAB3 enhanced the growth defects of paf1Δ and ctr9Δ suggests the idea that the Paf1 complex 
regulates an inappropriate function of Nab3 (Table 9). The Spt- phenotype of rtf1-107 cells is 
more pronounced than any defect these cells may have in growth. We also observed  that high-
copy-number NAB3 was not a bypass suppressor of the Spt- phenotype conferred by the rtf1 
point mutants (Figure 9).  
5.4.3 TRO analysis did not definitively determine whether the Paf1 complex is involved 
in RNA polymerase II transcript termination 
Tight coupling of 3'-end formation and transcription termination exists in the production of 
RNA polymerase II transcripts (Bentley, 2005; Proudfoot, 2004). The observation that Paf1 
complex member mutants produce 3'-extended snoRNA messages suggests that 1) the Paf1 
complex is required for 3'-end formation or 2) the Paf1 complex is required for snoRNA 
transcription termination. Mutations of nab3 and nrd1 cause the production of 3'-extended 
snoRNA transcripts (Carroll et al., 2004; Sheldon et al., 2005; Steinmetz et al., 2001). However, 
this defect on its own is not enough to ascribe a role for Nrd1 and Nab3 let alone the Paf1 
complex in transcription termination since termination is coupled with 3'-end formation 
(Bentley, 2005; Proudfoot, 2004). TRO assays where the density of RNA polymerase II 
molecules were compared in wild-type, nrd1 or nab3 cells revealed increased density of RNA 
polymerase II molecules beyond sequences required for proper 3'-end formation in the nrd1 and 
nab3 strains (Steinmetz et al., 2001). TRO experiments conducted in wild-type, paf1Δ or nrd1-5 
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 cells tested the hypothesis that the Paf1 complex participates in RNA polymerase II transcription 
termination.  
Wild-type, paf1Δ, and nrd1-5 cells were transformed with the G-less cassette pG-SNR13-
125-232.CYC.ds and pG-CYC.ds constructs for TRO analysis (Figure 26A-26D). The pG-
CYC.ds construct contains the 262 bp G-less cassette separated from the 132 bp G-less by inert 
spacer sequence from the CYC1 gene (Steinmetz and Brow, 2003). The pG-SNR13-125-
232.CYC.ds is similar to the first G-less cassette construct except that the inert spacer DNA is 
replaced with the sequences necessary for transcription termination of the SNR13 transcript 
(Steinmetz and Brow, 2003). All three strains transcribed the inert spacer sequence between the 
G-less cassettes of pG-CYC.ds as indicated by the two G-less cassette transcripts of 262 nt and 
132 nt in length (Figure 26). Alternatively, in strains harboring the pG-SNR13-125-232.CYC.ds 
construct only the 262 nt G-less cassette was observed indicative of no defect in transcription 
termination (Figure 26A and 26B). Even nrd1-5 cells, the positive control for this TRO 
experiment, did not cause an observable defect in transcription termination using this construct 
(Figure 26A and 26B). This result was odd since Nrd1 is involved in 3'-end formation and 
transcription termination of SNR13. In fact the Corden lab argues that Nrd1 is primarily 
responsible for termination at SNR13 and not Nab3 (Carroll et al., 2004). To increase the 
sensitivity of this experiment, cells underwent a temperature shift from 30°C to 37°C for two 
hours prior to TRO analysis. Surprisingly the increased temperature did not contribute to an 
increase in downstream G-less cassette transcription (Figure 26A-26C). This result is also in 
contrast with the moderate temperature sensitivity observed for nrd1-5 mutants (Figure 11). 
However, this observation came from the plasmid shuffle experiment in our strain background 
using a plasmid borne version of nrd1-5 to cover the nrd1Δ mutation, which is lethal (Steinmetz 
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 and Brow, 1996). The TRO experiment utilized a nrd1-5 strain that was not isogenic to the 
S288c background used in our laboratory (Steinmetz and Brow, 1996). The most likely reason 
we did not observe transcription termination defects using the nrd1-5 strain is because this allele 
was not the nrd1 mutant used in TRO experiments (Steinmetz et al., 2001) 
In another effort to determine if the Paf1 complex is involved in transcription termination, 
TRO assays using the sequences required for 3'-end formation of snR47 were performed (Carroll 
et al., 2004; Steinmetz et al., 2001). This experiment involved the subcloning of the seventy base 
pairs required for optimal 3'-end formation of SNR47 into the region between the 262 nt G-less 
and 132 nt G-less cassettes. The resulting construct was pG-SNR47(70)-CYC.ds. pG-CYC.ds 
and pG-SNR47(70).CYC.ds were transformed into wild-type, paf1Δ, ctr9Δ and nrd1-5 cells and 
preliminary experiments were performed (Figure 26A and 26D). Again, the 262 nt and 132 nt G-
less cassettes were observed in RNaseT1 digested RNA construct that contained the inert spacer 
sequence (Figure 26A and 26D). Interestingly, the nrd1-5 cells transformed with the pG-
SNR47(70).CYC.ds construct exhibited the presence of both 262 nt and 132 nt G-less cassettes 
as predicted if Nrd1 participates in transcription termination (Figure 26A and 26D). Surprisingly, 
wild-type cells containing the pG-SNR47(70).CYC.ds construct also exhibited both the 262 nt 
and 132 nt G-less cassettes but the 132 nt band was not as strong as the 132 nt band from the 
nrd1-5 cells (Figure 26D). Most unusually, the paf1Δ cells by virtue of this particular TRO assay 
exhibited the least amount of 132 nt G-less cassette (Figure 26D) and this result would be 
consistent with the idea that the Paf1 complex antagonizes transcription termination. While 
preliminary, two biological replicates were examined in the TRO experiment.   
The results of the TRO analysis together with the observations from the ChIP experiment 
appear to be at odds. The ChIP results indicate, in the absence of the Paf1 complex, almost two 
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 times as much RNA polymerase II signal is associated with the promoter/5' region of YDR042c 
as compared to PAF1 cells (Figure 21C). Meanwhile the TRO experiment indicated that paf1Δ 
cells terminated transcription better that wild-type or nrd1-5 cells using the sequences required 
for 3'-end formation of SNR47 transcripts (Figure 26D). The TRO experiment performed above 
utilized a heterologous template, which may introduce artifacts of the system that cannot be 
accounted for in these experiments. The fact that the positive control for transcription 
termination defects using the pG-SNR13-125-232.CYC.ds construct did not result in the 
predicted manner may indicate that any results of the TRO experiment performed with the pG-
SNR47(70).CYC.ds construct should be suspect. Alternatively, if the model that Nab3 function 
is in part responsible for antagonizing the task of the Paf1 complex in transcription holds, it is 
conceivable that absence of the Paf1 complex results in better transcription termination. 
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5.5 What genes are regulated by the Paf1 complex? 
In one approach to identify Paf1 complex target genes, DNA microarray analysis was 
implemented. By analyzing the expression profiles of individual Paf1 complex member mutants, 
genes that are differentially regulated by different Paf1 complex components may be identified. 
A second complementary approach to identify genes differentially regulated by the Paf1 complex 
relied on genetic interactions with know transcriptional activators and elongation factors. 
5.5.1 Members of the Paf1 complex genetically interact with genes that encode certain 
transcriptional activators 
5.5.1.1 Does the Paf1 complex regulate genes in the SBF pathway? 
The components of the heterodimeric transcriptional activator complex SBF were identified 
in a synthetic lethality screen using an rtf1Δ strain (Costa and Arndt, 2000). SBF regulates the 
transcription of genes required for the G1/S transition of the cell cycle and is composed of Swi4 
and Swi6 (Bean et al., 2005; Ho et al., 1999). Mutations in MBP1, which encodes the DNA-
binding component of a heterodimeric transcriptional activator together with Swi6 (MBF) that is 
analogous to SBF, were not recovered in the synthetic lethal screen with rtf1Δ cells. This result 
was somewhat surprising because the function of SBF and MBF are somewhat redundant (Bean 
et al., 2005). In an effort to confirm that the mutations identified in the synthetic lethality screen 
were caused by recessive mutations in swi4 and swi6, SWI4 and SWI6 were individually deleted 
in our strain background and crossed by rtf1Δ cells. Tetrad dissection and double mutant analysis 
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 revealed that both rtf1Δ swi4Δ and rtf1Δ swi6Δ combinations resulted in lethality (Figure 28). 
Intriguingly, overexpression of either SWI4 or MBP1 in paf1Δ cells partially suppressed the 
temperature sensitivity, caffeine or hydroxyurea phenotypes (Betz et al., 2002; Porter et al., 
2002). A logical explanation for this result is that SBF and members of the Paf1 complex are 
required for the transcription of a set of overlapping genes. In support of this idea, evidence from 
the Jaehning lab indicates that certain members of the Paf1 complex are required for 
transcription of genes expressed during the G1/S phase of the cell cycle (Penheiter et al., 2005; 
Porter et al., 2002). We had previously tried to identify genes regulated by Rtf1 using Northern 
analysis with hybridization probes designed transcripts of genes regulated by SBF. We did not 
observed significant reduction of the transcripts analyzed using total RNA isolated from rtf1Δ 
strains (K. E. Sheldon and K. M. Arndt, unpublished observations). One possible reason for not 
observing a significant decrease in expression of SBF target genes in rtf1Δ cells is that rtf1 
mutant phenotypes are not as severe as paf1Δ or ctr9Δ phenotypes (Betz et al., 2002; Porter et 
al., 2002). The severity of the ctr9Δ and paf1Δ phenotypes could indicate that the SBF-target 
genes are more dependent on the function of Paf1 and Ctr9 as compared to Rtf1.  
5.5.1.2 The Paf1 complex may regulate genes involved in the retrograde signaling pathway 
One high-copy-number library plasmid that suppressed the Spt- phenotype of rtf1-107 
contained RTG3 (Table 8). Rtg3 was a very interesting high-copy-number suppressor candidate 
of the point mutation in RTF1 because it participates in the retrograde (RTG) signaling pathway 
that mediates communication between the mitochondria and nucleus (Epstein et al., 2001; Sekito 
et al., 2000). In particular, Rtg3 forms a heterodimeric transcriptional activator in association 
with Rtg1 and regulates the expression genes that contain R boxes (GGTCAC) within their 
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 upstream activating sequences (Jia et al., 1997; Rothermel et al., 1997). Trans-activation 
domains of Rtg3 map to the amino and carboxyl terminal regions of the protein. When these 
domains are fused in frame with the Gal4 DNA binding domain, are sufficient for the activation 
of  UASG-lacZ reporter constructs in yeast (Jia et al., 1997; Rothermel et al., 1997). Moreover, 
Rtg2 a potential master regulator of RTG signaling that positively regulates Rtg1-Rtg3 is a 
component of the SAGA-like or SLIK coactivator complex, which is important for transcription 
at a subset of genes (Pray-Grant et al., 2002). Analysis of SAGA and the compositionally similar 
SLIK coactivator complex revealed that the Rtg2 component may contribute a potential role for 
SLIK and not SAGA in the regulation of genes in the RTG response pathway by mediating 
activation in trans by the Rtg1-Rtg3 heterodimer  (Liu et al., 2003; Pray-Grant et al., 2002; 
Rothermel et al., 1997; Sekito et al., 2000). To determine if high-copy-number RTG3 was 
responsible for the suppression of the Spt- phenotype of the rtf1 point mutant, RTG3 was 
subcloned into a high-copy-number vector and retransformed into rtf1 strains. Multicopy RTG3 
partially suppressed the Spt- phenotype of rtf1-107 in addition to rtf1-105 and rtf1Δ cells (Figure 
10). The observation that increased dosage of RTG3 partially suppressed the Spt- phenotype of 
the rtf1 point mutants could be explained either in the context of chromatin structure or 
overlapping target genes. Like defects in members of the Paf1 complex mutation of certain 
components of SAGA and SLIK also confer Spt- phenotypes (Winston and Sudarsanam, 1998). 
Therefore, the likelihood exists that increased copies of Rtg3 may compensate for any possible 
defects in chromatin structure attributable to mutations in RTF1, since mutations conferring Spt- 
phenotypes are associated with defects in chromatin structure (Kaplan et al., 2003). 
Alternatively, overexpression of Rtg3 may partially reverse the Spt- phenotype of mutations in 
rtf1 by increasing the recruitment of additional SLIK complexes to the promoters of genes 
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 coordinately regulated by Rtg1-Rtg3 and the Paf1 complex. Support for this explanation comes 
from microarray analyses where a downstream target of RTG, ACO1, was identified as a gene 
that requires Ctr9 for its regulated expression (Table 16). While ACO1 is one example of a gene 
regulated by both Rtg1-Rtg3 (Epstein et al., 2001; Liu et al., 2003; Rothermel et al., 1997) and 
the Paf1 complex, the possibility remains that there are other genes regulated by both complexes. 
However, the ACO1 gene could be a particularly interesting model to study the regulation of 
transcription since RTG signaling regulates its expression in response to carbon and nitrogen 
sources (Pierce et al., 2001) and the Paf1 complex is required for its repression (K. E. Sheldon 
and K. M. Arndt, unpublished observations). 
5.5.2 IMD2 requires the Paf1 complex for proper transcriptional induction in the 
presence of 6AU 
Mutations in genes coding for transcription elongation factors exhibit defects in IMD2 
induction. The IMD2 gene is required for de novo synthesis of purine nucleotides and IMD2 
transcription is induced in the presence of 6AU (Exinger and Lacroute, 1992). Intracellular pools 
of GTP and UTP are reduced in cells treated with 6AU potentially resulting in increased RNA 
polymerase II pausing (Exinger and Lacroute, 1992). Cells lacking transcription elongation 
factors are thought to be more susceptible to RNA polymerase II pausing in response to lowered 
levels of GTP and UTP in cells exposed to 6AU resulting in 6AU sensitivity (Exinger and 
Lacroute, 1992). rpb2-10 and dst1Δ cells exhibited defects in inducing IMD2 in the presence of 
6AU consistent with the idea that Rpb2 and Dst1 act positively to regulate transcription 
elongation (Shaw and Reines, 2000). Since RTF1 interacts with DST1 and other genes encoding 
transcription elongation factors, we asked if Rtf1 and Paf1 were required for IMD2 induction 
(Squazzo et al., 2002). Deletion of RTF1 or PAF1 resulted in impaired IMD2 induction in the 
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 presence of 6AU (Figure 29 and (Squazzo et al., 2002)). This observation alone was not 
sufficient to connect the Paf1 complex to transcription elongation, since impaired IMD2 
induction could result from a defect in transcription initiation. Impaired IMD2 induction in paf1Δ 
and rtf1Δ cells taken together with genetic and biochemical data strongly suggest a role for the 
Paf1 complex in regulating events during transcriptional elongation.  
5.5.3 Microarray analysis identifies genes regulated by Ctr9 
Two color microarray analysis utilizing cDNA prepared from total RNA isolated from 
CTR9 and ctr9Δ cells was performed to identify differentially regulated genes. Using this 
approach, we identified genes that are positively and negatively regulated by Ctr9. SER3 and 
ARG1 both required the Paf1 complex for their repression under noninducing conditions (Figure 
30A-30D; Figure 31A-31D). Consistent with a role for the Paf1 complex in repression of SER3 
and ARG1, microarray analysis performed in the Jaehning lab revealed that absence of Paf1 
caused an increase in SER3 and ARG1 expression (Penheiter et al., 2005). Mechanistically, the 
Paf1 complex may function differently in the repression of SER3 and ARG1. The Paf1 complex 
may indirectly act to repress transcription from SER3 in the presence of serine. The promoter of 
SER3 harbors the SRG1 gene that is transcribed in the presence of serine to repress transcription 
of SER3 via transcriptional interference. Transcription of SRG1 occludes transcriptional 
activators from binding to their cognate sites within the SER3 promoter, thus preventing the 
formation of the PIC and recruitment of RNA polymerase II (Martens et al., 2004). ChIP 
experiments revealed the highest Paf1 complex density over the SRG1 locus with occupancy 
decreasing across the SER3 gene (Figure 31B-30D). Unlike the SRG1-SER3 region, the 
occupancy of the Paf1 complex across ARG1 remains constant (Figure 30B-30D), indicating 
direct association between ARG1 and the Paf1 complex may be required for regulating 
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 transcription of ARG1.  To further understand the mechanism by which the Paf1 complex 
regulates ARG1, the next question to address is what happens to the ARG1-Paf1 complex 
association under inducing conditions. Decreased occupancy across ARG1 would indicate a role 
for the Paf1 complex in forming repressive chromatin structure. This is a possibility since Rtf1 
associates with the chromatin remodeling factor Chd1, which is implicated in regulating the 
transcription of certain genes both positively and negatively (Tran et al., 2000).  
The transcription profiles of paf1Δ and ctr9Δ strains were analyzed by the Jaehning lab and 
their studies suggest a role for the Paf1 complex in regulating the transcription of genes required 
for cell cycle progression through the G1/S phase of the cell cycle (Penheiter et al., 2005; Porter 
et al., 2002). Comparison of transcriptional profiles for each member of the Paf1 complex should 
address whether members of the Paf1 complex perform functions outside of the complex or if 
they function together to regulate the transcription of genes. Since the mutant phenotypes of the 
Paf1 complex do vary in severity, it is possible Paf1 and Ctr9 may be required for the 
transcription of genes outside of the Paf1 complex. However, immunoblotting analysis revealed 
deletion of individual members of the Paf1 complex caused reduction of Paf1 complex 
component levels (Mueller et al., 2004). Further, when individual components of the Paf1 
complex are absent, association of the remaining Paf1 complex members with chromatin drops 
to background levels (Mueller et al., 2004). 
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5.6 What aspects of the Paf1 complex  have been elucidated? 
The goal of my research project was to further define the function of Rtf1 and the Paf1 
complex in coordinating events during transcription elongation. Research from several labs 
indicate the Paf1 complex is important for directing specific histone modifications during 
elongation (Krogan et al., 2002; Krogan et al., 2003; Laribee et al., 2005; Ng et al., 2002). 
However our work is consistent with the Paf1 complex linking transcriptional elongation to 3'-
end formation of the nascent transcript (Sheldon et al., 2005). Observations that the Paf1 
complex is required for regulating the length of the poly(A) tail of polyadenylated transcripts, 
poly(A) site utilization, and 3'-end formation of certain snoRNAs and polyadenylated RNAs 
supports the idea that the Paf1 complex may couple transcription with RNA processing (Mueller 
et al., 2004; Penheiter et al., 2005; Sheldon et al., 2005). 
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 6.0  Chapter 6: Future Directions 
6.1 Introduction 
This study defined new functions for the Paf1 complex and provides the groundwork for 
future investigations. Identification of Ctr9-regulated genes using microarray analysis provided 
an initial list of genes that require Ctr9 for transcriptional regulation. This study provided a basis 
to initiate comparisons between transcription profiles across the individual members of the Paf1 
complex. Once the transcription profiling studies are complete, testing for the direct involvement 
of Paf1 complex members in regulating target genes must be addressed, since the possibility 
exists that only certain members of the Paf1 complex may be essential for transcriptional 
regulation of a subset of yeast genes. Microarray analysis used in my research consisted of 
cDNAs representative of the protein-coding genes in yeast. Therefore, the involvement of the 
Paf1 complex in forming the 3'-ends of SNR13 and SNR47 may not have been discovered using 
conventional microarrays. The high-copy-number genetic screen with rtf1-107 cells identified 
many library plasmids with interesting candidates for further study. A major focus of my 
research came from this multicopy suppressor screen, which revealed a role for the Paf1 complex 
in forming 3'-ends of certain transcripts. Moreover, the possibility remains that the Paf1 complex 
is important for proper 3'-end formation of other snRNA or snoRNA transcripts. To add to the 
understanding of how the Paf1 complex participates in 3'-end formation, new lines of inquiry 
should be directed toward investigating the link between 3'-end formation and snoRNA 
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 processing mediated by the exosome. This section will focus on addressing the important 
questions that remain regarding the function of the Paf1 complex.   
6.1.1 rtf1 point mutations as tools for investigating the function of the Paf1 complex 
Three rtf1 point mutants were isolated and characterized in this study. The resulting amino 
acid substitutions occurred within the central conserved region of Rtf1 (Figure 7). Moreover, the 
three mutants could be categorized by their phenotypes. The rtf1-100 allele (Rtf1-Q17R) 
conferred a conditional Spt- phenotype, while the rtf1-105 and rtf1-107 alleles (Rtf1-V274D and 
Rtf1-M289K, respectively) caused weak Spt- phenotypes and conditional sensitivity to 6AU 
(Figure 6). In addition, immunoblotting analysis revealed that levels of Rtf1 protein were not 
significantly altered when expressed from the point mutations at either 30°C or 37°C (Figure 
8A). Nor did these mutations cause defects in histone H3 K4 trimethylation (Figure 8B). 
Analysis of the rtf1 mutant strains indicated these particular mutations did not result in complete 
loss-of-function of Rtf1 at 30°C (Figure 8A). However, these mutations do result in the 
impairment of certain Rtf1 functions since they confer rtf1Δ mutant phenotypes. What function 
of Rtf1 is it that these missense mutations alter? One possibility is that incorporation of mutant 
Rtf1 protein into the Paf1 complex is impaired. To address this possibility, affinity purification 
using RTF1 and rtf1 mutant strains could be used to determine if less Rtf1 protein is associated 
with the Paf1 complex. ChIP analyses could be implemented to determine whether the Paf1 
complex remains associated with Paf1 complex-regulated genes in RTF1 and rtf1 cells. This 
study could be compared to the situation where cells lacking RTF1 caused impaired Paf1 
complex association with Paf1 complex-regulated genes (Mueller et al., 2004).   
The high-copy-number genetic screen using rtf1-107 cells revealed several interesting 
candidates capable of suppressing the Spt- of rtf1-107.  Performing another multicopy 
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 suppression screen using the rtf1-100 strain could identify similar and non-overlapping dosage 
suppressors capable of suppressing the conditional Spt- phenotype of this strain. The candidate 
multicopy suppressors could provide additional insight into the possible loss of Rtf1 function 
that correlates with the Spt- phenotype.  
6.1.2 Further characterization of multicopy suppressors of rtf1-107 cells 
Investigation of the NAB3 dosage suppressor of rtf1-107 revealed a functional connection 
between an RNA polymerase II-associated elongation factor with proteins involved in 
transcription termination. Library plasmids containing RTG3 and SSD1 may also reveal novel 
functions of the Paf1 complex. These two candidate genes are particularly interesting because 
they have reported functions relevant to RNA polymerase II transcription. Rtg3 is a 
transcriptional activator that regulates the transcription of genes involved in the RTG pathway 
(Velot et al., 1996). One of these genes induced in response to signals between the nucleus and 
mitochondria is ACO1.  Microarray analysis indicates that Paf1 and Ctr9 are both responsible for 
negatively regulating ACO1 transcription (Table 16) (Penheiter et al., 2005). Over expression of 
RTG3 partially suppresses the Spt- phenotype of rtf1 point mutants and rtf1Δ cells (Figure 10), 
indicating that RTF1 and RTG3 genetically interact. To begin to investigate the role of the Paf1 
complex in regulating RTG-target genes, Northern analysis with hybridization probes toward 
ACO1 and other RTG-target genes should be used to analyze their transcript levels in strains 
lacking members of the Paf1 complex and rtg3Δ strains. If transcript levels are altered by 
deletion of individual members of the Paf1 complex, then ChIP analysis should be performed to 
determine whether the Paf1 complex participates directly in the regulation of RTG-target genes.  
A library plasmid that contained SSD1 suppressed the Spt- phenotype of rtf1-107 cells. 
Evidence suggests Ssd1 is important for RNA polymerase II transcription including the 
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 observation that Ssd1 associates with phosphorylated CTD repeats (Kizer et al., 2005), and 
RNA. Furthermore, increased dosage of SSD1 suppresses mutations within SPT16 (A, F, 
O'Donnell and R. A. Singer, personal communication) and genes coding for subunits of RNA 
polymerase I, II, and III (Stettler et al., 1993). The connection between Ssd1 and RNA 
polymerase II transcription indicates SSD1 overexpression is the most likely candidate on library 
isolate 281 important for suppressing the Spt- phenotype of rtf1-107 cells. The first step to 
characterize potential genetic interactions between SSD1 and RTF1 would include subcloning 
SSD1 into a high-copy-number vector to determine if it was capable of suppressing the Spt- 
phenotypes of mutations within RTF1. If multicopy number SSD1 is required for suppressing the 
Spt- phenotype of rtf1 point mutants, then future investigation should focus on the mechanism of 
the observed suppression. For example, does increased dosage of SSD1 bypass the requirement 
for Rtf1? If SSD1 does not bypass the requirement for RTF1, then it is possible that Ssd1 and 
Rtf1 could coordinate events occurring during transcription elongation. In this situation, the Paf1 
complex may be required for the recruitment of Ssd1 to the phosphorylated CTD during 
elongation. ChIP experiments could be used to determine if Ssd1 colocalizes to actively 
transcribed genes and whether this association is dependent upon the Paf1 complex. 
Alternatively, high-copy-number SSD1 could bypass the requirement for the Paf1 complex 
altogether. In this instance, Ssd1 may compensate for Paf1 complex function during transcript 
elongation or other processes that require the Paf1 complex.   
6.1.3 How is the Paf1 complex loaded onto genes? 
Genome-wide expression analysis provided a list of genes that require Ctr9 for proper 
expression. Genes that require Ctr9 for their expression or repression were identified. The Paf1 
complex may be directly involved in repressing transcription from ARG1. Yeast cultures grown 
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 in the absence of arginine could be washed into medium containing arginine and ChIP 
experiments could be used to monitor the association kinetics of factors involved in ARG1 
repression. Replication of this experiment in strains lacking members of the Paf1 complex could 
indicate which ARG1 repressors require the Paf1 complex for their association. Alternatively, the 
ARG1 repressors could be important for recruiting the Paf1 complex to ARG1 for repression 
during growth in medium containing arginine. The Paf1 complex may also be directly involved 
in repressing transcription from the ACO1 locus (Table 16). Therefore, Northern analyses should 
be performed to investigate the transcription of ACO1 in strains lacking individual members of 
the Paf1 complex to verify the results of the Ctr9 microarrays. Activated transcription of ACO1 
is induced in response to the RTG signaling pathway through the transcriptional activator 
complex Rtg1-Rtg3 (Velot et al., 1996). Transcriptional activation of ACO1 by Rtg1-Rtg3 may 
be transduced through SLIK in order to initiate PIC assembly because SLIK is implicated in 
regulating transcription of genes activated by the RTG signaling pathway (Pray-Grant et al., 
2005; Pray-Grant et al., 2002). SLIK contains the chromatin remodeling protein Chd1 and Rtg2 a 
protein that functions upstream of Rtg1-Rtg3 (Pray-Grant et al., 2005). Rtf1 associates with 
Chd1 via two-hybrid interaction (Simic et al., 2003), therefore, performing ChIP analysis in 
CTR9 and ctr9Δ strains may reveal requirements for the Paf1 complex in regulating ACO1 
transcription. 
 
6.1.4 What other factors require the Paf1 complex for association with SNR47? 
The Paf1 complex and CTD Ser-2 phosphorylation are important for the association of 
Nrd1 with SNR47 (Figure 25). Nrd1 association with RNA polymerase II may be mediated 
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 through Ser-2 phosphorylation of the CTD based on the structure of Pcf11 and the similarity 
between the CID of Pcf11 and Nrd1 (Hollingworth et al., 2005; Meinhart and Cramer, 2004; 
Noble et al., 2005). Evidence from the Jaehning lab suggests that association of the Paf1 
complex is required for normal levels of CTD Ser-2 phosphorylation (Mueller et al., 2004). ChIP 
experiments could be performed in PAF1 and paf1Δ cells to determine if the Paf1 complex is 
required for the association of Ctk1 with SNR47. I anticipate that absence of Paf1 would result in 
reduced occupancy of Ctk1 on the SNR47 gene since ctk1Δ rtf1Δ cells are lethal (Costa and 
Arndt, 2000). To test this possibility, ChIP experiments could be performed using an inducible 
RTF1 degron in a ctk1Δ background to determine whether Nrd1 association with SNR47 is 
reduced to background levels upon Rtf1 degradation. 
6.1.5 Determine if deletion of individual Paf1 complex members result in transcription 
termination defects 
Initial attempts to investigate the requirement for the Paf1 complex in transcription 
termination using TRO analysis were inconclusive. ChIP evidence indicates that the level of 
RNA polymerase II is increased over the 5' region of the gene downstream of SNR47, indicating 
a possible role for the Paf1 complex in transcription termination. However, the sensitivity of the 
TRO assays used in this study was too low to determine if there was increased RNA polymerase 
II density downstream of SNR13 termination sequences in the absence of the Paf1 complex or 
even in a nrd1 strain (Figure 26). To further investigate the requirement for the Paf1 complex in 
transcription termination we could implement another version of the TRO assay in PAF1 or 
paf1Δ  cells. This assay is similar to the one we used in the current study but differs in that 
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 radiolabeled transcripts are hybridized to specific, immobilized DNA sequences corresponding 
to regions within and downstream of the SNR genes of interest. The benefit of this TRO method 
is that the investigator chooses the loci to analyze and TRO does not depend on heterologous 
sequences.  
Results from the Jaehning lab indicated that the Paf1 complex is involved in the 3'-end 
formation of certain polyadenylated transcripts and that 3'-extended mRNAs produced in strains 
lacking Paf1 were targets for nonsense-mediated decay (Penheiter et al., 2005).  These 
observations are consistent with a role for the Paf1 complex in linking RNA processing factors 
with transcription. Our work revealed the requirement for the Paf1 complex in recruiting 
termination factors to snoRNAs. However, due to the limit of resolution of ChIP analysis and 
short length of snoRNAs (approximately 100 bp) less information is known about recruitment of 
such factors to these genes. Analysis of recruitment of these factors to a heterologous gene 
containing a snoRNA promoter and snoRNA termination sequences flanking a protein coding 
gene could reveal a more detailed description of how these factors are recruited, what proteins 
are required for association, and perhaps whether the Paf1 complex is important for transcription 
termination. 
6.1.6 Investigate interactions between the Paf1 complex and RNA metabolism 
If the Paf1 complex and other RNA polymerase II-associated factors are not important for 
elongation rate or processivity of RNA polymerase II, then exactly what function are these 
proteins responsible for? Emerging evidence suggests these proteins may be involved in coupling 
RNA polymerase II transcription with RNA processing. In support of this idea, we have 
presented compelling evidence that the Paf1 complex is required for the association of  the Nrd1-
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 Nab3 transcription termination factors with regions of SNR47 important for transcript 
termination (Figure 21 and Figure 22). Is the Paf1 complex involved in coordinating the 
association of other factors important for RNA processing during RNA polymerase II 
transcription? Addressing this question requires knowledge of RNA processing events occurring 
during transcription and what proteins are involved in regulating them. Future studies including 
reconstituting 3'-end formation in vitro may be utilized to analyze factors involved in the process 
and to identify new factors that are important for 3'-end formation. Including different templates 
in reconstituted 3'-end formation could also provide information on what genes require the Paf1 
complex for 3'-end formation and could provide information regarding specific sequence 
requirements for 3'-end formation of this transcript.  
6.1.6.1 Is the Paf1 complex linked with exosome function? 
A complex that associates with the open reading frames of RNA polymerase II transcribed 
genes is the nuclear exosome complex (Andrulis et al., 2002; Haile et al., 2003). The exosome 
possesses 3'-5' exonuclease activity involved in maturation of snRNA and snoRNA transcripts in 
addition to polyadenylated transcripts (Estevez et al., 2003; LaCava et al., 2005; Mitchell et al., 
2003; Mitchell and Tollervey, 2003). The exosome and the Ski complex, another multisubunit 
complex with RNA helicase function, have been implicated in the degradation of cytoplasmic 
mRNAs (Mitchell and Tollervey, 2003; Roth et al., 2005; Vanacova et al., 2005; Wyers et al., 
2005). Moreover, subunits of the exosome have been shown to physically interact with members 
of the Ski complex indicating both complexes are important for regulated RNA decay. 
Components of the human Paf1 complex have been shown to associate in vivo with components 
of the Ski complex (Yart et al., 2005). However, the question remains whether the Paf1 complex 
is involved in linking the Ski complex to actively transcribed genes through interactions with the 
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 exosome. ChIP experiments could be used to determine whether association of the exosome and 
Ski complex depends on the Paf1 complex.  In this model, the exosome and the Ski complex 
could participate in maturation of the nascent transcript or in RNA surveillance within the 
nucleus during transcript elongation.  
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6.2 Summary 
In conclusion, my research has extended the function of the Paf1 complex to a role in 
linking RNA processing factors to elongating RNA polymerase II. My data supports the idea that 
the Paf1 complex is important for recruiting transcription termination factors. This function of 
the Paf1 complex appears to be distinct from its role in coordinating histone modifications with 
actively transcribed genes. However, it remains a possibility that certain histone modifications 
are important for events that occur during transcript elongation since a component of the 
COMPASS histone methyltransferase, Swd2, is also involved in proper 3'-end formation of 
snoRNAs (Cheng et al., 2004; Dichtl et al., 2004). The future directions outlined above propose 
experiments that could provide insight into how the Paf1 complex could coordinate such events. 
Further downstream genetic and biochemical studies could reveal how the Paf1 complex fits 
within the bigger picture of co-transcriptional RNA processing events and their regulation.  
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